Query 038552
Match_columns 659
No_of_seqs 541 out of 5244
Neff 10.6
Searched_HMMs 46136
Date Fri Mar 29 12:13:28 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/038552.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/038552hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PLN00113 leucine-rich repeat r 100.0 7.8E-66 1.7E-70 593.5 46.1 483 6-498 139-621 (968)
2 PLN00113 leucine-rich repeat r 100.0 7.6E-55 1.7E-59 502.3 37.6 478 2-485 88-585 (968)
3 KOG4194 Membrane glycoprotein 100.0 3.2E-39 7E-44 314.8 7.9 373 34-465 81-456 (873)
4 KOG0472 Leucine-rich repeat pr 100.0 8.1E-42 1.7E-46 318.7 -11.2 452 8-484 46-541 (565)
5 KOG4194 Membrane glycoprotein 100.0 2.2E-37 4.8E-42 302.0 7.4 395 58-486 55-454 (873)
6 KOG0472 Leucine-rich repeat pr 100.0 2.8E-40 6.1E-45 308.4 -13.5 434 2-461 63-541 (565)
7 KOG0618 Serine/threonine phosp 100.0 1.6E-36 3.4E-41 311.9 -7.1 444 9-484 23-489 (1081)
8 KOG0444 Cytoskeletal regulator 100.0 1.7E-34 3.6E-39 284.0 -0.3 373 52-466 4-380 (1255)
9 KOG0444 Cytoskeletal regulator 100.0 2E-34 4.3E-39 283.5 -2.2 369 4-437 4-375 (1255)
10 KOG0618 Serine/threonine phosp 100.0 3.9E-33 8.4E-38 287.0 -5.7 442 11-482 2-463 (1081)
11 PLN03210 Resistant to P. syrin 99.9 7.4E-24 1.6E-28 244.7 26.9 317 71-411 580-904 (1153)
12 PLN03210 Resistant to P. syrin 99.9 1.1E-22 2.5E-27 234.9 26.9 338 73-434 552-903 (1153)
13 KOG4237 Extracellular matrix p 99.9 2.5E-25 5.5E-30 208.4 -4.4 283 57-340 69-359 (498)
14 KOG4237 Extracellular matrix p 99.9 5.8E-25 1.2E-29 206.0 -3.0 285 22-315 60-358 (498)
15 PRK15387 E3 ubiquitin-protein 99.8 1.2E-19 2.6E-24 194.3 18.4 264 32-347 202-465 (788)
16 PRK15387 E3 ubiquitin-protein 99.8 1.5E-19 3.2E-24 193.7 17.9 265 128-444 201-465 (788)
17 PRK15370 E3 ubiquitin-protein 99.8 5.2E-18 1.1E-22 183.2 13.9 246 153-437 179-428 (754)
18 cd00116 LRR_RI Leucine-rich re 99.8 2.3E-19 4.9E-24 180.9 3.0 208 11-221 2-236 (319)
19 PRK15370 E3 ubiquitin-protein 99.8 2.5E-18 5.5E-23 185.6 10.8 245 33-316 180-428 (754)
20 cd00116 LRR_RI Leucine-rich re 99.7 2.3E-19 5E-24 180.9 0.9 282 156-459 2-318 (319)
21 KOG0617 Ras suppressor protein 99.7 3.7E-19 8.1E-24 147.9 -4.7 165 3-174 29-194 (264)
22 KOG0617 Ras suppressor protein 99.7 6.3E-19 1.4E-23 146.5 -4.1 158 251-437 29-186 (264)
23 PLN03150 hypothetical protein; 99.5 5.2E-14 1.1E-18 152.0 11.9 118 377-497 419-538 (623)
24 KOG0532 Leucine-rich repeat (L 99.3 1.1E-13 2.3E-18 137.0 -4.0 194 254-458 74-270 (722)
25 KOG1909 Ran GTPase-activating 99.2 1.5E-12 3.2E-17 121.7 -1.0 62 279-340 157-226 (382)
26 KOG0532 Leucine-rich repeat (L 99.2 1.6E-12 3.4E-17 128.9 -3.0 171 9-189 77-247 (722)
27 KOG1259 Nischarin, modulator o 99.1 1.6E-11 3.5E-16 112.1 2.6 130 346-482 279-410 (490)
28 PLN03150 hypothetical protein; 99.1 8.9E-11 1.9E-15 127.1 8.7 110 356-465 422-532 (623)
29 COG4886 Leucine-rich repeat (L 99.1 1.1E-10 2.3E-15 121.1 7.9 180 253-465 114-294 (394)
30 KOG1909 Ran GTPase-activating 99.1 1.4E-11 3E-16 115.3 1.0 198 251-460 88-310 (382)
31 KOG3207 Beta-tubulin folding c 99.1 1.7E-11 3.6E-16 118.0 1.3 209 253-462 119-340 (505)
32 COG4886 Leucine-rich repeat (L 99.1 1.3E-10 2.9E-15 120.4 8.1 199 209-442 96-295 (394)
33 KOG1259 Nischarin, modulator o 99.1 2.7E-11 5.8E-16 110.7 1.0 133 325-464 282-415 (490)
34 KOG3207 Beta-tubulin folding c 99.0 4.9E-11 1.1E-15 114.9 1.3 161 29-190 119-285 (505)
35 KOG4658 Apoptotic ATPase [Sign 99.0 2.1E-10 4.5E-15 126.7 6.2 127 8-138 524-652 (889)
36 PF14580 LRR_9: Leucine-rich r 99.0 2.7E-10 6E-15 100.3 4.5 127 29-160 17-148 (175)
37 PF14580 LRR_9: Leucine-rich r 99.0 2.9E-10 6.3E-15 100.1 4.4 83 372-455 60-147 (175)
38 KOG4658 Apoptotic ATPase [Sign 99.0 5.4E-10 1.2E-14 123.5 6.5 128 31-162 523-652 (889)
39 PF13855 LRR_8: Leucine rich r 98.8 2.2E-09 4.8E-14 77.5 3.2 59 377-435 2-60 (61)
40 PF13855 LRR_8: Leucine rich r 98.8 2.6E-09 5.7E-14 77.1 2.7 61 400-460 1-61 (61)
41 KOG1859 Leucine-rich repeat pr 98.8 1.2E-10 2.7E-15 118.8 -5.8 123 357-485 169-293 (1096)
42 KOG0531 Protein phosphatase 1, 98.8 1.3E-09 2.8E-14 113.0 -0.1 57 378-437 234-290 (414)
43 KOG0531 Protein phosphatase 1, 98.7 2.8E-09 6.1E-14 110.5 0.7 214 233-461 74-290 (414)
44 KOG1859 Leucine-rich repeat pr 98.6 1.2E-09 2.6E-14 111.8 -5.7 128 328-462 165-293 (1096)
45 KOG1187 Serine/threonine prote 98.6 7.3E-08 1.6E-12 96.9 6.6 68 572-652 285-354 (361)
46 KOG2120 SCF ubiquitin ligase, 98.4 6E-09 1.3E-13 95.6 -5.6 158 128-290 185-349 (419)
47 KOG2120 SCF ubiquitin ligase, 98.3 3.1E-08 6.7E-13 91.1 -4.3 180 104-289 186-373 (419)
48 COG5238 RNA1 Ran GTPase-activa 98.2 3.9E-07 8.4E-12 82.9 1.5 120 199-340 85-227 (388)
49 KOG2982 Uncharacterized conser 98.2 6.9E-07 1.5E-11 82.4 2.8 186 29-220 69-263 (418)
50 COG5238 RNA1 Ran GTPase-activa 98.2 1.7E-07 3.6E-12 85.2 -1.2 66 251-316 210-285 (388)
51 KOG4579 Leucine-rich repeat (L 98.2 1.6E-07 3.6E-12 76.1 -1.3 84 376-461 53-136 (177)
52 KOG2982 Uncharacterized conser 98.1 8.5E-07 1.8E-11 81.8 1.0 187 254-462 70-263 (418)
53 KOG4579 Leucine-rich repeat (L 98.0 5E-07 1.1E-11 73.4 -2.4 105 257-365 29-136 (177)
54 PRK15386 type III secretion pr 97.9 3.9E-05 8.5E-10 76.5 8.2 57 251-313 48-104 (426)
55 KOG3665 ZYG-1-like serine/thre 97.8 6E-06 1.3E-10 89.5 1.5 119 102-222 147-266 (699)
56 PF12799 LRR_4: Leucine Rich r 97.8 3.3E-05 7E-10 50.8 3.6 35 402-437 3-37 (44)
57 KOG4341 F-box protein containi 97.8 8.3E-07 1.8E-11 85.8 -5.6 136 204-339 292-438 (483)
58 PF13306 LRR_5: Leucine rich r 97.7 9E-05 1.9E-09 63.1 7.1 122 26-154 7-128 (129)
59 PF12799 LRR_4: Leucine Rich r 97.7 3.7E-05 8E-10 50.5 3.4 36 56-92 2-37 (44)
60 KOG4341 F-box protein containi 97.7 1.7E-06 3.6E-11 83.8 -4.7 110 252-362 317-436 (483)
61 PRK15386 type III secretion pr 97.7 0.00018 3.9E-09 71.8 8.9 134 277-434 50-187 (426)
62 PF13306 LRR_5: Leucine rich r 97.6 0.00017 3.8E-09 61.3 7.2 105 3-112 8-112 (129)
63 KOG1644 U2-associated snRNP A' 97.6 0.00016 3.5E-09 63.4 6.0 58 57-116 44-101 (233)
64 KOG3665 ZYG-1-like serine/thre 97.6 3.4E-05 7.4E-10 83.8 2.4 135 31-168 122-266 (699)
65 KOG1644 U2-associated snRNP A' 97.5 0.00016 3.4E-09 63.5 5.3 127 10-140 22-152 (233)
66 KOG2739 Leucine-rich acidic nu 96.8 0.001 2.2E-08 61.2 3.0 65 26-92 38-104 (260)
67 KOG2123 Uncharacterized conser 96.7 7.6E-05 1.6E-09 68.6 -4.8 87 30-120 18-105 (388)
68 KOG2739 Leucine-rich acidic nu 96.3 0.0033 7.3E-08 57.9 3.3 66 372-437 61-129 (260)
69 KOG2123 Uncharacterized conser 96.2 0.00025 5.5E-09 65.3 -4.2 95 356-454 23-123 (388)
70 KOG4308 LRR-containing protein 96.1 2.2E-05 4.8E-10 81.5 -13.3 168 147-316 110-303 (478)
71 KOG1947 Leucine rich repeat pr 96.0 0.0019 4.2E-08 69.1 0.1 111 30-140 187-307 (482)
72 KOG1187 Serine/threonine prote 95.2 0.0054 1.2E-07 62.0 0.1 49 549-598 61-109 (361)
73 KOG1947 Leucine rich repeat pr 95.1 0.0042 9.1E-08 66.5 -1.0 16 299-314 358-373 (482)
74 KOG4308 LRR-containing protein 94.7 0.00034 7.4E-09 72.8 -10.1 188 257-461 89-303 (478)
75 PF00560 LRR_1: Leucine Rich R 94.7 0.016 3.5E-07 31.4 1.1 10 58-67 3-12 (22)
76 PF00560 LRR_1: Leucine Rich R 94.6 0.017 3.7E-07 31.3 1.1 12 426-437 2-13 (22)
77 cd05038 PTKc_Jak_rpt2 Catalyti 91.9 0.11 2.5E-06 50.8 2.7 31 621-651 254-284 (284)
78 KOG0473 Leucine-rich repeat pr 91.7 0.0051 1.1E-07 55.4 -6.1 88 26-116 37-124 (326)
79 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 90.2 0.22 4.8E-06 48.8 3.0 31 621-651 254-284 (284)
80 cd05063 PTKc_EphR_A2 Catalytic 89.7 0.33 7.1E-06 47.1 3.6 30 621-650 238-267 (268)
81 KOG0473 Leucine-rich repeat pr 89.5 0.0076 1.6E-07 54.3 -7.1 84 53-140 40-123 (326)
82 cd05094 PTKc_TrkC Catalytic do 89.5 0.34 7.3E-06 47.8 3.6 33 621-653 253-285 (291)
83 cd05045 PTKc_RET Catalytic dom 88.7 0.43 9.3E-06 47.0 3.7 31 621-651 257-287 (290)
84 cd05080 PTKc_Tyk2_rpt2 Catalyt 88.4 0.38 8.2E-06 47.1 3.1 31 621-651 252-282 (283)
85 PF13504 LRR_7: Leucine rich r 88.2 0.31 6.6E-06 24.4 1.2 11 81-91 3-13 (17)
86 cd05033 PTKc_EphR Catalytic do 88.0 0.49 1.1E-05 45.8 3.6 29 622-650 237-265 (266)
87 smart00370 LRR Leucine-rich re 87.7 0.53 1.2E-05 26.6 2.2 21 103-124 2-22 (26)
88 smart00369 LRR_TYP Leucine-ric 87.7 0.53 1.2E-05 26.6 2.2 21 103-124 2-22 (26)
89 KOG3864 Uncharacterized conser 87.6 0.076 1.6E-06 47.2 -2.1 82 31-112 101-185 (221)
90 cd05052 PTKc_Abl Catalytic dom 87.3 0.59 1.3E-05 45.2 3.6 29 622-650 234-262 (263)
91 cd05053 PTKc_FGFR Catalytic do 87.2 0.59 1.3E-05 46.0 3.7 31 621-651 262-292 (293)
92 PF13516 LRR_6: Leucine Rich r 87.0 0.2 4.4E-06 27.7 0.1 20 6-25 1-20 (24)
93 smart00370 LRR Leucine-rich re 86.7 0.71 1.5E-05 26.0 2.3 16 424-439 2-17 (26)
94 smart00369 LRR_TYP Leucine-ric 86.7 0.71 1.5E-05 26.0 2.3 16 424-439 2-17 (26)
95 cd05097 PTKc_DDR_like Catalyti 86.6 0.55 1.2E-05 46.3 3.1 28 621-648 267-294 (295)
96 cd05148 PTKc_Srm_Brk Catalytic 86.5 0.56 1.2E-05 45.2 3.0 28 622-649 233-260 (261)
97 cd05102 PTKc_VEGFR3 Catalytic 86.5 0.62 1.3E-05 47.1 3.5 31 622-652 306-336 (338)
98 cd05093 PTKc_TrkB Catalytic do 86.0 0.74 1.6E-05 45.2 3.6 32 622-653 251-282 (288)
99 PF07714 Pkinase_Tyr: Protein 85.9 0.59 1.3E-05 45.1 2.8 26 622-647 234-259 (259)
100 cd05054 PTKc_VEGFR Catalytic d 85.9 0.71 1.5E-05 46.6 3.5 32 621-652 304-335 (337)
101 cd05112 PTKc_Itk Catalytic dom 85.7 0.64 1.4E-05 44.6 3.0 27 621-647 229-255 (256)
102 cd05068 PTKc_Frk_like Catalyti 85.6 0.64 1.4E-05 44.8 2.9 29 621-649 232-260 (261)
103 cd05074 PTKc_Tyro3 Catalytic d 85.5 0.7 1.5E-05 44.9 3.1 31 621-651 243-273 (273)
104 cd05089 PTKc_Tie1 Catalytic do 85.4 0.9 2E-05 44.9 4.0 33 622-654 247-279 (297)
105 cd05114 PTKc_Tec_Rlk Catalytic 85.2 0.71 1.5E-05 44.4 3.0 27 621-647 229-255 (256)
106 cd05051 PTKc_DDR Catalytic dom 85.1 0.68 1.5E-05 45.7 2.9 28 621-648 268-295 (296)
107 cd05048 PTKc_Ror Catalytic Dom 84.8 0.65 1.4E-05 45.4 2.6 29 621-649 254-282 (283)
108 cd05058 PTKc_Met_Ron Catalytic 84.7 0.87 1.9E-05 43.9 3.4 30 622-651 231-260 (262)
109 cd05047 PTKc_Tie Catalytic dom 84.6 0.88 1.9E-05 44.2 3.4 29 622-650 240-268 (270)
110 cd08228 STKc_Nek6 Catalytic do 84.6 0.92 2E-05 43.9 3.5 30 622-651 237-266 (267)
111 cd05050 PTKc_Musk Catalytic do 84.6 0.74 1.6E-05 45.2 2.8 28 621-648 260-287 (288)
112 PHA02988 hypothetical protein; 84.4 0.97 2.1E-05 44.3 3.6 31 622-652 251-281 (283)
113 cd08528 STKc_Nek10 Catalytic d 84.4 0.82 1.8E-05 44.3 3.1 26 623-648 243-268 (269)
114 cd05095 PTKc_DDR2 Catalytic do 83.9 0.99 2.1E-05 44.5 3.4 28 621-648 268-295 (296)
115 cd05104 PTKc_Kit Catalytic dom 83.8 0.84 1.8E-05 46.9 3.0 28 622-649 346-373 (375)
116 cd05111 PTK_HER3 Pseudokinase 83.7 1.3 2.8E-05 43.3 4.1 31 622-652 240-270 (279)
117 cd05043 PTK_Ryk Pseudokinase d 83.5 1.1 2.3E-05 43.8 3.5 31 622-652 248-278 (280)
118 cd05066 PTKc_EphR_A Catalytic 83.5 1.1 2.3E-05 43.4 3.5 29 622-650 238-266 (267)
119 cd05075 PTKc_Axl Catalytic dom 83.3 1.1 2.4E-05 43.4 3.6 29 622-650 243-271 (272)
120 cd05072 PTKc_Lyn Catalytic dom 83.3 0.91 2E-05 43.7 2.9 28 622-649 233-260 (261)
121 cd05060 PTKc_Syk_like Catalyti 83.2 0.84 1.8E-05 43.9 2.6 31 621-651 226-256 (257)
122 cd08229 STKc_Nek7 Catalytic do 83.2 1.2 2.7E-05 42.9 3.8 29 622-650 237-265 (267)
123 cd05035 PTKc_Axl_like Catalyti 83.1 1.1 2.4E-05 43.4 3.4 30 621-650 243-272 (273)
124 cd05098 PTKc_FGFR1 Catalytic d 83.0 1.5 3.3E-05 43.5 4.4 32 622-653 271-302 (307)
125 cd05065 PTKc_EphR_B Catalytic 82.8 1.1 2.5E-05 43.3 3.3 29 622-650 240-268 (269)
126 cd05096 PTKc_DDR1 Catalytic do 82.5 1.1 2.4E-05 44.4 3.2 28 621-648 276-303 (304)
127 cd05085 PTKc_Fer Catalytic dom 82.5 0.96 2.1E-05 43.2 2.6 28 621-648 222-249 (250)
128 cd05101 PTKc_FGFR2 Catalytic d 82.3 1.3 2.8E-05 43.9 3.6 31 622-652 268-298 (304)
129 cd08224 STKc_Nek6_Nek7 Catalyt 81.9 1.4 3.1E-05 42.4 3.7 30 622-651 237-266 (267)
130 cd05103 PTKc_VEGFR2 Catalytic 81.8 1.3 2.7E-05 45.0 3.3 31 622-652 311-341 (343)
131 cd05059 PTKc_Tec_like Catalyti 81.4 1.1 2.4E-05 43.0 2.7 27 621-647 229-255 (256)
132 cd05106 PTKc_CSF-1R Catalytic 81.4 1.3 2.9E-05 45.4 3.3 29 622-650 344-372 (374)
133 cd05079 PTKc_Jak1_rpt2 Catalyt 81.3 1.4 3.1E-05 43.1 3.4 30 621-650 254-283 (284)
134 KOG3864 Uncharacterized conser 81.0 0.23 4.9E-06 44.3 -2.0 35 151-185 150-185 (221)
135 cd05084 PTKc_Fes Catalytic dom 81.0 1.3 2.8E-05 42.3 3.0 28 621-648 224-251 (252)
136 cd05062 PTKc_IGF-1R Catalytic 80.9 1.1 2.3E-05 43.7 2.4 27 622-648 250-276 (277)
137 cd05064 PTKc_EphR_A10 Catalyti 80.4 1.7 3.6E-05 42.1 3.5 29 622-650 237-265 (266)
138 cd05110 PTKc_HER4 Catalytic do 80.1 1.8 3.9E-05 42.8 3.7 31 622-652 240-270 (303)
139 cd05039 PTKc_Csk_like Catalyti 79.7 1.3 2.8E-05 42.5 2.5 29 622-650 228-256 (256)
140 cd05099 PTKc_FGFR4 Catalytic d 79.2 2.5 5.4E-05 42.1 4.4 32 622-653 265-296 (314)
141 cd05091 PTKc_Ror2 Catalytic do 79.2 1.5 3.3E-05 42.8 2.8 27 622-648 255-281 (283)
142 cd05082 PTKc_Csk Catalytic dom 79.0 1.5 3.2E-05 42.2 2.6 29 622-650 228-256 (256)
143 cd05078 PTK_Jak2_Jak3_rpt1 Pse 78.5 1.3 2.8E-05 42.7 2.0 27 622-648 232-258 (258)
144 cd05055 PTKc_PDGFR Catalytic d 78.3 2.1 4.6E-05 42.4 3.6 29 622-650 273-301 (302)
145 cd05105 PTKc_PDGFR_alpha Catal 78.2 1.8 3.8E-05 44.9 3.0 30 622-651 369-398 (400)
146 cd05116 PTKc_Syk Catalytic dom 78.0 1.7 3.6E-05 41.8 2.7 28 622-649 227-254 (257)
147 cd05088 PTKc_Tie2 Catalytic do 77.8 2.3 4.9E-05 42.2 3.6 31 622-652 252-282 (303)
148 cd05100 PTKc_FGFR3 Catalytic d 77.0 2.5 5.4E-05 42.6 3.7 31 622-652 265-295 (334)
149 cd05056 PTKc_FAK Catalytic dom 76.9 2.7 5.7E-05 40.7 3.8 31 622-652 237-267 (270)
150 cd05113 PTKc_Btk_Bmx Catalytic 76.7 1.9 4.2E-05 41.4 2.7 28 621-648 229-256 (256)
151 cd05071 PTKc_Src Catalytic dom 76.3 2.8 6.1E-05 40.4 3.7 29 621-649 231-259 (262)
152 cd05061 PTKc_InsR Catalytic do 76.2 2.2 4.7E-05 41.9 3.0 31 621-651 249-279 (288)
153 cd05107 PTKc_PDGFR_beta Cataly 76.1 2.2 4.8E-05 44.2 3.1 29 622-650 371-399 (401)
154 cd05070 PTKc_Fyn_Yrk Catalytic 75.8 2.5 5.4E-05 40.6 3.2 29 621-649 231-259 (260)
155 cd05036 PTKc_ALK_LTK Catalytic 74.9 2.7 5.9E-05 40.9 3.3 28 621-648 249-276 (277)
156 cd05044 PTKc_c-ros Catalytic d 74.4 2.7 5.9E-05 40.6 3.1 27 622-648 242-268 (269)
157 cd05076 PTK_Tyk2_rpt1 Pseudoki 74.3 2.4 5.2E-05 41.2 2.7 26 622-647 248-273 (274)
158 cd05086 PTKc_Aatyk2 Catalytic 74.3 4.6 0.0001 39.0 4.7 20 628-648 248-267 (268)
159 cd05108 PTKc_EGFR Catalytic do 73.9 3.1 6.8E-05 41.4 3.5 31 622-652 240-270 (316)
160 cd05040 PTKc_Ack_like Catalyti 73.8 3.1 6.7E-05 39.8 3.3 28 621-648 229-256 (257)
161 cd05092 PTKc_TrkA Catalytic do 73.2 2.6 5.7E-05 41.1 2.7 27 622-648 253-279 (280)
162 cd05073 PTKc_Hck Catalytic dom 73.2 2.9 6.3E-05 40.2 3.0 28 622-649 232-259 (260)
163 cd05090 PTKc_Ror1 Catalytic do 72.8 3.1 6.7E-05 40.6 3.1 28 622-649 255-282 (283)
164 cd05069 PTKc_Yes Catalytic dom 72.7 3.4 7.4E-05 39.7 3.3 28 622-649 232-259 (260)
165 cd05032 PTKc_InsR_like Catalyt 71.9 3.2 7E-05 40.2 3.0 28 621-648 249-276 (277)
166 cd05083 PTKc_Chk Catalytic dom 71.9 3 6.6E-05 39.9 2.7 27 622-648 226-252 (254)
167 cd05049 PTKc_Trk Catalytic dom 71.3 3.8 8.2E-05 39.8 3.3 27 622-648 253-279 (280)
168 cd05067 PTKc_Lck_Blk Catalytic 71.2 3.6 7.8E-05 39.5 3.1 28 622-649 232-259 (260)
169 cd05041 PTKc_Fes_like Catalyti 70.8 3.4 7.3E-05 39.4 2.8 27 622-648 224-250 (251)
170 cd00192 PTKc Catalytic domain 70.7 3.2 7E-05 39.7 2.6 27 622-648 236-262 (262)
171 cd05109 PTKc_HER2 Catalytic do 69.7 4 8.7E-05 39.7 3.1 32 622-653 240-271 (279)
172 smart00750 KIND kinase non-cat 68.6 5.4 0.00012 35.5 3.5 32 621-652 140-171 (176)
173 cd08217 STKc_Nek2 Catalytic do 67.8 3.7 8E-05 39.4 2.4 26 621-646 237-262 (265)
174 cd05034 PTKc_Src_like Catalyti 67.3 4.8 0.0001 38.6 3.1 28 622-649 233-260 (261)
175 cd05037 PTK_Jak_rpt1 Pseudokin 66.7 3.7 8.1E-05 39.3 2.1 27 621-647 232-258 (259)
176 smart00220 S_TKc Serine/Threon 66.2 4.7 0.0001 37.9 2.7 25 621-645 216-240 (244)
177 cd05077 PTK_Jak1_rpt1 Pseudoki 65.1 4.6 9.9E-05 38.9 2.4 26 622-647 236-261 (262)
178 smart00365 LRR_SD22 Leucine-ri 64.3 6.1 0.00013 22.4 1.8 13 401-413 3-15 (26)
179 cd06642 STKc_STK25-YSK1 Cataly 64.3 5.8 0.00012 38.5 3.0 25 622-646 229-253 (277)
180 smart00219 TyrKc Tyrosine kina 63.9 5 0.00011 38.3 2.4 26 622-647 233-258 (258)
181 cd08529 STKc_FA2-like Catalyti 62.9 5.8 0.00013 37.8 2.7 24 622-645 229-252 (256)
182 cd05115 PTKc_Zap-70 Catalytic 62.2 7.2 0.00016 37.4 3.2 29 622-650 227-255 (257)
183 cd08218 STKc_Nek1 Catalytic do 61.7 5.7 0.00012 38.0 2.3 24 622-645 229-252 (256)
184 KOG0192 Tyrosine kinase specif 61.5 12 0.00025 38.1 4.5 34 622-655 275-308 (362)
185 cd05046 PTK_CCK4 Pseudokinase 61.3 7.1 0.00015 37.8 3.0 28 621-648 247-274 (275)
186 KOG0194 Protein tyrosine kinas 61.1 8.9 0.00019 40.0 3.7 27 627-653 397-423 (474)
187 smart00368 LRR_RI Leucine rich 59.5 4.8 0.0001 23.2 0.8 14 7-20 2-15 (28)
188 KOG2345 Serine/threonine prote 59.4 11 0.00023 35.3 3.4 29 622-650 272-300 (302)
189 cd07835 STKc_CDK1_like Catalyt 58.9 6 0.00013 38.5 2.0 25 621-645 255-279 (283)
190 PF04478 Mid2: Mid2 like cell 58.9 5.3 0.00011 33.9 1.3 27 507-533 50-76 (154)
191 cd06621 PKc_MAPKK_Pek1_like Ca 58.6 8.2 0.00018 37.7 2.9 24 622-645 242-265 (287)
192 cd07846 STKc_CDKL2_3 Catalytic 58.6 6.8 0.00015 38.2 2.3 25 621-645 258-282 (286)
193 cd08223 STKc_Nek4 Catalytic do 57.6 7.7 0.00017 37.0 2.5 24 622-645 230-253 (257)
194 cd07830 STKc_MAK_like Catalyti 57.1 8.9 0.00019 37.3 2.9 25 621-645 255-279 (283)
195 smart00364 LRR_BAC Leucine-ric 56.7 7.2 0.00016 22.0 1.2 13 425-437 3-15 (26)
196 cd06620 PKc_MAPKK_Byr1_like Ca 56.6 6.5 0.00014 38.3 1.8 27 622-648 242-268 (284)
197 cd05057 PTKc_EGFR_like Catalyt 56.3 13 0.00027 36.2 3.8 31 622-652 240-270 (279)
198 PF01102 Glycophorin_A: Glycop 54.8 7 0.00015 32.1 1.4 25 512-536 70-94 (122)
199 cd07833 STKc_CDKL Catalytic do 54.4 7.5 0.00016 37.9 1.8 25 621-645 260-284 (288)
200 cd06606 STKc_MAPKKK Catalytic 54.3 10 0.00022 36.1 2.7 24 622-645 233-256 (260)
201 cd06624 STKc_ASK Catalytic dom 54.2 10 0.00023 36.4 2.8 24 622-645 241-264 (268)
202 cd08220 STKc_Nek8 Catalytic do 53.5 9.1 0.0002 36.5 2.2 24 622-645 229-252 (256)
203 KOG4242 Predicted myosin-I-bin 53.2 76 0.0016 32.9 8.4 37 304-340 414-453 (553)
204 cd06638 STKc_myosinIIIA Cataly 53.1 11 0.00024 36.6 2.9 25 622-646 259-283 (286)
205 cd06612 STKc_MST1_2 Catalytic 53.0 8.3 0.00018 36.7 1.9 23 623-645 230-252 (256)
206 TIGR00864 PCC polycystin catio 52.5 9.3 0.0002 48.1 2.4 32 406-437 1-32 (2740)
207 cd07840 STKc_CDK9_like Catalyt 52.0 11 0.00024 36.6 2.6 25 621-645 259-283 (287)
208 cd06640 STKc_MST4 Catalytic do 51.9 12 0.00025 36.4 2.7 26 621-646 228-253 (277)
209 KOG3763 mRNA export factor TAP 51.9 7.3 0.00016 40.7 1.3 38 399-438 243-284 (585)
210 KOG4242 Predicted myosin-I-bin 51.8 54 0.0012 33.9 7.1 84 377-460 355-452 (553)
211 cd05118 STKc_CMGC Catalytic do 51.1 12 0.00026 36.3 2.7 25 621-645 255-279 (283)
212 cd08225 STKc_Nek5 Catalytic do 49.8 11 0.00025 35.8 2.3 23 623-645 231-253 (257)
213 cd05087 PTKc_Aatyk1_Aatyk3 Cat 48.9 13 0.00028 35.8 2.5 20 628-648 249-268 (269)
214 PF00069 Pkinase: Protein kina 48.5 12 0.00026 35.6 2.2 25 621-645 232-256 (260)
215 cd06641 STKc_MST3 Catalytic do 48.4 14 0.00031 35.8 2.7 25 622-646 229-253 (277)
216 cd06615 PKc_MEK Catalytic doma 48.1 12 0.00025 37.1 2.1 25 622-646 263-287 (308)
217 cd06609 STKc_MST3_like Catalyt 48.0 13 0.00028 35.9 2.4 23 623-645 228-250 (274)
218 cd07841 STKc_CDK7 Catalytic do 47.9 13 0.00029 36.4 2.5 26 621-646 257-282 (298)
219 cd06637 STKc_TNIK Catalytic do 46.4 15 0.00033 35.4 2.5 24 622-645 245-268 (272)
220 cd06608 STKc_myosinIII_like Ca 45.9 13 0.00029 35.7 2.1 24 622-645 248-271 (275)
221 cd05122 PKc_STE Catalytic doma 45.9 14 0.0003 34.9 2.1 24 622-645 227-250 (253)
222 cd07842 STKc_CDK8_like Catalyt 45.7 14 0.00031 36.5 2.3 25 621-645 288-312 (316)
223 cd06619 PKc_MKK5 Catalytic dom 45.2 13 0.00029 36.0 1.9 25 622-646 229-253 (279)
224 cd06629 STKc_MAPKKK_Bck1_like 45.1 15 0.00033 35.4 2.3 23 623-645 246-268 (272)
225 smart00367 LRR_CC Leucine-rich 45.1 16 0.00034 20.5 1.4 11 400-410 2-12 (26)
226 cd08219 STKc_Nek3 Catalytic do 45.0 15 0.00033 34.9 2.3 23 624-646 230-252 (255)
227 cd06651 STKc_MEKK3 Catalytic d 44.5 14 0.0003 35.5 2.0 18 628-645 243-260 (266)
228 cd06639 STKc_myosinIIIB Cataly 44.3 14 0.00031 36.0 2.1 24 622-645 263-286 (291)
229 cd07831 STKc_MOK Catalytic dom 44.3 17 0.00036 35.2 2.5 25 621-645 254-278 (282)
230 cd07838 STKc_CDK4_6_like Catal 44.1 17 0.00037 35.3 2.6 24 622-645 260-283 (287)
231 cd07860 STKc_CDK2_3 Catalytic 43.4 17 0.00038 35.2 2.5 23 623-645 258-280 (284)
232 cd00180 PKc Catalytic domain o 43.2 15 0.00032 33.3 1.8 29 618-646 186-214 (215)
233 cd07847 STKc_CDKL1_4 Catalytic 43.0 17 0.00037 35.3 2.3 24 622-645 259-282 (286)
234 cd07861 STKc_CDK1_euk Catalyti 43.0 15 0.00033 35.6 2.0 23 623-645 259-281 (285)
235 cd06610 STKc_OSR1_SPAK Catalyt 42.9 18 0.00039 34.6 2.5 24 622-645 240-263 (267)
236 cd07852 STKc_MAPK15 Catalytic 42.7 18 0.00039 36.3 2.5 26 621-646 270-295 (337)
237 cd08221 STKc_Nek9 Catalytic do 42.3 17 0.00037 34.6 2.2 25 622-646 229-253 (256)
238 PLN00009 cyclin-dependent kina 42.0 17 0.00038 35.5 2.2 24 622-645 260-283 (294)
239 cd08227 PK_STRAD_alpha Pseudok 41.7 15 0.00032 36.8 1.7 24 622-645 283-306 (327)
240 cd06626 STKc_MEKK4 Catalytic d 41.5 20 0.00043 34.2 2.5 22 624-645 239-260 (264)
241 cd07858 STKc_TEY_MAPK_plant Ca 41.2 17 0.00037 36.5 2.1 31 621-651 266-298 (337)
242 cd08530 STKc_CNK2-like Catalyt 41.2 21 0.00045 33.9 2.6 24 622-645 229-252 (256)
243 cd06605 PKc_MAPKK Catalytic do 41.2 22 0.00047 34.0 2.7 23 623-645 234-256 (265)
244 cd06616 PKc_MKK4 Catalytic dom 41.0 19 0.0004 35.1 2.3 25 622-646 243-267 (288)
245 cd06632 STKc_MEKK1_plant Catal 40.8 19 0.00041 34.2 2.2 22 624-645 233-254 (258)
246 cd08216 PK_STRAD Pseudokinase 40.4 19 0.00042 35.6 2.3 25 622-646 271-295 (314)
247 cd06646 STKc_MAP4K5 Catalytic 39.0 16 0.00034 35.2 1.3 25 622-646 241-265 (267)
248 cd07829 STKc_CDK_like Catalyti 38.9 24 0.00051 34.2 2.6 25 621-645 254-278 (282)
249 cd06618 PKc_MKK7 Catalytic dom 38.7 22 0.00047 34.9 2.3 25 622-646 249-273 (296)
250 cd07832 STKc_CCRK Catalytic do 38.7 23 0.00049 34.4 2.5 25 621-645 257-281 (286)
251 cd06917 STKc_NAK1_like Catalyt 38.6 25 0.00055 33.9 2.8 25 622-646 231-255 (277)
252 cd06635 STKc_TAO1 Catalytic do 38.5 23 0.00049 35.2 2.5 25 622-646 253-277 (317)
253 cd06607 STKc_TAO Catalytic dom 38.3 21 0.00047 35.2 2.2 25 622-646 243-267 (307)
254 cd06627 STKc_Cdc7_like Catalyt 38.0 18 0.0004 34.2 1.7 24 622-645 227-250 (254)
255 cd06613 STKc_MAP4K3_like Catal 37.9 22 0.00048 33.9 2.2 24 622-645 236-259 (262)
256 cd06649 PKc_MEK2 Catalytic dom 37.5 24 0.00052 35.4 2.4 25 622-646 277-301 (331)
257 KOG3763 mRNA export factor TAP 37.2 20 0.00042 37.7 1.7 65 398-464 216-286 (585)
258 cd07849 STKc_ERK1_2_like Catal 37.1 21 0.00047 35.8 2.1 26 621-646 267-292 (336)
259 cd05042 PTKc_Aatyk Catalytic d 36.8 28 0.00061 33.4 2.8 21 627-648 248-268 (269)
260 cd07866 STKc_BUR1 Catalytic do 36.5 24 0.00052 34.8 2.3 25 621-645 283-307 (311)
261 cd07862 STKc_CDK6 Catalytic do 36.3 24 0.00052 34.4 2.2 23 623-645 264-286 (290)
262 PTZ00382 Variant-specific surf 35.8 51 0.0011 25.9 3.5 6 509-514 69-74 (96)
263 KOG0195 Integrin-linked kinase 35.6 24 0.00053 33.3 1.9 29 623-651 419-447 (448)
264 cd05583 STKc_MSK_N N-terminal 35.6 20 0.00044 34.9 1.5 28 623-650 240-267 (288)
265 cd06631 STKc_YSK4 Catalytic do 35.4 26 0.00057 33.5 2.3 23 623-645 239-261 (265)
266 PF15102 TMEM154: TMEM154 prot 35.3 35 0.00077 28.9 2.6 9 508-516 58-66 (146)
267 cd06656 STKc_PAK3 Catalytic do 35.2 26 0.00057 34.4 2.3 22 624-645 247-268 (297)
268 cd07844 STKc_PCTAIRE_like Cata 35.1 25 0.00054 34.3 2.1 24 622-645 264-287 (291)
269 cd06623 PKc_MAPKK_plant_like C 35.0 30 0.00066 32.9 2.7 25 622-646 232-256 (264)
270 cd08226 PK_STRAD_beta Pseudoki 34.8 30 0.00065 34.6 2.6 32 621-652 283-316 (328)
271 cd07857 STKc_MPK1 Catalytic do 34.7 30 0.00065 34.6 2.7 24 622-645 268-291 (332)
272 cd06650 PKc_MEK1 Catalytic dom 34.7 31 0.00068 34.6 2.8 24 622-645 275-298 (333)
273 cd07865 STKc_CDK9 Catalytic do 34.5 26 0.00056 34.5 2.1 24 622-645 283-306 (310)
274 cd07859 STKc_TDY_MAPK_plant Ca 34.0 28 0.0006 34.9 2.3 24 622-645 266-289 (338)
275 cd07851 STKc_p38 Catalytic dom 33.8 28 0.00061 35.1 2.3 25 621-645 273-297 (343)
276 cd07864 STKc_CDK12 Catalytic d 33.7 28 0.00061 34.1 2.3 24 622-645 275-298 (302)
277 cd08215 STKc_Nek Catalytic dom 33.7 30 0.00065 32.7 2.4 24 622-645 231-254 (258)
278 cd06614 STKc_PAK Catalytic dom 33.6 30 0.00064 33.7 2.4 25 622-646 246-270 (286)
279 cd07839 STKc_CDK5 Catalytic do 33.1 27 0.00059 33.8 2.0 24 622-645 257-280 (284)
280 cd06645 STKc_MAP4K3 Catalytic 33.1 31 0.00067 33.0 2.4 24 622-645 241-264 (267)
281 cd08222 STKc_Nek11 Catalytic d 32.9 33 0.00071 32.7 2.5 23 623-645 234-256 (260)
282 cd07874 STKc_JNK3 Catalytic do 32.8 30 0.00064 35.1 2.3 24 622-645 287-310 (355)
283 cd06654 STKc_PAK1 Catalytic do 32.6 35 0.00077 33.4 2.7 24 623-646 247-270 (296)
284 cd07843 STKc_CDC2L1 Catalytic 32.5 31 0.00067 33.7 2.3 22 624-645 268-289 (293)
285 cd06611 STKc_SLK_like Catalyti 32.4 28 0.00061 33.7 2.0 22 624-645 240-261 (280)
286 cd07870 STKc_PFTAIRE2 Catalyti 32.3 30 0.00066 33.7 2.2 23 623-645 265-287 (291)
287 cd07837 STKc_CdkB_plant Cataly 32.1 31 0.00067 33.7 2.2 24 622-645 267-290 (295)
288 cd06643 STKc_SLK Catalytic dom 31.8 32 0.0007 33.3 2.3 23 623-645 239-261 (282)
289 PLN00181 protein SPA1-RELATED; 31.8 31 0.00068 39.6 2.5 23 623-645 242-264 (793)
290 cd06648 STKc_PAK_II Catalytic 31.4 31 0.00068 33.5 2.1 24 622-645 245-268 (285)
291 cd06634 STKc_TAO2 Catalytic do 31.0 39 0.00084 33.4 2.7 25 622-646 243-267 (308)
292 cd07879 STKc_p38delta_MAPK13 C 30.8 31 0.00068 34.7 2.1 30 622-651 273-304 (342)
293 cd07855 STKc_ERK5 Catalytic do 30.8 36 0.00078 34.1 2.5 25 622-646 270-294 (334)
294 cd07863 STKc_CDK4 Catalytic do 30.6 35 0.00076 33.1 2.3 24 622-645 261-284 (288)
295 cd05579 STKc_MAST_like Catalyt 29.8 28 0.00062 33.1 1.5 27 622-648 230-256 (265)
296 KOG0196 Tyrosine kinase, EPH ( 29.7 17 0.00037 39.9 -0.1 35 617-651 858-892 (996)
297 PF05393 Hum_adeno_E3A: Human 29.6 62 0.0014 24.5 2.8 15 524-538 48-62 (94)
298 cd07856 STKc_Sty1_Hog1 Catalyt 29.1 39 0.00085 33.8 2.4 25 622-646 264-288 (328)
299 PF05454 DAG1: Dystroglycan (D 29.1 18 0.0004 34.9 0.0 14 548-561 189-202 (290)
300 cd06644 STKc_STK10_LOK Catalyt 28.9 42 0.00091 32.7 2.5 24 622-645 245-268 (292)
301 cd06622 PKc_MAPKK_PBS2_like Ca 28.8 44 0.00095 32.4 2.6 23 623-645 239-261 (286)
302 cd06655 STKc_PAK2 Catalytic do 28.6 37 0.0008 33.3 2.1 22 624-645 247-268 (296)
303 PHA03265 envelope glycoprotein 28.2 57 0.0012 32.0 3.1 29 507-535 348-376 (402)
304 PLN00034 mitogen-activated pro 28.0 42 0.0009 34.0 2.4 23 623-645 305-327 (353)
305 cd06628 STKc_MAPKKK_Byr2_like 28.0 46 0.001 31.8 2.6 22 624-645 242-263 (267)
306 cd06633 STKc_TAO3 Catalytic do 27.8 38 0.00082 33.5 2.0 23 623-645 250-272 (313)
307 cd07836 STKc_Pho85 Catalytic d 27.5 41 0.00088 32.5 2.2 24 622-645 257-280 (284)
308 PTZ00024 cyclin-dependent prot 27.1 46 0.00099 33.3 2.5 24 622-645 289-312 (335)
309 PF01034 Syndecan: Syndecan do 27.0 21 0.00045 25.3 -0.0 10 509-518 12-21 (64)
310 cd06630 STKc_MEKK1 Catalytic d 26.5 50 0.0011 31.6 2.5 24 622-645 240-263 (268)
311 cd07850 STKc_JNK Catalytic dom 26.2 45 0.00097 33.7 2.3 24 622-645 287-310 (353)
312 cd06625 STKc_MEKK3_like Cataly 26.2 49 0.0011 31.5 2.4 22 624-645 238-259 (263)
313 KOG1989 ARK protein kinase fam 26.1 63 0.0014 35.9 3.3 29 624-652 285-313 (738)
314 PHA03209 serine/threonine kina 26.0 39 0.00085 34.3 1.8 21 625-645 330-350 (357)
315 cd07834 STKc_MAPK Catalytic do 25.2 51 0.0011 32.8 2.5 30 622-651 265-296 (330)
316 cd07873 STKc_PCTAIRE1 Catalyti 25.0 47 0.001 32.6 2.1 23 623-645 263-285 (301)
317 cd07853 STKc_NLK Catalytic dom 24.7 50 0.0011 33.7 2.3 24 622-645 264-287 (372)
318 cd06658 STKc_PAK5 Catalytic do 23.8 56 0.0012 31.9 2.4 20 627-646 253-272 (292)
319 cd07848 STKc_CDKL5 Catalytic d 23.1 60 0.0013 31.5 2.4 24 622-645 260-283 (287)
320 cd06617 PKc_MKK3_6 Catalytic d 22.7 58 0.0013 31.4 2.2 23 623-645 238-260 (283)
321 cd06659 STKc_PAK6 Catalytic do 22.7 67 0.0014 31.5 2.7 23 624-646 249-271 (297)
322 cd07854 STKc_MAPK4_6 Catalytic 22.3 58 0.0012 32.8 2.2 24 622-645 276-299 (342)
323 PRK13281 succinylarginine dihy 22.3 43 0.00094 33.5 1.1 41 575-627 394-436 (442)
324 cd07867 STKc_CDC2L6 Catalytic 21.9 60 0.0013 32.0 2.2 24 622-645 290-313 (317)
325 cd06647 STKc_PAK_I Catalytic d 21.8 61 0.0013 31.7 2.2 23 624-646 247-269 (293)
326 PTZ00283 serine/threonine prot 21.6 66 0.0014 34.5 2.5 25 622-646 273-297 (496)
327 KOG0596 Dual specificity; seri 20.9 55 0.0012 34.6 1.6 24 622-645 603-626 (677)
328 KOG1095 Protein tyrosine kinas 20.7 91 0.002 36.1 3.4 37 620-656 931-967 (1025)
329 cd06636 STKc_MAP4K4_6 Catalyti 20.6 66 0.0014 31.0 2.1 24 622-645 255-278 (282)
330 TIGR03241 arg_catab_astB succi 20.6 49 0.0011 33.1 1.1 41 575-627 396-438 (443)
331 PF12191 stn_TNFRSF12A: Tumour 20.2 59 0.0013 26.7 1.3 7 528-534 99-105 (129)
332 PF04996 AstB: Succinylarginin 20.1 51 0.0011 33.1 1.1 40 575-626 391-432 (439)
No 1
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=7.8e-66 Score=593.53 Aligned_cols=483 Identities=35% Similarity=0.593 Sum_probs=346.1
Q ss_pred CCCCCEEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEE
Q 038552 6 YSNLIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLN 85 (659)
Q Consensus 6 ~~~L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 85 (659)
+++|++|++++|.+.+.+|..++++++|++|++++|.+.+.+|..+.++++|++|++++|.+.+.+|..++++++|++|+
T Consensus 139 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (968)
T PLN00113 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218 (968)
T ss_pred cCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE
Confidence 34444444444444444555555555555555555555555555555555555555555555555555555555555555
Q ss_pred eecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCc
Q 038552 86 VGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLK 165 (659)
Q Consensus 86 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~ 165 (659)
+++|.+++.+|..++++++|++|++++|.+++.+|..+. .+++|+.|++++|.+++.+|..+.++++|++|++++|.+.
T Consensus 219 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 297 (968)
T PLN00113 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297 (968)
T ss_pred CcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec
Confidence 555555555555555555555555555555545555444 4555555555555555555555555555555555555555
Q ss_pred cccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhccccCCEEEcccCcccc
Q 038552 166 GKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGANQISG 245 (659)
Q Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~ 245 (659)
+.+|..+..+++|+.|++++|.+.+ ..+..+..+++|+.|++++|.+.+.+|..+..+. +|+.|++++|.+++
T Consensus 298 ~~~p~~~~~l~~L~~L~l~~n~~~~------~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~ 370 (968)
T PLN00113 298 GEIPELVIQLQNLEILHLFSNNFTG------KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTG 370 (968)
T ss_pred cCCChhHcCCCCCcEEECCCCccCC------cCChhHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEe
Confidence 5555555555555555555555543 3344555666677777777766666666666654 67777777777776
Q ss_pred cCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcC
Q 038552 246 TIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGN 325 (659)
Q Consensus 246 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 325 (659)
.+|.++..+++|+.|++++|.+.+.+|..++.+++|+.|++++|++.+.+|..+..++.|+.|++++|.+.+.+|..+..
T Consensus 371 ~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 450 (968)
T PLN00113 371 EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450 (968)
T ss_pred eCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhcc
Confidence 66766666777777777777777777777777777777777777777777777777777888888887777777777777
Q ss_pred CCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeE
Q 038552 326 CQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYL 405 (659)
Q Consensus 326 ~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L 405 (659)
+++|+.|++++|++.+.+|..+ ..+.++ .|++++|++.+..|..+..+++|++|+|++|++.+.+|..+.++++|++|
T Consensus 451 l~~L~~L~L~~n~~~~~~p~~~-~~~~L~-~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 528 (968)
T PLN00113 451 MPSLQMLSLARNKFFGGLPDSF-GSKRLE-NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL 528 (968)
T ss_pred CCCCcEEECcCceeeeecCccc-ccccce-EEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEE
Confidence 7888888888888877777654 346676 89999999999999999999999999999999999999999999999999
Q ss_pred ECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCcCCcCcccCCCCCccCCcccccccCCCCCc
Q 038552 406 NISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHFEGEVPKKGVFSNKTKISLQGNVKLC 485 (659)
Q Consensus 406 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~lc 485 (659)
+|++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|+.+++++|++.+.+|..+.+..+...++.||+.+|
T Consensus 529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc 608 (968)
T PLN00113 529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608 (968)
T ss_pred ECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999989899999999999
Q ss_pred ccCCCCCCCCCCC
Q 038552 486 GGIDELHLPSCPS 498 (659)
Q Consensus 486 ~~~~~~~~~~c~~ 498 (659)
++.+....++|..
T Consensus 609 ~~~~~~~~~~c~~ 621 (968)
T PLN00113 609 GGDTTSGLPPCKR 621 (968)
T ss_pred CCccccCCCCCcc
Confidence 8765555667753
No 2
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=7.6e-55 Score=502.31 Aligned_cols=478 Identities=32% Similarity=0.537 Sum_probs=326.2
Q ss_pred CCCCCCCCCEEEccCCcccccCchhhc-CCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCC
Q 038552 2 NLSRYSNLIELRVSKNKLEGQIPEEIG-SLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRN 80 (659)
Q Consensus 2 ~~~~~~~L~~L~ls~n~~~~~~~~~~~-~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 80 (659)
+|..+++|++|+|++|.+++.+|..+. .+.+|++|++++|.+++.+|. +.+++|++|++++|.+.+.+|..++++++
T Consensus 88 ~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~ 165 (968)
T PLN00113 88 AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSS 165 (968)
T ss_pred HHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCC
Confidence 356788888888888888877777654 777788888877777766553 34666666666666666666666666666
Q ss_pred CCEEEeecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEcc
Q 038552 81 LVDLNVGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLT 160 (659)
Q Consensus 81 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~ 160 (659)
|++|++++|.+.+.+|..++++++|++|++++|.+.+.+|..+. .+++|+.|++++|.+++.+|..++++++|++|+++
T Consensus 166 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 244 (968)
T PLN00113 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244 (968)
T ss_pred CCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHc-CcCCccEEECcCCccCCcCChhHhcCCCCCEEECc
Confidence 66666666666666666666666666666666666655665554 56666666666666666666666666666666666
Q ss_pred CCCCccccccccCCCCCCCEEECCCCCCCCCCCCC------------------ccccccccCCCCCcEEEccCCcccccc
Q 038552 161 SNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTAND------------------LDFVTFLTNCSSLKVISLYANQFGGEL 222 (659)
Q Consensus 161 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~------------------~~~~~~l~~~~~L~~L~l~~n~~~~~~ 222 (659)
+|.+.+..|..++++++|+.|++++|.+.+..+.. ..++..+..+++|+.|++++|.+.+..
T Consensus 245 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~ 324 (968)
T PLN00113 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324 (968)
T ss_pred CceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC
Confidence 66666666666666666666666666554310000 022233344444444444444444444
Q ss_pred ChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCC
Q 038552 223 PHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNL 302 (659)
Q Consensus 223 ~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 302 (659)
|..+..++ +|+.|++++|.+.+.+|..++.+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+.+.+|..++.+
T Consensus 325 ~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~ 403 (968)
T PLN00113 325 PVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403 (968)
T ss_pred ChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCC
Confidence 44444443 45555555555554455555555555555555555555555555555555555555555555555556666
Q ss_pred CCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceee
Q 038552 303 TKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLD 382 (659)
Q Consensus 303 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 382 (659)
++|+.|++++|.+++.+|..+..++.|+.|++++|.+++.+|..+..++.++ .|++++|.+.+.+|..+ ..++|+.|+
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~n~~~~~~p~~~-~~~~L~~L~ 481 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ-MLSLARNKFFGGLPDSF-GSKRLENLD 481 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc-EEECcCceeeeecCccc-ccccceEEE
Confidence 6666666666666666666666666677777777766666666666666666 67777777766666544 357788888
Q ss_pred cCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCcCCcCcc
Q 038552 383 ISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHFEG 462 (659)
Q Consensus 383 L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~~ 462 (659)
+++|++++..|..+.++++|++|++++|.+.+.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|++++|++++
T Consensus 482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 88888888888889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCC-CccCCcccccccCCCCCc
Q 038552 463 EVPKK-GVFSNKTKISLQGNVKLC 485 (659)
Q Consensus 463 ~~p~~-~~~~~~~~~~~~~n~~lc 485 (659)
.+|.. ..+..++.+++++|+..+
T Consensus 562 ~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 562 EIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred cCChhHhcCcccCEEeccCCccee
Confidence 88864 456778999999998665
No 3
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-39 Score=314.77 Aligned_cols=373 Identities=23% Similarity=0.267 Sum_probs=236.9
Q ss_pred cEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEEeccCc
Q 038552 34 QTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWIYLPFN 113 (659)
Q Consensus 34 ~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 113 (659)
+.|++++|.+....+..|.++++|+.+++.+|.+ ..+|..-....+|+.|+|.+|.|+..-.+++..++.|+.|||+.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~L-t~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNEL-TRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchh-hhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 3355555555555555555555555555555554 234443333444555555555555444444555555555555555
Q ss_pred cccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCC
Q 038552 114 RFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTA 193 (659)
Q Consensus 114 ~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 193 (659)
.++ ++|...+..-.++++|+|++|.++..--..|..+.+|..|.|+.|.++...+..|.++++|+.|+|..|.+..
T Consensus 160 ~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iri--- 235 (873)
T KOG4194|consen 160 LIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRI--- 235 (873)
T ss_pred hhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceee---
Confidence 554 4444333233445555555555544444444444555555555555544444444444444444444443321
Q ss_pred CCccccccccCCCCCcEEEccCCccccccChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCc
Q 038552 194 NDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPD 273 (659)
Q Consensus 194 ~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~ 273 (659)
.-...|..+++|+.|.|..|.+...-..
T Consensus 236 ----------------------------------------------------ve~ltFqgL~Sl~nlklqrN~I~kL~DG 263 (873)
T KOG4194|consen 236 ----------------------------------------------------VEGLTFQGLPSLQNLKLQRNDISKLDDG 263 (873)
T ss_pred ----------------------------------------------------ehhhhhcCchhhhhhhhhhcCcccccCc
Confidence 1112355666777777777777666666
Q ss_pred cccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccc
Q 038552 274 TIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTL 353 (659)
Q Consensus 274 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l 353 (659)
.|..+.++++|+|..|+++..-..++.++++|+.|+++.|.+...-+..++.+++|+.|++++|+++..-+..+..+..+
T Consensus 264 ~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L 343 (873)
T KOG4194|consen 264 AFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL 343 (873)
T ss_pred ceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHh
Confidence 67777777777777777776666667777788888888887777667777777888888888888876666677777777
Q ss_pred cceeccccccccCCCccccccCCCCceeecCCCcccccCC---ccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEE
Q 038552 354 TLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIP---VTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFN 430 (659)
Q Consensus 354 ~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~---~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 430 (659)
+ +|+|++|.++..-..+|..+++|++|||++|.++..+. ..|.++++|+.|++.+|++..+...+|.++++|+.||
T Consensus 344 e-~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld 422 (873)
T KOG4194|consen 344 E-ELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD 422 (873)
T ss_pred h-hhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence 7 78888888876666677888888888888888765433 3567788888888888888877777888888888888
Q ss_pred CCCCcccccchhhhcCCCCCCeeeCcCCcCcccCC
Q 038552 431 VSSNNLSGLIPEFLKNLSFMEFLDLSYNHFEGEVP 465 (659)
Q Consensus 431 l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p 465 (659)
|.+|.+..+-|+.|..+ .|++|-+..-.+.+.+.
T Consensus 423 L~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 423 LGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred CCCCcceeecccccccc-hhhhhhhcccceEEecc
Confidence 88888877778888777 77777776666666554
No 4
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=100.00 E-value=8.1e-42 Score=318.66 Aligned_cols=452 Identities=30% Similarity=0.441 Sum_probs=368.0
Q ss_pred CCCEEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEee
Q 038552 8 NLIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVG 87 (659)
Q Consensus 8 ~L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 87 (659)
.+..+++++|.+. .+-..+.++..|.+|++.+|++. ..|.+++.+..++.++.++|.+ ..+|..++.+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~l-s~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKL-SELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchH-hhccHHHhhhhhhhhhhcc
Confidence 4667888888887 56777888888999999998888 7788888888899999998888 5678888888899999999
Q ss_pred cCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCccc
Q 038552 88 ENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKGK 167 (659)
Q Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~ 167 (659)
+|.+. .+|++++.+..|..++..+|+++ .+|.+++ .+.+|..+++.+|+++...|..+. ++.|++||...|-+. .
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHH-HHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence 88887 67888888888888888888888 8888887 788888889989988865555444 888999998888776 6
Q ss_pred cccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhccccCCEEEcccCcccccC
Q 038552 168 VSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTI 247 (659)
Q Consensus 168 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~ 247 (659)
+|..++.+.+|.-|+++.|++. +.+.+++|+.|+++++..|++. .+|......-.++..|++.+|+++ ..
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~--------~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR--------FLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc--------cCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 6777888888888999888874 4457888889999999888876 677777754458888899999888 67
Q ss_pred CcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCC---------------------------------
Q 038552 248 PPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGS--------------------------------- 294 (659)
Q Consensus 248 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~--------------------------------- 294 (659)
|..++.+.+|..||+++|.++ .+|..++++ +|+.|.+.+|++...
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 888888888999999999888 456678888 888898888876410
Q ss_pred -----CCcc---ccCCCCCcEEEccCCccccccCccCcCC---CCCCEEeCCCcccccccchhhhhcccccceecccccc
Q 038552 295 -----IPSS---LGNLTKLVELPLSYNNLQGNIPSSLGNC---QILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNL 363 (659)
Q Consensus 295 -----~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~~~~---~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~ 363 (659)
.+.. ...+.+.+.|++++-+++ .+|...-.. .-....+++.|++. ++|..+..+..+...+.+++|.
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence 0001 122445677777777776 455443222 23678889999988 7888888888877677888887
Q ss_pred ccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhh
Q 038552 364 LNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEF 443 (659)
Q Consensus 364 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 443 (659)
++ -+|..++.+++|..|+|++|.+. .+|..++.+..|++|+++.|++. .+|..+..+..++.+-.++|++....|+.
T Consensus 424 is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~ 500 (565)
T KOG0472|consen 424 IS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSG 500 (565)
T ss_pred cc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHH
Confidence 76 77888999999999999999887 68888999999999999999998 78888888888888888889998887888
Q ss_pred hcCCCCCCeeeCcCCcCcccCCCCCccCCcccccccCCCCC
Q 038552 444 LKNLSFMEFLDLSYNHFEGEVPKKGVFSNKTKISLQGNVKL 484 (659)
Q Consensus 444 l~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~l 484 (659)
+..+.+|..||+.+|.+....|..|.+.+++.+.+.|||.-
T Consensus 501 l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 501 LKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 99999999999999999988888899999999999999864
No 5
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-37 Score=302.02 Aligned_cols=395 Identities=20% Similarity=0.208 Sum_probs=312.7
Q ss_pred cEEEccCCccCcccccccCCC--CCCCEEEeecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEc
Q 038552 58 KVFYIIGNSLGGKIPTTLGLL--RNLVDLNVGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAI 135 (659)
Q Consensus 58 ~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l 135 (659)
+.|+.+++.+....-..+... +.-++|++++|.+...-+..|.++++|+.+++.+|.++ .+|.... ...+|+.|+|
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L 132 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDL 132 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEee
Confidence 456666665532211222221 23456888888888777777888888888888888887 7776543 4556888888
Q ss_pred cCCcCCcccChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccC
Q 038552 136 GGNNFFGSIPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYA 215 (659)
Q Consensus 136 ~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~ 215 (659)
.+|.++.+-.+.++.++.|+.|||+.|.++......|..-.++++|+|+.|.++..... .+.++.
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~------~F~~ln--------- 197 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETG------HFDSLN--------- 197 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccc------cccccc---------
Confidence 88888777777788888888888888887766666677777788888887777654332 222223
Q ss_pred CccccccChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCC
Q 038552 216 NQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSI 295 (659)
Q Consensus 216 n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 295 (659)
+|..|.++.|.++..-+..|.+++.|+.|+|..|.+.-.-.-.|.++++|+.|.+..|.+...-
T Consensus 198 ----------------sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~ 261 (873)
T KOG4194|consen 198 ----------------SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLD 261 (873)
T ss_pred ----------------hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccccc
Confidence 4555555566665444566778999999999999987544567899999999999999999888
Q ss_pred CccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccC
Q 038552 296 PSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNL 375 (659)
Q Consensus 296 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l 375 (659)
...|..+.++++|+|..|+++..-..++-++++|+.|++++|.+...-+..+..++.+. +|+|++|++....+.+|..+
T Consensus 262 DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~-~LdLs~N~i~~l~~~sf~~L 340 (873)
T KOG4194|consen 262 DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK-ELDLSSNRITRLDEGSFRVL 340 (873)
T ss_pred Ccceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce-eEeccccccccCChhHHHHH
Confidence 88999999999999999999977778889999999999999999988899999999998 99999999998889999999
Q ss_pred CCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCc---ccccCCCCCCEEECCCCcccccchhhhcCCCCCCe
Q 038552 376 KNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIP---LSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEF 452 (659)
Q Consensus 376 ~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 452 (659)
..|++|+|++|.++......|..+++|++|||++|.++..+. ..|.++++|+.|++.+|++..+.-..|..++.|+.
T Consensus 341 ~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~ 420 (873)
T KOG4194|consen 341 SQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEH 420 (873)
T ss_pred HHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccce
Confidence 999999999999997777889999999999999999987654 35788999999999999998766689999999999
Q ss_pred eeCcCCcCcccCCCCCccCCcccccccCCCCCcc
Q 038552 453 LDLSYNHFEGEVPKKGVFSNKTKISLQGNVKLCG 486 (659)
Q Consensus 453 l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 486 (659)
||+.+|.+...-|..-....+.++.+..-..+|.
T Consensus 421 LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 421 LDLGDNAIASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred ecCCCCcceeecccccccchhhhhhhcccceEEe
Confidence 9999999987766542223556666665555664
No 6
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=100.00 E-value=2.8e-40 Score=308.39 Aligned_cols=434 Identities=29% Similarity=0.443 Sum_probs=370.1
Q ss_pred CCCCCCCCCEEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCC
Q 038552 2 NLSRYSNLIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNL 81 (659)
Q Consensus 2 ~~~~~~~L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 81 (659)
.+.++..+.+|++.+|.+. ..|.+++.+..++.++.++|.+. .+|..+..+.+|+.+++++|.+ ...|++++.+..|
T Consensus 63 dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~-~el~~~i~~~~~l 139 (565)
T KOG0472|consen 63 DLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNEL-KELPDSIGRLLDL 139 (565)
T ss_pred hhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccce-eecCchHHHHhhh
Confidence 4568889999999999998 78999999999999999999998 8899999999999999999998 5678889999999
Q ss_pred CEEEeecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccC
Q 038552 82 VDLNVGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTS 161 (659)
Q Consensus 82 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~ 161 (659)
..++..+|+++ ..|.+++.+.+|..+++.+|.++ .+|.+.- .++.|+.++...|-++ .+|..++.+.+|+.|++..
T Consensus 140 ~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 140 EDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhh
Confidence 99999999998 78999999999999999999998 7777665 5899999999888886 7788899999999999999
Q ss_pred CCCccccccccCCCCCCCEEECCCCCCCCCCCCCcccccc-ccCCCCCcEEEccCCccccccChhHHhccccCCEEEccc
Q 038552 162 NQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTF-LTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGA 240 (659)
Q Consensus 162 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~-l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~ 240 (659)
|.+. ..| .|+.+..|++|++..|++.. +++. ..+++++.+||+..|++. +.|+.+.-+. +|.+|++++
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~~-------lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr-sL~rLDlSN 284 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIEM-------LPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR-SLERLDLSN 284 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHHh-------hHHHHhcccccceeeeccccccc-cCchHHHHhh-hhhhhcccC
Confidence 9987 455 79999999999999998864 3333 448899999999999998 8899888876 899999999
Q ss_pred CcccccCCcccccCCCcCeeecccccCCCC--------------------------------------CCc---cccCCC
Q 038552 241 NQISGTIPPGIRNLVNLIALTMEINKLHGT--------------------------------------IPD---TIGELK 279 (659)
Q Consensus 241 ~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~--------------------------------------~~~---~~~~~~ 279 (659)
|.++ .+|.+++++ .|+.|.+.+|.+... .+. ......
T Consensus 285 N~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i 362 (565)
T KOG0472|consen 285 NDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAII 362 (565)
T ss_pred Cccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhh
Confidence 9998 578899999 899999888865210 000 112345
Q ss_pred CCcEEEccCCCCCCCCCc-cccCC--CCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccce
Q 038552 280 NLQQLSLYNNSLQGSIPS-SLGNL--TKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLS 356 (659)
Q Consensus 280 ~L~~L~l~~n~l~~~~~~-~~~~l--~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~ 356 (659)
+.+.|++++-+++ .+|. .|..- .-....+++.|++. .+|..+..+..+.+.-+..|+..+.+|..+++++.++ .
T Consensus 363 ~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt-~ 439 (565)
T KOG0472|consen 363 TTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLT-F 439 (565)
T ss_pred hhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcce-e
Confidence 7888999998888 4554 44332 23778999999998 7888777776665544444444558999999999999 9
Q ss_pred eccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcc
Q 038552 357 LDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNL 436 (659)
Q Consensus 357 L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 436 (659)
|++++|.+. .+|..++.+..|+.|+++.|+|. .+|..+..+..++.+-.++|++....|..+.++.+|..||+.+|.+
T Consensus 440 L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdl 517 (565)
T KOG0472|consen 440 LDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDL 517 (565)
T ss_pred eecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCch
Confidence 999999887 78899999999999999999997 7888888888899999999999988888899999999999999999
Q ss_pred cccchhhhcCCCCCCeeeCcCCcCc
Q 038552 437 SGLIPEFLKNLSFMEFLDLSYNHFE 461 (659)
Q Consensus 437 ~~~~~~~l~~l~~L~~l~l~~n~l~ 461 (659)
. .+|..++++++|++|++++|+|.
T Consensus 518 q-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 518 Q-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred h-hCChhhccccceeEEEecCCccC
Confidence 7 67899999999999999999998
No 7
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-36 Score=311.87 Aligned_cols=444 Identities=30% Similarity=0.381 Sum_probs=289.5
Q ss_pred CCEEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeec
Q 038552 9 LIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGE 88 (659)
Q Consensus 9 L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 88 (659)
+..|+++.|.+...--+.+..+.+|+.|++++|.+. ..|..+..+++|+.|+++.|.+ ...|.+..++.+|++|.|.+
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i-~~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI-RSVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH-hhCchhhhhhhcchhheecc
Confidence 556666666655322233445556777777777765 6677777777777777777776 45566667777777777777
Q ss_pred CcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCC-------------------cCCcccChhcc
Q 038552 89 NRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGN-------------------NFFGSIPNSLS 149 (659)
Q Consensus 89 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n-------------------~~~~~~~~~l~ 149 (659)
|.+. ..|..+..+.+|++|+++.|.+. .+|.-+. .++.+..+..++| .+.+.++..+.
T Consensus 101 n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~-~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~ 177 (1081)
T KOG0618|consen 101 NRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIE-VLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY 177 (1081)
T ss_pred chhh-cCchhHHhhhcccccccchhccC-CCchhHH-hhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh
Confidence 7665 66777777777777777777775 6665444 4444444444444 44444444444
Q ss_pred CCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhc
Q 038552 150 NASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANL 229 (659)
Q Consensus 150 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~ 229 (659)
.++. .|++.+|.+. -..+..+.+|+.+....|++.... -.-++|+.|+.+.|.++...+. ..
T Consensus 178 ~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----------~~g~~l~~L~a~~n~l~~~~~~---p~ 239 (1081)
T KOG0618|consen 178 NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----------ISGPSLTALYADHNPLTTLDVH---PV 239 (1081)
T ss_pred hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----------ecCcchheeeeccCcceeeccc---cc
Confidence 4443 4555555544 123445555555555555543211 1225566677777766522111 12
Q ss_pred cccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEE
Q 038552 230 SSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELP 309 (659)
Q Consensus 230 ~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 309 (659)
+.++++++++.++++ .+|.|++.+.+|+.++..+|.++ .+|..+....+|+.|.+.+|.+. .+|.....+++|++|+
T Consensus 240 p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLd 316 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLD 316 (1081)
T ss_pred cccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeee
Confidence 336778888888877 45678888888888888888774 56666677777888888888777 6666677788888888
Q ss_pred ccCCccccccCc-cCcCCCC-CCEEeCCCcccccccch-hhhhcccccceeccccccccCCCccccccCCCCceeecCCC
Q 038552 310 LSYNNLQGNIPS-SLGNCQI-LRMFNASRNKLTGALPH-QLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGN 386 (659)
Q Consensus 310 l~~n~l~~~~~~-~~~~~~~-L~~L~l~~n~l~~~~~~-~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n 386 (659)
|..|++. ..|. .+..... |..|+.+.|.+. ..|. .-...+.+. .|++.+|.+++.....+.++.+|+.|+|++|
T Consensus 317 L~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq-~LylanN~Ltd~c~p~l~~~~hLKVLhLsyN 393 (1081)
T KOG0618|consen 317 LQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQ-ELYLANNHLTDSCFPVLVNFKHLKVLHLSYN 393 (1081)
T ss_pred ehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHH-HHHHhcCcccccchhhhccccceeeeeeccc
Confidence 8888776 3343 2222222 555666666655 2221 122334444 7888888888777777888888888888888
Q ss_pred cccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCcCCcCcccCCC
Q 038552 387 QFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHFEGEVPK 466 (659)
Q Consensus 387 ~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~ 466 (659)
++.......+.++..|++|+||+|+++ .+|.+...++.|+.|...+|++.. .| .+..++.|+.+|++.|+++...-.
T Consensus 394 rL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~ 470 (1081)
T KOG0618|consen 394 RLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLP 470 (1081)
T ss_pred ccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-ch-hhhhcCcceEEecccchhhhhhhh
Confidence 887555566778888888888888887 667788888888888888888873 45 667788888888888888654332
Q ss_pred CCcc-CCcccccccCCCCC
Q 038552 467 KGVF-SNKTKISLQGNVKL 484 (659)
Q Consensus 467 ~~~~-~~~~~~~~~~n~~l 484 (659)
.... ++++.++++||.++
T Consensus 471 ~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 471 EALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhCCCcccceeeccCCccc
Confidence 3333 77888888888764
No 8
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=99.98 E-value=1.7e-34 Score=283.99 Aligned_cols=373 Identities=28% Similarity=0.407 Sum_probs=254.0
Q ss_pred cCCCCCcEEEccCCccC-cccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCC
Q 038552 52 GNLSALKVFYIIGNSLG-GKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNL 130 (659)
Q Consensus 52 ~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 130 (659)
+-++..|-.++++|.++ +..|.....+++++.|.|....+. .+|+.++.+.+|++|.++.|++. .+--.+. .++.|
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs-~Lp~L 80 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELS-DLPRL 80 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhc-cchhh
Confidence 34556677788888876 566777778888888888887776 67888888888888888888776 4444444 67788
Q ss_pred cEEEccCCcCC-cccChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCc
Q 038552 131 KALAIGGNNFF-GSIPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLK 209 (659)
Q Consensus 131 ~~L~l~~n~~~-~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~ 209 (659)
+.+.++.|++. .-+|..+-.+..|..|||++|++. .+|..+..-+++-+|+|++|++..+.. ..+.+++.|-
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn------~lfinLtDLL 153 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPN------SLFINLTDLL 153 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCc------hHHHhhHhHh
Confidence 88888777765 236667777888888888888776 566777777777778888777764321 2234455566
Q ss_pred EEEccCCccccccChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCC
Q 038552 210 VISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNN 289 (659)
Q Consensus 210 ~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n 289 (659)
.|||++|.+. . +|+.+..+..|+.|+|++|.+...--..+..+.+|+.|.+++.
T Consensus 154 fLDLS~NrLe-~-------------------------LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~T 207 (1255)
T KOG0444|consen 154 FLDLSNNRLE-M-------------------------LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNT 207 (1255)
T ss_pred hhccccchhh-h-------------------------cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccc
Confidence 6666666654 3 3444455555555555555543322222334555566666655
Q ss_pred CCC-CCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCC
Q 038552 290 SLQ-GSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSL 368 (659)
Q Consensus 290 ~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~ 368 (659)
+-+ ..+|.++..+.+|..+++|.|.+. .+|..+-++++|+.|++++|.++ .+......+..++ .|++|+|+++ .+
T Consensus 208 qRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lE-tLNlSrNQLt-~L 283 (1255)
T KOG0444|consen 208 QRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLE-TLNLSRNQLT-VL 283 (1255)
T ss_pred cchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhh-hhccccchhc-cc
Confidence 433 245666666666666666666665 56666666666666666666666 4444455555666 6777777776 67
Q ss_pred ccccccCCCCceeecCCCccc-ccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCC
Q 038552 369 PLQVGNLKNLVKLDISGNQFS-GVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNL 447 (659)
Q Consensus 369 ~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 447 (659)
|.++..+++|+.|.+.+|+++ ..+|+.++.+.+|+++..++|.+. ..|+.+..|.+|+.|.|++|.+. .+|+.+.-+
T Consensus 284 P~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL 361 (1255)
T KOG0444|consen 284 PDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLL 361 (1255)
T ss_pred hHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhc
Confidence 777777777888887777765 247778888888888888888776 77788888888888888888876 467888888
Q ss_pred CCCCeeeCcCCcCcccCCC
Q 038552 448 SFMEFLDLSYNHFEGEVPK 466 (659)
Q Consensus 448 ~~L~~l~l~~n~l~~~~p~ 466 (659)
+.|+.||+..|+-..-.|.
T Consensus 362 ~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 362 PDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred CCcceeeccCCcCccCCCC
Confidence 8888888888876544444
No 9
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=99.98 E-value=2e-34 Score=283.48 Aligned_cols=369 Identities=25% Similarity=0.366 Sum_probs=216.2
Q ss_pred CCCCCCCEEEccCCccc-ccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCC
Q 038552 4 SRYSNLIELRVSKNKLE-GQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLV 82 (659)
Q Consensus 4 ~~~~~L~~L~ls~n~~~-~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 82 (659)
+-++-.+-+|+++|.++ +.+|.....+..++-|.|...++. .+|+.++.+.+|++|.+++|.+. .+-..+..++.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 44666777788888887 567777777778887877777766 67777778888888888877763 4445667777777
Q ss_pred EEEeecCcCC-ccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccC
Q 038552 83 DLNVGENRFS-GMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTS 161 (659)
Q Consensus 83 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~ 161 (659)
.+.+.+|++. .-+|..+..+..|..|+|+.|.+. +.|.++- ...++-.|+|++|++..+....+.+++.|-.|||++
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE-~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLE-YAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhh-hhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence 7777777765 346777777777777777777777 7777665 566777777777777644444556777777777777
Q ss_pred CCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhccccCCEEEcccC
Q 038552 162 NQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGAN 241 (659)
Q Consensus 162 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~ 241 (659)
|.+. ..|.....+..|++|.|++|.+.. .....+..++.|++|.+++.+-+
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~h------fQLrQLPsmtsL~vLhms~TqRT---------------------- 210 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNH------FQLRQLPSMTSLSVLHMSNTQRT---------------------- 210 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhH------HHHhcCccchhhhhhhcccccch----------------------
Confidence 7765 344456666677777777665543 12223334444444444443211
Q ss_pred cccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCc
Q 038552 242 QISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPS 321 (659)
Q Consensus 242 ~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 321 (659)
..-+|.++..+.+|..++++.|.+. .+|+.+.++++|+.|+||+|.++ .+..
T Consensus 211 --------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~ 262 (1255)
T KOG0444|consen 211 --------------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNM 262 (1255)
T ss_pred --------------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeec
Confidence 0122333333344444444444443 34444444444444444444443 2222
Q ss_pred cCcCCCCCCEEeCCCcccccccchhhhhcccccceecccccccc-CCCccccccCCCCceeecCCCcccccCCccccCCC
Q 038552 322 SLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLN-GSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACV 400 (659)
Q Consensus 322 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 400 (659)
..+...+|++|+++.|+++ .+|..++.++.++ .|.+.+|++. ..+|..++.+.+|+.+..++|.+. ..|+.+..|.
T Consensus 263 ~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~-kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~ 339 (1255)
T KOG0444|consen 263 TEGEWENLETLNLSRNQLT-VLPDAVCKLTKLT-KLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCV 339 (1255)
T ss_pred cHHHHhhhhhhccccchhc-cchHHHhhhHHHH-HHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhH
Confidence 2223334444555555544 4455555555554 4555555444 234555555555666665555554 5555566666
Q ss_pred CCCeEECCCCCCCCCCcccccCCCCCCEEECCCCccc
Q 038552 401 SLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLS 437 (659)
Q Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 437 (659)
.|+.|.|+.|++. .+|+++.-++.|+.||+..|.-.
T Consensus 340 kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 340 KLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred HHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 6666666666655 45555555666666666666543
No 10
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=99.97 E-value=3.9e-33 Score=286.99 Aligned_cols=442 Identities=27% Similarity=0.374 Sum_probs=349.1
Q ss_pred EEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCc
Q 038552 11 ELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENR 90 (659)
Q Consensus 11 ~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 90 (659)
++|++..+++ .+|..+.+...++.|+++.|.+....-+.+.+.-+|+.|++++|.+ +..|..+..+.+|+.|+++.|.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccc-ccCCchhhhHHHHhhcccchhh
Confidence 4678888887 7888887777799999999988754344556666799999999998 6889999999999999999999
Q ss_pred CCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCC--------
Q 038552 91 FSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSN-------- 162 (659)
Q Consensus 91 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n-------- 162 (659)
+. .+|.+..++.+|++|.|.+|.+. .+|.++. .+.+|++|++++|.+. .+|..+..++.++.+..++|
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~-~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~ 155 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASIS-ELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ 155 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHH-hhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc
Confidence 98 78899999999999999999887 8999887 7999999999999997 56666666665555555555
Q ss_pred -----------CCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhccc
Q 038552 163 -----------QLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSS 231 (659)
Q Consensus 163 -----------~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~ 231 (659)
.+.+.++.+...+.. .|+|++|.+.. ..+..+++|+.|....|++.. +....+
T Consensus 156 ~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---------~dls~~~~l~~l~c~rn~ls~-----l~~~g~ 219 (1081)
T KOG0618|consen 156 TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---------LDLSNLANLEVLHCERNQLSE-----LEISGP 219 (1081)
T ss_pred ccchhhhhhhhhcccchhcchhhhhe--eeecccchhhh---------hhhhhccchhhhhhhhcccce-----EEecCc
Confidence 334444444444443 47777776532 345566677777777666541 111123
Q ss_pred cCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcc
Q 038552 232 TMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLS 311 (659)
Q Consensus 232 ~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 311 (659)
+++.|+..+|.++...+ -....+|+.+++++|.+++ +|++++.+.+|+.+...+|.++ .+|..+....+|+.|...
T Consensus 220 ~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred chheeeeccCcceeecc--ccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 78888888888773332 2344689999999999984 5699999999999999999996 788888888999999999
Q ss_pred CCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccc-cceeccccccccCCCccccccCCCCceeecCCCcccc
Q 038552 312 YNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTL-TLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSG 390 (659)
Q Consensus 312 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l-~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 390 (659)
.|.+. .+|.......+|++|++..|++. ..|..+...... ...++.+.|.+.......=..++.|+.|++.+|.+++
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 99998 67777888999999999999998 566655444332 2257777777764332233456789999999999998
Q ss_pred cCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCcCCcCcccCCCCCcc
Q 038552 391 VIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHFEGEVPKKGVF 470 (659)
Q Consensus 391 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p~~~~~ 470 (659)
..-..+.+...|+.|+|++|++.......+.+++.|++|+||+|+++ .+|+.+..++.|++|...+|++. ..|.....
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l 451 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQL 451 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhc
Confidence 87778899999999999999999666677899999999999999998 56899999999999999999998 56777788
Q ss_pred CCcccccccCCC
Q 038552 471 SNKTKISLQGNV 482 (659)
Q Consensus 471 ~~~~~~~~~~n~ 482 (659)
+.+..++++.|.
T Consensus 452 ~qL~~lDlS~N~ 463 (1081)
T KOG0618|consen 452 PQLKVLDLSCNN 463 (1081)
T ss_pred CcceEEecccch
Confidence 889999998873
No 11
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.92 E-value=7.4e-24 Score=244.69 Aligned_cols=317 Identities=21% Similarity=0.237 Sum_probs=165.6
Q ss_pred cccccCCCC-CCCEEEeecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhcc
Q 038552 71 IPTTLGLLR-NLVDLNVGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLS 149 (659)
Q Consensus 71 ~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~ 149 (659)
+|..|..++ +|+.|.+.++.++ .+|..+ ...+|+.|++++|.+. .++..+. .+++|+.|+++++.....+|. +.
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~-~l~~Lk~L~Ls~~~~l~~ip~-ls 654 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVH-SLTGLRNIDLRGSKNLKEIPD-LS 654 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccc-cCCCCCEEECCCCCCcCcCCc-cc
Confidence 333444332 3555555554443 344443 2345555555555444 3444332 445555555554433333332 44
Q ss_pred CCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhc
Q 038552 150 NASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANL 229 (659)
Q Consensus 150 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~ 229 (659)
.+++|+.|++++|.....+|..++++++|+.|++++|..-. .++..+ ++++|+.|++++|.....+|..
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~------~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---- 723 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE------ILPTGI-NLKSLYRLNLSGCSRLKSFPDI---- 723 (1153)
T ss_pred cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcC------ccCCcC-CCCCCCEEeCCCCCCccccccc----
Confidence 55555555555554434444455555555555555442111 111111 3455555555555433333321
Q ss_pred cccCCEEEcccCcccccCCcccccCCCcCeeecccccCC-------CCCCccccCCCCCcEEEccCCCCCCCCCccccCC
Q 038552 230 SSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLH-------GTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNL 302 (659)
Q Consensus 230 ~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~-------~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 302 (659)
..+++.|++++|.+. .+|..+ .+++|+.|.+.++... ...+..+...++|+.|++++|...+.+|..++++
T Consensus 724 ~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L 801 (1153)
T PLN03210 724 STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNL 801 (1153)
T ss_pred cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCC
Confidence 225556666666554 344333 3555666665543211 1111122334677777777777666777777777
Q ss_pred CCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceee
Q 038552 303 TKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLD 382 (659)
Q Consensus 303 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 382 (659)
++|+.|++++|...+.+|... ++++|+.|++++|.....+|... ..+. .|++++|.+. .+|.++..+++|+.|+
T Consensus 802 ~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~---~nL~-~L~Ls~n~i~-~iP~si~~l~~L~~L~ 875 (1153)
T PLN03210 802 HKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDIS---TNIS-DLNLSRTGIE-EVPWWIEKFSNLSFLD 875 (1153)
T ss_pred CCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccc---cccC-EeECCCCCCc-cChHHHhcCCCCCEEE
Confidence 777777777775545666554 56777777777775544444322 2343 5666666665 4566666666677776
Q ss_pred cCCCcccccCCccccCCCCCCeEECCCCC
Q 038552 383 ISGNQFSGVIPVTLSACVSLEYLNISRNF 411 (659)
Q Consensus 383 L~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 411 (659)
|++|+-...+|..+..++.|+.+++++|.
T Consensus 876 L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 876 MNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCCcCccCcccccccCCCeeecCCCc
Confidence 66643333455556666666666666664
No 12
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.91 E-value=1.1e-22 Score=234.91 Aligned_cols=338 Identities=19% Similarity=0.235 Sum_probs=162.5
Q ss_pred cccCCCCCCCEEEeecCc------CCccCcccccCCC-CCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccC
Q 038552 73 TTLGLLRNLVDLNVGENR------FSGMFPRSICNIS-SLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIP 145 (659)
Q Consensus 73 ~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 145 (659)
.+|.++++|++|.+..+. +...+|..+..++ +|+.|.+.++.+. .+|..+ ...+|+.|++.++.+. .++
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-ccc
Confidence 345666666666665432 1223444454443 4666666666555 555544 3456666666666554 344
Q ss_pred hhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChh
Q 038552 146 NSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHS 225 (659)
Q Consensus 146 ~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~ 225 (659)
..+..+++|+.|+++++.....+| .++.+++|+.|++.+|.... .++..+..+++|+.|++++|.....+|..
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~------~lp~si~~L~~L~~L~L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLV------ELPSSIQYLNKLEDLDMSRCENLEILPTG 700 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCcc------ccchhhhccCCCCEEeCCCCCCcCccCCc
Confidence 445556666666666554333333 25555666666665543221 33444555556666666555433344443
Q ss_pred HHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCC-------CCCCcc
Q 038552 226 IANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQ-------GSIPSS 298 (659)
Q Consensus 226 ~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~-------~~~~~~ 298 (659)
+ .+ .+|+.|++++|.....+|.. .++|+.|++++|.+. .+|..+ .+++|++|++.++... ...+..
T Consensus 701 i-~l-~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~ 773 (1153)
T PLN03210 701 I-NL-KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLM 773 (1153)
T ss_pred C-CC-CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhh
Confidence 3 22 24555555555433333321 234555555555543 233322 3445555555442211 011111
Q ss_pred ccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCC
Q 038552 299 LGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNL 378 (659)
Q Consensus 299 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L 378 (659)
+..+++|+.|++++|...+.+|..++++++|+.|++++|...+.+|..+ +++.+. .|++++|.....+|.. .++|
T Consensus 774 ~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~-~L~Ls~c~~L~~~p~~---~~nL 848 (1153)
T PLN03210 774 TMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLE-SLDLSGCSRLRTFPDI---STNI 848 (1153)
T ss_pred hhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccC-EEECCCCCcccccccc---cccc
Confidence 2223455555555555444555555555555555555554333444433 344444 4555554433333321 2345
Q ss_pred ceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCC
Q 038552 379 VKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSN 434 (659)
Q Consensus 379 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 434 (659)
++|+|++|.++ .+|..+..+++|++|++++|.-...+|..+..+++|+.+++++|
T Consensus 849 ~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 849 SDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence 55555555554 34444555555555555554333334444445555555555555
No 13
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.89 E-value=2.5e-25 Score=208.44 Aligned_cols=283 Identities=19% Similarity=0.188 Sum_probs=175.5
Q ss_pred CcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEEeccC-ccccccChHHHhcCCCCCcEEEc
Q 038552 57 LKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWIYLPF-NRFSGSLPLDIAVNLPNLKALAI 135 (659)
Q Consensus 57 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~~~~~~~~~~~~~l~~L~~L~l 135 (659)
-..++|..|.|+...|.+|+.+++|+.|||++|+|+.+-|++|..+..|..|-+.+ |.++ .+|.+.+.++.+|+.|.+
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhc
Confidence 34556666666555556666666666666666666666666666666665555444 5665 666666666666666666
Q ss_pred cCCcCCcccChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCc------cccccccCCCCCc
Q 038552 136 GGNNFFGSIPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDL------DFVTFLTNCSSLK 209 (659)
Q Consensus 136 ~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~------~~~~~l~~~~~L~ 209 (659)
.-|++..+..+.|..+++|..|.+.+|.+.......|..+..++.+.+..|.+-....-.| ..+...+......
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 6666665556666666666666666666654444466666666666666554211100000 0011111111222
Q ss_pred EEEccCCccccccChhHHhccccCCEEEcccCcccccCC-cccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccC
Q 038552 210 VISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIP-PGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYN 288 (659)
Q Consensus 210 ~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 288 (659)
-..+.++++...-+..+......+..--.+.+...+..| ..|..+++|+.|++++|++++.-+.+|.+...+++|+|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 222222222211111111100011111112222333333 3578899999999999999999899999999999999999
Q ss_pred CCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccc
Q 038552 289 NSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLT 340 (659)
Q Consensus 289 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 340 (659)
|++...-...|.++..|+.|+|++|+++...|.+|..+.+|..|++-.|.+.
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 9998777778899999999999999999889999999999999999877653
No 14
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.88 E-value=5.8e-25 Score=206.05 Aligned_cols=285 Identities=20% Similarity=0.252 Sum_probs=195.9
Q ss_pred cCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeec-CcCCccCccccc
Q 038552 22 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGE-NRFSGMFPRSIC 100 (659)
Q Consensus 22 ~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~ 100 (659)
.+|..+. +.-..+.|..|+|+...+.+|+.+++||.|+|++|.|+.+.|++|.++++|-.|-+.+ |+|+......|+
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 3454443 2456677788888877777888888888888888888888888888888887777766 777755556788
Q ss_pred CCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCcc------------cc
Q 038552 101 NISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKG------------KV 168 (659)
Q Consensus 101 ~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~------------~~ 168 (659)
++..|+.|.+.-|.+. -++.+.+..++++..|.+..|.+..+....+..+..++.+.+..|.+.. ..
T Consensus 138 gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~ 216 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN 216 (498)
T ss_pred hHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence 8888888888888776 6777777778888888888888775555577788888888777765321 11
Q ss_pred ccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChh-HHhccccCCEEEcccCcccccC
Q 038552 169 SIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHS-IANLSSTMTDFRIGANQISGTI 247 (659)
Q Consensus 169 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~-~~~~~~~L~~L~l~~~~~~~~~ 247 (659)
+..++.........+.+.++...... ........+..-..+.+...+..|.. +..++ +|+.+++++|.+++.-
T Consensus 217 ~ietsgarc~~p~rl~~~Ri~q~~a~-----kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~-~L~~lnlsnN~i~~i~ 290 (498)
T KOG4237|consen 217 PIETSGARCVSPYRLYYKRINQEDAR-----KFLCSLESLPSRLSSEDFPDSICPAKCFKKLP-NLRKLNLSNNKITRIE 290 (498)
T ss_pred hhhcccceecchHHHHHHHhcccchh-----hhhhhHHhHHHhhccccCcCCcChHHHHhhcc-cceEeccCCCccchhh
Confidence 22233333333333333333222111 11111111211122233334444543 44444 8888899999888888
Q ss_pred CcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCcc
Q 038552 248 PPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNL 315 (659)
Q Consensus 248 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 315 (659)
+.+|.....++.|.|..|++...-...|.++..|+.|+|.+|+++..-|..|..+.+|.+|.+-.|.+
T Consensus 291 ~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 291 DGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred hhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 88888999999999999988766667788899999999999999988888888889999998877754
No 15
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.83 E-value=1.2e-19 Score=194.27 Aligned_cols=264 Identities=26% Similarity=0.285 Sum_probs=144.4
Q ss_pred CCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEEecc
Q 038552 32 NLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWIYLP 111 (659)
Q Consensus 32 ~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 111 (659)
.-..|+++++.++ .+|..+. ++|+.|++++|.++ .+|. .+++|++|++++|+++ .+|.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 4556777777776 5666554 36777777777774 3443 2467777777777777 34532 3567777777
Q ss_pred CccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCC
Q 038552 112 FNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMG 191 (659)
Q Consensus 112 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ 191 (659)
.|.++ .+|. ...+|+.|++++|+++. +|. ..++|+.|++++|.+++. |.. ..+|+.|++.+|.++..
T Consensus 271 ~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~L 337 (788)
T PRK15387 271 SNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTSL 337 (788)
T ss_pred CCchh-hhhh----chhhcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCC---cccccccccccCccccc
Confidence 77776 5554 23467777777777763 343 235677777777777643 221 23466667777766532
Q ss_pred CCCCccccccccCCCCCcEEEccCCccccccChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCC
Q 038552 192 TANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTI 271 (659)
Q Consensus 192 ~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 271 (659)
. . + ..+|+.|++++|.+. .+|.. +.+++.|++++|.+++ +|.. ..+|+.|++++|.+++ +
T Consensus 338 P-------~-l--p~~Lq~LdLS~N~Ls-~LP~l----p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-L 397 (788)
T PRK15387 338 P-------T-L--PSGLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-L 397 (788)
T ss_pred c-------c-c--ccccceEecCCCccC-CCCCC----Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-C
Confidence 1 1 1 135666666666665 23321 2245555555555552 3322 2345555555555543 2
Q ss_pred CccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhh
Q 038552 272 PDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQL 347 (659)
Q Consensus 272 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 347 (659)
|.. .++|+.|++++|++.+ +|.. ..+|+.|++++|+++ .+|..+..+++|+.+++++|++++..+..+
T Consensus 398 P~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 398 PVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 221 2345555555555542 3322 223445555555554 445555555555555555555554444433
No 16
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.83 E-value=1.5e-19 Score=193.66 Aligned_cols=265 Identities=28% Similarity=0.370 Sum_probs=168.8
Q ss_pred CCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCC
Q 038552 128 PNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSS 207 (659)
Q Consensus 128 ~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~ 207 (659)
..-..|+++.+.++ .+|..+. ++|+.|++.+|+++. +|. .+++|++|++++|+++... . ..++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP-------~---lp~s 263 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLP-------V---LPPG 263 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCccc-------C---cccc
Confidence 34566777777776 4566554 367777777777764 332 2467777777777776431 1 1246
Q ss_pred CcEEEccCCccccccChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEcc
Q 038552 208 LKVISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLY 287 (659)
Q Consensus 208 L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 287 (659)
|+.|+++.|.+. .+|. ....|+.|++++|.++. +|. .+++|+.|++++|.+.+ +|.. ..+|+.|+++
T Consensus 264 L~~L~Ls~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls 330 (788)
T PRK15387 264 LLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAY 330 (788)
T ss_pred cceeeccCCchh-hhhh----chhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC---cccccccccc
Confidence 777777777765 3333 22357777777777763 443 23567788888887774 3332 2456777777
Q ss_pred CCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCC
Q 038552 288 NNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGS 367 (659)
Q Consensus 288 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~ 367 (659)
+|.+.+ +|.. .++|+.|++++|+++ .+|.. .++|+.|++++|.+. .+|... ..+. .|++++|.+.+
T Consensus 331 ~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L~-~LdLs~N~Lt~- 396 (788)
T PRK15387 331 NNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPALP---SGLK-ELIVSGNRLTS- 396 (788)
T ss_pred cCcccc-cccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCcccc---cccc-eEEecCCcccC-
Confidence 777763 4431 246778888888777 34542 245677777777776 355432 3444 67777777763
Q ss_pred CccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhh
Q 038552 368 LPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFL 444 (659)
Q Consensus 368 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 444 (659)
+|.. .++|+.|++++|+++. +|.. ..+|+.|++++|.++ .+|..+..+++|+.|++++|++++..+..+
T Consensus 397 LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 397 LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 4432 2567777888887774 4532 245677788888777 567777777788888888888877766655
No 17
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.76 E-value=5.2e-18 Score=183.19 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=140.0
Q ss_pred CCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhcccc
Q 038552 153 NLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSST 232 (659)
Q Consensus 153 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~ 232 (659)
+...|+++++.++. +|..+. +.|+.|++++|+++.. +..+ +++|+.|++++|.+. .+|..+. .+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~LtsL-------P~~l--~~nL~~L~Ls~N~Lt-sLP~~l~---~~ 242 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELKSL-------PENL--QGNIKTLYANSNQLT-SIPATLP---DT 242 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCcC-------Chhh--ccCCCEEECCCCccc-cCChhhh---cc
Confidence 45677787777763 444332 4677888888877642 2222 246777788777776 4555443 25
Q ss_pred CCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccC
Q 038552 233 MTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSY 312 (659)
Q Consensus 233 L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 312 (659)
|+.|++++|.+. .+|..+. ++|+.|++++|.+. .+|..+. ++|+.|++++|++.+ +|..+. ++|+.|++++
T Consensus 243 L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~ 313 (754)
T PRK15370 243 IQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQS 313 (754)
T ss_pred ccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcC
Confidence 777777777766 4555443 46777777777766 3454432 467777777777663 343322 3566677777
Q ss_pred CccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccC
Q 038552 313 NNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVI 392 (659)
Q Consensus 313 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 392 (659)
|.++. +|..+. ++|+.|++++|.+++ +|..+. +.+. .|++++|++. .+|..+. ++|++|+|++|+++. +
T Consensus 314 N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~-~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-L 382 (754)
T PRK15370 314 NSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQ-VLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-L 382 (754)
T ss_pred Ccccc-CCcccc--ccceeccccCCcccc-CChhhc--Cccc-EEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-C
Confidence 76663 443322 456666666666663 454432 3444 5666666665 3444332 456666666666652 3
Q ss_pred CccccCCCCCCeEECCCCCCCCCCcccc----cCCCCCCEEECCCCccc
Q 038552 393 PVTLSACVSLEYLNISRNFFHGIIPLSL----SSLKSIKEFNVSSNNLS 437 (659)
Q Consensus 393 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~ 437 (659)
|..+. .+|+.|++++|++. .+|..+ ..++.+..|++.+|+++
T Consensus 383 P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 383 PENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 33332 24566666666655 333222 23355566666666654
No 18
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.75 E-value=2.3e-19 Score=180.89 Aligned_cols=208 Identities=23% Similarity=0.283 Sum_probs=145.8
Q ss_pred EEEccCCcccc-cCchhhcCCCCCcEEeccccCCCcc----ccccccCCCCCcEEEccCCccC------cccccccCCCC
Q 038552 11 ELRVSKNKLEG-QIPEEIGSLLNLQTLAIDFNYLTGQ----LPDFVGNLSALKVFYIIGNSLG------GKIPTTLGLLR 79 (659)
Q Consensus 11 ~L~ls~n~~~~-~~~~~~~~~~~L~~L~ls~~~~~~~----~~~~~~~l~~L~~L~l~~n~l~------~~~~~~~~~l~ 79 (659)
.|+|+.+.+++ .....+..+.+|++|+++++.+++. ++..+...++|++|+++++.+. ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 57788888873 3455567778899999999988543 5556678888999999988774 22345567788
Q ss_pred CCCEEEeecCcCCccCcccccCCCC---CCEEeccCcccccc----ChHHHhcCC-CCCcEEEccCCcCCcc----cChh
Q 038552 80 NLVDLNVGENRFSGMFPRSICNISS---LEWIYLPFNRFSGS----LPLDIAVNL-PNLKALAIGGNNFFGS----IPNS 147 (659)
Q Consensus 80 ~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~l~~n~~~~~----~~~~~~~~l-~~L~~L~l~~n~~~~~----~~~~ 147 (659)
+|++|++++|.+.+..+..+..+.+ |++|++++|.+++. +...+. .+ ++|+.|++++|.+++. ++..
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~-~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK-DLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHH-hCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 9999999998887656666655555 99999998887631 222333 45 7888899988888732 3345
Q ss_pred ccCCCCCCEEEccCCCCccc----cccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccc
Q 038552 148 LSNASNLEILDLTSNQLKGK----VSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGE 221 (659)
Q Consensus 148 l~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~ 221 (659)
+..+++|+.|++++|.+++. ++..+..+++|+.|++++|.++..... .+...+..+++|++|++++|.+++.
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--ALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--HHHHHhcccCCCCEEecCCCcCchH
Confidence 66777888888888887742 223345567888888888877643211 2344566777888888888877653
No 19
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.75 E-value=2.5e-18 Score=185.59 Aligned_cols=245 Identities=22% Similarity=0.379 Sum_probs=121.0
Q ss_pred CcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEEeccC
Q 038552 33 LQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWIYLPF 112 (659)
Q Consensus 33 L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 112 (659)
...|+++++.++ .+|..+. ++|+.|++++|.++ .+|..+. ++|++|++++|.++ .+|..+. .+|+.|++++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 344555554444 2343321 34555555555543 2333222 34555555555554 3343332 2455555555
Q ss_pred ccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCCCCCCC
Q 038552 113 NRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNNLGMGT 192 (659)
Q Consensus 113 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 192 (659)
|.+. .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|++++|.+++ +|..+. .+|+.|++++|.++..
T Consensus 251 N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L- 319 (754)
T PRK15370 251 NRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL- 319 (754)
T ss_pred CccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC-
Confidence 5554 4554432 24555555555554 2343332 345555555555543 222221 2455555555555421
Q ss_pred CCCccccccccCCCCCcEEEccCCccccccChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCC
Q 038552 193 ANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIP 272 (659)
Q Consensus 193 ~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 272 (659)
+..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|.++ .+|..+ .++|+.|++++|.++. +|
T Consensus 320 ------P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~---~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~-LP 383 (754)
T PRK15370 320 ------PETL--PPGLKTLEAGENALTS-LPASLP---PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTN-LP 383 (754)
T ss_pred ------Cccc--cccceeccccCCcccc-CChhhc---CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCC-CC
Confidence 1111 1355666666665552 444332 35666666666665 344433 2466777777776663 34
Q ss_pred ccccCCCCCcEEEccCCCCCCCCCcc----ccCCCCCcEEEccCCccc
Q 038552 273 DTIGELKNLQQLSLYNNSLQGSIPSS----LGNLTKLVELPLSYNNLQ 316 (659)
Q Consensus 273 ~~~~~~~~L~~L~l~~n~l~~~~~~~----~~~l~~L~~L~l~~n~l~ 316 (659)
..+. .+|+.|++++|++. .+|.. ++.++.+..|++.+|+++
T Consensus 384 ~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 384 ENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 4332 35667777777766 33432 333466777777777765
No 20
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.74 E-value=2.3e-19 Score=180.86 Aligned_cols=282 Identities=27% Similarity=0.316 Sum_probs=134.3
Q ss_pred EEEccCCCCc-cccccccCCCCCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCccccccChhHHhccccCC
Q 038552 156 ILDLTSNQLK-GKVSIDFSSLKNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMT 234 (659)
Q Consensus 156 ~L~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~ 234 (659)
.|+|..+.++ ......+..+.+|+.++++++.++..... .+...+...++++.++++.+.+.+ .+..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~--~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~~------- 71 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAK--ALASALRPQPSLKELCLSLNETGR-IPRGLQ------- 71 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHH--HHHHHHhhCCCceEEeccccccCC-cchHHH-------
Confidence 3555555555 22233344555677777776665431111 233344455556666666555431 111111
Q ss_pred EEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCC---CcEEEccCCCCCC----CCCccccCC-CCCc
Q 038552 235 DFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKN---LQQLSLYNNSLQG----SIPSSLGNL-TKLV 306 (659)
Q Consensus 235 ~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~---L~~L~l~~n~l~~----~~~~~~~~l-~~L~ 306 (659)
.++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|.+.+ .+...+..+ ++|+
T Consensus 72 -----------~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~ 140 (319)
T cd00116 72 -----------SLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140 (319)
T ss_pred -----------HHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCce
Confidence 12233444556666666666655444444433333 6666666666552 122233344 5666
Q ss_pred EEEccCCccccc----cCccCcCCCCCCEEeCCCcccccc----cchhhhhcccccceeccccccccCC----Ccccccc
Q 038552 307 ELPLSYNNLQGN----IPSSLGNCQILRMFNASRNKLTGA----LPHQLLSITTLTLSLDLSNNLLNGS----LPLQVGN 374 (659)
Q Consensus 307 ~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~~~~l~~~L~l~~n~l~~~----~~~~l~~ 374 (659)
.|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+...+.++ .|++++|.+.+. ++..+..
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~-~L~L~~n~i~~~~~~~l~~~~~~ 219 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE-VLDLNNNGLTDEGASALAETLAS 219 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCC-EEeccCCccChHHHHHHHHHhcc
Confidence 666666665522 223344555666666666665532 122222333444 455555554422 1223344
Q ss_pred CCCCceeecCCCcccccCCcccc-----CCCCCCeEECCCCCCCC----CCcccccCCCCCCEEECCCCccccc----ch
Q 038552 375 LKNLVKLDISGNQFSGVIPVTLS-----ACVSLEYLNISRNFFHG----IIPLSLSSLKSIKEFNVSSNNLSGL----IP 441 (659)
Q Consensus 375 l~~L~~L~L~~n~l~~~~~~~~~-----~~~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~----~~ 441 (659)
+++|++|++++|.+++.....+. ..+.|++|++++|.++. .+...+..+++|+.+++++|.++.. ..
T Consensus 220 ~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~ 299 (319)
T cd00116 220 LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLA 299 (319)
T ss_pred cCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHH
Confidence 55566666666655532221111 12456666666665541 1223344445566666666665533 22
Q ss_pred hhhcCC-CCCCeeeCcCCc
Q 038552 442 EFLKNL-SFMEFLDLSYNH 459 (659)
Q Consensus 442 ~~l~~l-~~L~~l~l~~n~ 459 (659)
..+... +.|+.+++.+|+
T Consensus 300 ~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 300 ESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHhhcCCchhhcccCCCC
Confidence 333333 455555555554
No 21
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.69 E-value=3.7e-19 Score=147.87 Aligned_cols=165 Identities=28% Similarity=0.491 Sum_probs=124.0
Q ss_pred CCCCCCCCEEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCC
Q 038552 3 LSRYSNLIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLV 82 (659)
Q Consensus 3 ~~~~~~L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 82 (659)
+.++++++.|.||+|.++ .+|..+.++.+|+.|++++|++. .+|..++.++.|+.|+++-|.+ ...|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl-~~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRL-NILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhh-hcCccccCCCchhh
Confidence 345666777788888877 66777888888888888888877 6777788888888888877776 56778888888888
Q ss_pred EEEeecCcCC-ccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccC
Q 038552 83 DLNVGENRFS-GMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTS 161 (659)
Q Consensus 83 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~ 161 (659)
.|||.+|++. ..+|..|..++.|+.|++++|.+. -+|.+++ ++++|+.|.++.|.+. ..|..++.++.|++|.+.+
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg-~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG-KLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh-hhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 8888887775 357777777788888888888776 7777777 7788888888877776 4677777788888888887
Q ss_pred CCCccccccccCC
Q 038552 162 NQLKGKVSIDFSS 174 (659)
Q Consensus 162 n~l~~~~~~~l~~ 174 (659)
|.++ .+|..+++
T Consensus 183 nrl~-vlppel~~ 194 (264)
T KOG0617|consen 183 NRLT-VLPPELAN 194 (264)
T ss_pred ceee-ecChhhhh
Confidence 7776 34444443
No 22
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.69 E-value=6.3e-19 Score=146.52 Aligned_cols=158 Identities=30% Similarity=0.513 Sum_probs=92.9
Q ss_pred cccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCC
Q 038552 251 IRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILR 330 (659)
Q Consensus 251 l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~ 330 (659)
+.++++++.|.+++|.++ .+|..+..+.+|+.|++.+|++. .+|..++.++.|+.|++.-|.+. ..|..|+.+|.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344555666666666666 44555666666777777666666 55666666666666666666665 5666666666666
Q ss_pred EEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCC
Q 038552 331 MFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRN 410 (659)
Q Consensus 331 ~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n 410 (659)
.||+++|++.. ..+|..|..++.|+-|+|+.|.+. .+|..++++++|+.|.+.+|
T Consensus 106 vldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 106 VLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence 66666665541 123344444455555555555554 44555555555555555555
Q ss_pred CCCCCCcccccCCCCCCEEECCCCccc
Q 038552 411 FFHGIIPLSLSSLKSIKEFNVSSNNLS 437 (659)
Q Consensus 411 ~l~~~~~~~~~~l~~L~~L~l~~n~l~ 437 (659)
.+. .+|..++.+..|++|++.+|+++
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee
Confidence 554 44555555566666666666555
No 23
>PLN03150 hypothetical protein; Provisional
Probab=99.52 E-value=5.2e-14 Score=152.01 Aligned_cols=118 Identities=31% Similarity=0.522 Sum_probs=103.4
Q ss_pred CCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCc
Q 038552 377 NLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLS 456 (659)
Q Consensus 377 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~ 456 (659)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|+.+..+++|+.|+++
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCC--CccCCcccccccCCCCCcccCCCCCCCCCC
Q 038552 457 YNHFEGEVPKK--GVFSNKTKISLQGNVKLCGGIDELHLPSCP 497 (659)
Q Consensus 457 ~n~l~~~~p~~--~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~ 497 (659)
+|+++|.+|.. ........+++.+|+.+|+.+. .+.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence 99999999964 2234556788999999997432 34564
No 24
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=99.29 E-value=1.1e-13 Score=137.00 Aligned_cols=194 Identities=28% Similarity=0.489 Sum_probs=133.2
Q ss_pred CCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEe
Q 038552 254 LVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFN 333 (659)
Q Consensus 254 l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 333 (659)
+..-...|++.|.+. ++|..++.+..|+.+.+..|.+. .+|..+.++..|.+|+|+.|+++ .+|..+..++ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 344455667777776 56666777777777777777776 66777777777777777777776 5666666665 77777
Q ss_pred CCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCC
Q 038552 334 ASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFH 413 (659)
Q Consensus 334 l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 413 (659)
+++|+++ .+|..++....+. .||.+.|.+. .+|..++++.+|+.|.+..|++. .+|.++. .-.|..||++.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~-~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLA-HLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS 224 (722)
T ss_pred EecCccc-cCCcccccchhHH-Hhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee
Confidence 7777776 6777777666666 6777777776 56667777777777777777776 4555555 345777888888777
Q ss_pred CCCcccccCCCCCCEEECCCCcccccchhhh---cCCCCCCeeeCcCC
Q 038552 414 GIIPLSLSSLKSIKEFNVSSNNLSGLIPEFL---KNLSFMEFLDLSYN 458 (659)
Q Consensus 414 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l---~~l~~L~~l~l~~n 458 (659)
.+|..|.+|..|+.|-|.+|.+.. .|..+ +...-.++|+..-|
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhc
Confidence 677777788888888888887763 34333 22333456666555
No 25
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=99.20 E-value=1.5e-12 Score=121.74 Aligned_cols=62 Identities=21% Similarity=0.358 Sum_probs=31.6
Q ss_pred CCCcEEEccCCCCCCC----CCccccCCCCCcEEEccCCcccc----ccCccCcCCCCCCEEeCCCcccc
Q 038552 279 KNLQQLSLYNNSLQGS----IPSSLGNLTKLVELPLSYNNLQG----NIPSSLGNCQILRMFNASRNKLT 340 (659)
Q Consensus 279 ~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~~~~L~~L~l~~n~l~ 340 (659)
+.|+++...+|++... +...|...+.|+.+.++.|.+.. .+...|..|++|+.||+.+|.++
T Consensus 157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence 4455555555554422 22234444555555555555431 12234556666666666666665
No 26
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=99.16 E-value=1.6e-12 Score=128.91 Aligned_cols=171 Identities=27% Similarity=0.473 Sum_probs=106.9
Q ss_pred CCEEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeec
Q 038552 9 LIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGE 88 (659)
Q Consensus 9 L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 88 (659)
-...|++.|.+. .+|..+..|..|+.+.+..|.+. .+|.++.++..|.+|+|+.|.+ ...|..++.| -|+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nql-S~lp~~lC~l-pLkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQL-SHLPDGLCDL-PLKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchh-hcCChhhhcC-cceeEEEec
Confidence 345566666665 56666666666666666666666 5666666666666666666666 3555555555 366666666
Q ss_pred CcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCcccc
Q 038552 89 NRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKGKV 168 (659)
Q Consensus 89 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 168 (659)
|+++ .+|..++...+|..|+.+.|.+. .+|..+. .+.+|+.|.+..|++. .+|..+..+ .|..||++.|.+. .+
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~-~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG-YLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YL 226 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh-hHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ec
Confidence 6665 56666666666666666666665 5666665 5666666666666665 345555533 3566666666665 45
Q ss_pred ccccCCCCCCCEEECCCCCCC
Q 038552 169 SIDFSSLKNLSWLNLEQNNLG 189 (659)
Q Consensus 169 ~~~l~~l~~L~~L~l~~n~l~ 189 (659)
|..|.+|+.|++|.|.+|.+.
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred chhhhhhhhheeeeeccCCCC
Confidence 556666666666666666554
No 27
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=99.14 E-value=1.6e-11 Score=112.12 Aligned_cols=130 Identities=29% Similarity=0.317 Sum_probs=69.1
Q ss_pred hhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCC
Q 038552 346 QLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKS 425 (659)
Q Consensus 346 ~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 425 (659)
.+..+..++ ++|||+|.++ .+..+..-.|.++.|++|+|.+..+ ..+..+++|+.|||++|.++.. ...-..+.+
T Consensus 279 ~~dTWq~Lt-elDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGN 353 (490)
T KOG1259|consen 279 SADTWQELT-ELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGN 353 (490)
T ss_pred ecchHhhhh-hccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcC
Confidence 334444554 5666666655 3334455556666666666666532 2255566666666666665532 122234555
Q ss_pred CCEEECCCCcccccchhhhcCCCCCCeeeCcCCcCcc--cCCCCCccCCcccccccCCC
Q 038552 426 IKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHFEG--EVPKKGVFSNKTKISLQGNV 482 (659)
Q Consensus 426 L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~~--~~p~~~~~~~~~~~~~~~n~ 482 (659)
++.|.|++|.+... ..++.+-+|..||+++|++.. .+...|.++-++.+.+.+||
T Consensus 354 IKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 354 IKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred EeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 66666666655432 444555556666666666543 23334455555555665555
No 28
>PLN03150 hypothetical protein; Provisional
Probab=99.14 E-value=8.9e-11 Score=127.10 Aligned_cols=110 Identities=35% Similarity=0.526 Sum_probs=102.6
Q ss_pred eeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCc
Q 038552 356 SLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNN 435 (659)
Q Consensus 356 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 435 (659)
.|+|++|.+.|.+|..+..+++|+.|+|++|.+.|.+|..+..+++|+.|+|++|.+.+.+|..++++++|+.|+|++|.
T Consensus 422 ~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred EEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhcCC-CCCCeeeCcCCcCcccCC
Q 038552 436 LSGLIPEFLKNL-SFMEFLDLSYNHFEGEVP 465 (659)
Q Consensus 436 l~~~~~~~l~~l-~~L~~l~l~~n~l~~~~p 465 (659)
++|.+|..+... .++..+++.+|+..|..|
T Consensus 502 l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 502 LSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred ccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999988654 467899999998776555
No 29
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.12 E-value=1.1e-10 Score=121.08 Aligned_cols=180 Identities=35% Similarity=0.544 Sum_probs=82.1
Q ss_pred cCCCcCeeecccccCCCCCCccccCCC-CCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCE
Q 038552 253 NLVNLIALTMEINKLHGTIPDTIGELK-NLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRM 331 (659)
Q Consensus 253 ~l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 331 (659)
.++.+..+++.+|.++ .++....... +|+.|++++|.+. .+|..++.++.|+.|++++|++. .+|...+..+.|+.
T Consensus 114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~ 190 (394)
T COG4886 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190 (394)
T ss_pred cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence 3344555555555554 2233333332 5555555555554 33333455555555555555554 33333334445555
Q ss_pred EeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCC
Q 038552 332 FNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNF 411 (659)
Q Consensus 332 L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 411 (659)
|++++|++. .+|... .....|++|.+++|++. ..+..+.++..+..+.+.+|+
T Consensus 191 L~ls~N~i~-~l~~~~-------------------------~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~ 243 (394)
T COG4886 191 LDLSGNKIS-DLPPEI-------------------------ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243 (394)
T ss_pred eeccCCccc-cCchhh-------------------------hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence 555555554 333333 33334444455544322 223334444444444444444
Q ss_pred CCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCcCCcCcccCC
Q 038552 412 FHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHFEGEVP 465 (659)
Q Consensus 412 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~~~~p 465 (659)
+.. .+..++.+++++.|++++|.++...+ +..+.+++.|++++|.+....|
T Consensus 244 ~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 244 LED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred eee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 442 13344444445555555555543321 4444555555555555444333
No 30
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=99.12 E-value=1.4e-11 Score=115.35 Aligned_cols=198 Identities=22% Similarity=0.264 Sum_probs=99.0
Q ss_pred cccCCCcCeeecccccCCCCCCcc----ccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCC
Q 038552 251 IRNLVNLIALTMEINKLHGTIPDT----IGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNC 326 (659)
Q Consensus 251 l~~l~~L~~L~l~~n~l~~~~~~~----~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 326 (659)
+..++.|++++||+|.+....++. +.++..|++|+|.+|.+...--..++. .|..|. . ......-
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~-------~kk~~~~ 156 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--V-------NKKAASK 156 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--H-------HhccCCC
Confidence 344556666666666665443332 234556666666665544111110000 000000 0 0011223
Q ss_pred CCCCEEeCCCcccccc----cchhhhhcccccceeccccccccCC----CccccccCCCCceeecCCCccccc----CCc
Q 038552 327 QILRMFNASRNKLTGA----LPHQLLSITTLTLSLDLSNNLLNGS----LPLQVGNLKNLVKLDISGNQFSGV----IPV 394 (659)
Q Consensus 327 ~~L~~L~l~~n~l~~~----~~~~~~~~~~l~~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~~~ 394 (659)
+.|+++....|++... +...+...+.+. .+.+..|.+... +...+..+++|+.|||..|.++.. +..
T Consensus 157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~le-evr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 157 PKLRVFICGRNRLENGGATALAEAFQSHPTLE-EVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred cceEEEEeeccccccccHHHHHHHHHhccccc-eEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 4455555555555421 122233333443 455555544321 223566777777777777766522 233
Q ss_pred cccCCCCCCeEECCCCCCCCCCcccc-----cCCCCCCEEECCCCccccc----chhhhcCCCCCCeeeCcCCcC
Q 038552 395 TLSACVSLEYLNISRNFFHGIIPLSL-----SSLKSIKEFNVSSNNLSGL----IPEFLKNLSFMEFLDLSYNHF 460 (659)
Q Consensus 395 ~~~~~~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~l~l~~n~l 460 (659)
.+..++.|++|++++|.+......++ ...|+|+.|.+.+|.++.. +...+...|.|..|++++|.+
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 45666777777777777664432222 2357777777777776532 223344566777777777766
No 31
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.11 E-value=1.7e-11 Score=118.03 Aligned_cols=209 Identities=22% Similarity=0.215 Sum_probs=118.9
Q ss_pred cCCCcCeeecccccCCCCCC-ccccCCCCCcEEEccCCCCCCC--CCccccCCCCCcEEEccCCccccccCc-cCcCCCC
Q 038552 253 NLVNLIALTMEINKLHGTIP-DTIGELKNLQQLSLYNNSLQGS--IPSSLGNLTKLVELPLSYNNLQGNIPS-SLGNCQI 328 (659)
Q Consensus 253 ~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~~~~ 328 (659)
++.+|+.+.|.++....... .....|++++.|+|+.|-+... +......+|+|+.|+++.|.+.-.... .-..++.
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 45556666665554432211 2344566666666666655532 223344566677777766665422111 1123456
Q ss_pred CCEEeCCCcccccc-cchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccC-CccccCCCCCCeEE
Q 038552 329 LRMFNASRNKLTGA-LPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVI-PVTLSACVSLEYLN 406 (659)
Q Consensus 329 L~~L~l~~n~l~~~-~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~L~~L~ 406 (659)
|+.|.++.|.++.. +-..+..++++. .|++..|.....-......+..|++|+|++|++.... -...+.++.|+.|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~-~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLE-VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHH-HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 77777777776622 223344566666 6777777533333334455677888888888775332 13456777788888
Q ss_pred CCCCCCCCC-Cccc-----ccCCCCCCEEECCCCcccccc-hhhhcCCCCCCeeeCcCCcCcc
Q 038552 407 ISRNFFHGI-IPLS-----LSSLKSIKEFNVSSNNLSGLI-PEFLKNLSFMEFLDLSYNHFEG 462 (659)
Q Consensus 407 l~~n~l~~~-~~~~-----~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~l~l~~n~l~~ 462 (659)
++.|.+... .|+. ...+++|+.|+++.|++..-- -..+..+++|+.+.+..|.+..
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888877644 2222 245677888888888774321 1344556667777777777654
No 32
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.11 E-value=1.3e-10 Score=120.44 Aligned_cols=199 Identities=31% Similarity=0.508 Sum_probs=135.2
Q ss_pred cEEEccCCccccccChhHHhccccCCEEEcccCcccccCCcccccCC-CcCeeecccccCCCCCCccccCCCCCcEEEcc
Q 038552 209 KVISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLV-NLIALTMEINKLHGTIPDTIGELKNLQQLSLY 287 (659)
Q Consensus 209 ~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 287 (659)
..+++..+.+.... ..+... ..++.+.+.++.++ .++....... +|+.|++++|++. .+|..++.+++|+.|+++
T Consensus 96 ~~l~~~~~~~~~~~-~~~~~~-~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~ 171 (394)
T COG4886 96 PSLDLNLNRLRSNI-SELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS 171 (394)
T ss_pred ceeeccccccccCc-hhhhcc-cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccC
Confidence 36777777764222 223333 36899999999998 5676777774 9999999999998 455668899999999999
Q ss_pred CCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCC
Q 038552 288 NNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGS 367 (659)
Q Consensus 288 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~ 367 (659)
+|++. .+|...+..+.|+.|++++|.+. .+|........|+++.+++|... ..+..
T Consensus 172 ~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~--------------------- 227 (394)
T COG4886 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSS--------------------- 227 (394)
T ss_pred Cchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchh---------------------
Confidence 99999 66665668899999999999998 66665555566888888888533 23333
Q ss_pred CccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchh
Q 038552 368 LPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPE 442 (659)
Q Consensus 368 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 442 (659)
+..+.++..+.+.+|++.. .+..++.++++++|++++|.++...+ ++.+.+++.|++++|.++...|.
T Consensus 228 ----~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 228 ----LSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ----hhhcccccccccCCceeee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 3444444445555555442 24445555566666666666653322 55566666666666666554443
No 33
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=99.08 E-value=2.7e-11 Score=110.75 Aligned_cols=133 Identities=26% Similarity=0.288 Sum_probs=105.7
Q ss_pred CCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCe
Q 038552 325 NCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEY 404 (659)
Q Consensus 325 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~ 404 (659)
....|+.+|+++|.++ .+.+++.-.+.++ .|++|+|.+... ..+..+++|+.||||+|.++. +...-..+.++++
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir-~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLR-RLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKT 356 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhcccee-EEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEee
Confidence 3456888888888887 6677777777777 788999988744 348889999999999999874 3334456788999
Q ss_pred EECCCCCCCCCCcccccCCCCCCEEECCCCcccccch-hhhcCCCCCCeeeCcCCcCcccC
Q 038552 405 LNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIP-EFLKNLSFMEFLDLSYNHFEGEV 464 (659)
Q Consensus 405 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~l~l~~n~l~~~~ 464 (659)
|+|++|.+... ..++.+-+|..||+++|++..... ..++++|-|+.+.+.+|++.+.+
T Consensus 357 L~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 357 LKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred eehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 99999998743 467788899999999999976532 56789999999999999998644
No 34
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.04 E-value=4.9e-11 Score=114.89 Aligned_cols=161 Identities=20% Similarity=0.219 Sum_probs=83.4
Q ss_pred CCCCCcEEeccccCCCcccc--ccccCCCCCcEEEccCCccCccc--ccccCCCCCCCEEEeecCcCCccCc-ccccCCC
Q 038552 29 SLLNLQTLAIDFNYLTGQLP--DFVGNLSALKVFYIIGNSLGGKI--PTTLGLLRNLVDLNVGENRFSGMFP-RSICNIS 103 (659)
Q Consensus 29 ~~~~L~~L~ls~~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~ 103 (659)
++.+|+.+.+.++.+. ..+ .....|++++.|+|++|-+..-. ......|++|+.|+++.|.+..... ..-..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4556666666665554 222 24456666666666666543211 1223556666666666666541111 1112455
Q ss_pred CCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCcccc-ccccCCCCCCCEEE
Q 038552 104 SLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKGKV-SIDFSSLKNLSWLN 182 (659)
Q Consensus 104 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~ 182 (659)
+|+.|.++.|.++..--..+...+|+|+.|++.+|.....-......+..|++|||++|++-... ....+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 66666666666652222223335666666666666422222233445556666666666654322 12345566666666
Q ss_pred CCCCCCCC
Q 038552 183 LEQNNLGM 190 (659)
Q Consensus 183 l~~n~l~~ 190 (659)
++.+.+..
T Consensus 278 ls~tgi~s 285 (505)
T KOG3207|consen 278 LSSTGIAS 285 (505)
T ss_pred ccccCcch
Confidence 66665544
No 35
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=99.04 E-value=2.1e-10 Score=126.73 Aligned_cols=127 Identities=25% Similarity=0.367 Sum_probs=72.1
Q ss_pred CCCEEEccCCcccccCchhhcCCCCCcEEeccccC--CCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEE
Q 038552 8 NLIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNY--LTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLN 85 (659)
Q Consensus 8 ~L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~--~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 85 (659)
..+.+.+-+|.+. .++... .++.|++|-+..|. +....++.|..++.|++|||++|.-.+.+|..++.|-+||+|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 3455555555443 223322 23456666666664 3323333456666677777766654456666666666777777
Q ss_pred eecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcEEEccCC
Q 038552 86 VGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGN 138 (659)
Q Consensus 86 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 138 (659)
++++.+. .+|..++++..|.+|++..+.....+ ..+...+.+|++|.+...
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccc-cchhhhcccccEEEeecc
Confidence 6666666 56666666666666666655443233 233324666666666544
No 36
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.01 E-value=2.7e-10 Score=100.30 Aligned_cols=127 Identities=24% Similarity=0.358 Sum_probs=33.9
Q ss_pred CCCCCcEEeccccCCCcccccccc-CCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccc-cCCCCCC
Q 038552 29 SLLNLQTLAIDFNYLTGQLPDFVG-NLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSI-CNISSLE 106 (659)
Q Consensus 29 ~~~~L~~L~ls~~~~~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~ 106 (659)
++.+++.|+|.+|.|.. + +.++ .+.+|+.|++++|.+... +.+..+++|++|++++|.++. +...+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 44455566666665552 2 1233 355566666666655322 235555666666666666552 22223 2455666
Q ss_pred EEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccC---hhccCCCCCCEEEcc
Q 038552 107 WIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIP---NSLSNASNLEILDLT 160 (659)
Q Consensus 107 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~---~~l~~l~~L~~L~l~ 160 (659)
+|++++|.+..--.......+++|+.|++.+|.++.... ..+..+|+|+.||-.
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 666666655421111111245666666666666553211 135566777776654
No 37
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.00 E-value=2.9e-10 Score=100.13 Aligned_cols=83 Identities=24% Similarity=0.263 Sum_probs=31.0
Q ss_pred cccCCCCceeecCCCcccccCCccc-cCCCCCCeEECCCCCCCCCC-cccccCCCCCCEEECCCCcccccc---hhhhcC
Q 038552 372 VGNLKNLVKLDISGNQFSGVIPVTL-SACVSLEYLNISRNFFHGII-PLSLSSLKSIKEFNVSSNNLSGLI---PEFLKN 446 (659)
Q Consensus 372 l~~l~~L~~L~L~~n~l~~~~~~~~-~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~ 446 (659)
+..++.|++|++++|.++.. ...+ ..+++|++|++++|++.... -..+..+++|+.|++.+|+++... ...+..
T Consensus 60 l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~ 138 (175)
T PF14580_consen 60 LPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYK 138 (175)
T ss_dssp ----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH
T ss_pred ccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHH
Confidence 44456666666666666633 2223 34666666666666665321 134556677777777777765431 123456
Q ss_pred CCCCCeeeC
Q 038552 447 LSFMEFLDL 455 (659)
Q Consensus 447 l~~L~~l~l 455 (659)
+|+|+.||-
T Consensus 139 lP~Lk~LD~ 147 (175)
T PF14580_consen 139 LPSLKVLDG 147 (175)
T ss_dssp -TT-SEETT
T ss_pred cChhheeCC
Confidence 677766654
No 38
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=98.98 E-value=5.4e-10 Score=123.52 Aligned_cols=128 Identities=22% Similarity=0.249 Sum_probs=70.3
Q ss_pred CCCcEEeccccCCCccccccccCCCCCcEEEccCCc--cCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEE
Q 038552 31 LNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNS--LGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWI 108 (659)
Q Consensus 31 ~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 108 (659)
...+...+-+|.+. .++.. ..++.|++|-+.+|. +....+..|..++.|++|||++|.--+.+|..++++-+||+|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 34555555555543 22222 223356666666654 322223335566666666666655445666666666666666
Q ss_pred eccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCC
Q 038552 109 YLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSN 162 (659)
Q Consensus 109 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n 162 (659)
++++..+. .+|.++. ++..|.+|++..+.....+|.....+++|++|.+...
T Consensus 601 ~L~~t~I~-~LP~~l~-~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLG-NLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred cccCCCcc-ccchHHH-HHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence 66666665 6666665 5666666666655544444444455666666655443
No 39
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.84 E-value=2.2e-09 Score=77.50 Aligned_cols=59 Identities=34% Similarity=0.517 Sum_probs=31.1
Q ss_pred CCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCc
Q 038552 377 NLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNN 435 (659)
Q Consensus 377 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 435 (659)
+|++|++++|+++...+..|.++++|++|++++|.+....+..|.++++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554444455555555555555555554444455555555555555554
No 40
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.80 E-value=2.6e-09 Score=77.14 Aligned_cols=61 Identities=36% Similarity=0.574 Sum_probs=57.2
Q ss_pred CCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCcCCcC
Q 038552 400 VSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHF 460 (659)
Q Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l 460 (659)
++|++|++++|++....+..|.++++|+.|++++|.++...|..|..+++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999988888999999999999999999988889999999999999999975
No 41
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=98.80 E-value=1.2e-10 Score=118.83 Aligned_cols=123 Identities=28% Similarity=0.316 Sum_probs=51.4
Q ss_pred eccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcc
Q 038552 357 LDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNL 436 (659)
Q Consensus 357 L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 436 (659)
.++++|.+. .+..++.-++.|+.|+|++|+++... .+..|+.|++|||++|.+....--...++. |+.|++++|.+
T Consensus 169 a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l 244 (1096)
T KOG1859|consen 169 ASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNAL 244 (1096)
T ss_pred hhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHH
Confidence 344444443 22233444444444455555444332 344444455555555544422211222232 44555555544
Q ss_pred cccchhhhcCCCCCCeeeCcCCcCcccCC--CCCccCCcccccccCCCCCc
Q 038552 437 SGLIPEFLKNLSFMEFLDLSYNHFEGEVP--KKGVFSNKTKISLQGNVKLC 485 (659)
Q Consensus 437 ~~~~~~~l~~l~~L~~l~l~~n~l~~~~p--~~~~~~~~~~~~~~~n~~lc 485 (659)
+.. ..+.++.+|+.||+++|-+++.-. ..+.+..+..+.+.|||--|
T Consensus 245 ~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 245 TTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred Hhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 432 334444445555555554443111 11223334444455554444
No 42
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=98.76 E-value=1.3e-09 Score=113.00 Aligned_cols=57 Identities=30% Similarity=0.404 Sum_probs=27.2
Q ss_pred CceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCccc
Q 038552 378 LVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLS 437 (659)
Q Consensus 378 L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 437 (659)
|+.+++++|++.. .+..+..+..+..|++.+|++... ..+...+.+..+....|.+.
T Consensus 234 L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 234 LRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred HHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 5555555555542 223344455555555555555432 12333444444555555443
No 43
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=98.72 E-value=2.8e-09 Score=110.54 Aligned_cols=214 Identities=30% Similarity=0.326 Sum_probs=139.6
Q ss_pred CCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccC
Q 038552 233 MTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSY 312 (659)
Q Consensus 233 L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 312 (659)
+..+.+..|.+.. +-..++.+++|..+++.+|.+..... .+..+++|++|++++|.|....+ +..++.|+.|++++
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhheecc
Confidence 3344444454442 22335677788888888888764322 25678888888888888874432 56667788888888
Q ss_pred CccccccCccCcCCCCCCEEeCCCcccccccc-hhhhhcccccceeccccccccCCCccccccCCCCceeecCCCccccc
Q 038552 313 NNLQGNIPSSLGNCQILRMFNASRNKLTGALP-HQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGV 391 (659)
Q Consensus 313 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 391 (659)
|.+.. + ..+..++.|+.+++++|++...-+ . ...+..+. .+++.+|.+... ..+..+..+..+++..|.++..
T Consensus 150 N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~-~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 150 NLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLE-ELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred Ccchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchH-HHhccCCchhcc--cchHHHHHHHHhhcccccceec
Confidence 88873 2 245557888888888888874333 1 45566666 678888877533 2344445555667788877643
Q ss_pred CCccccCCCC--CCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeCcCCcCc
Q 038552 392 IPVTLSACVS--LEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDLSYNHFE 461 (659)
Q Consensus 392 ~~~~~~~~~~--L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l~~n~l~ 461 (659)
.+ +..+.. |+.+++++|++.. .+..+..+..+..+++.+|.+... ..+...+.+..+....|++.
T Consensus 224 ~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 224 EG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 22 223333 7888888888873 334567778888888888887655 34555666677777777665
No 44
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=98.60 E-value=1.2e-09 Score=111.83 Aligned_cols=128 Identities=29% Similarity=0.293 Sum_probs=100.3
Q ss_pred CCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEEC
Q 038552 328 ILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNI 407 (659)
Q Consensus 328 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l 407 (659)
.|...+++.|.+. ....++.-++.++ .|+|++|++.... .+..++.|++|||++|.+....--....|. |+.|++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale-~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALE-SLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhh-hhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeee
Confidence 4677788888887 5667777778887 8999999987553 788999999999999999744333444555 999999
Q ss_pred CCCCCCCCCcccccCCCCCCEEECCCCcccccch-hhhcCCCCCCeeeCcCCcCcc
Q 038552 408 SRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIP-EFLKNLSFMEFLDLSYNHFEG 462 (659)
Q Consensus 408 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~l~l~~n~l~~ 462 (659)
++|.++.. ..+.++.+|+.||+++|-+.+.-. ..+..+..|..|++.+|++.+
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99988744 357788999999999998877532 445667778999999999965
No 45
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=98.59 E-value=7.3e-08 Score=96.92 Aligned_cols=68 Identities=29% Similarity=0.389 Sum_probs=57.1
Q ss_pred cCCChHHHHHHHhccc-cccccccccc-hhhhccccchhhhhHHHHHHHHHHHHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 572 EGLTLHEYAKMALQEK-VMEIIDPSLL-MDVIENNSKIREDRRAKLEECLNAIIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 572 ~~~~l~~~~~~~~~~~-~~~i~d~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+..++++|++..+.++ +.+|+||++. +.+.. .+++.+++++|+.|++++|.+||+|.+||++|+.
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~-------------~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD-------------EKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCCh-------------HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 4556999999999986 9999999997 33332 0578899999999999999999999999999976
Q ss_pred HHH
Q 038552 650 TRE 652 (659)
Q Consensus 650 ~~~ 652 (659)
+..
T Consensus 352 ~~~ 354 (361)
T KOG1187|consen 352 ILS 354 (361)
T ss_pred hcc
Confidence 643
No 46
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]
Probab=98.42 E-value=6e-09 Score=95.60 Aligned_cols=158 Identities=22% Similarity=0.244 Sum_probs=91.0
Q ss_pred CCCcEEEccCCcCCcc-cChhccCCCCCCEEEccCCCCccccccccCCCCCCCEEECCCCC-CCCCCCCCccccccccCC
Q 038552 128 PNLKALAIGGNNFFGS-IPNSLSNASNLEILDLTSNQLKGKVSIDFSSLKNLSWLNLEQNN-LGMGTANDLDFVTFLTNC 205 (659)
Q Consensus 128 ~~L~~L~l~~n~~~~~-~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~l~~~ 205 (659)
+.|+++||+...++.. ...-+..|.+|+.|.+.++.+.+.+...+.+-.+|+.|+++.++ ++. ...-..+.+|
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~-----n~~~ll~~sc 259 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTE-----NALQLLLSSC 259 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccch-----hHHHHHHHhh
Confidence 3578888877766522 22346678888888888888887777778888888888887653 221 1333456788
Q ss_pred CCCcEEEccCCcccccc-ChhHHhccccCCEEEcccCccc---ccCCcccccCCCcCeeecccc-cCCCCCCccccCCCC
Q 038552 206 SSLKVISLYANQFGGEL-PHSIANLSSTMTDFRIGANQIS---GTIPPGIRNLVNLIALTMEIN-KLHGTIPDTIGELKN 280 (659)
Q Consensus 206 ~~L~~L~l~~n~~~~~~-~~~~~~~~~~L~~L~l~~~~~~---~~~~~~l~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~ 280 (659)
+.|..|++++|.+..+. .-.+.....+++.|+++++.-. ..+..-...+++|.+|||++| .++......|..++-
T Consensus 260 s~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~ 339 (419)
T KOG2120|consen 260 SRLDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNY 339 (419)
T ss_pred hhHhhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcch
Confidence 88888888888654332 2233444556777777665211 011111234555555555554 222222223334444
Q ss_pred CcEEEccCCC
Q 038552 281 LQQLSLYNNS 290 (659)
Q Consensus 281 L~~L~l~~n~ 290 (659)
|++|.++.|.
T Consensus 340 L~~lSlsRCY 349 (419)
T KOG2120|consen 340 LQHLSLSRCY 349 (419)
T ss_pred heeeehhhhc
Confidence 4555444443
No 47
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]
Probab=98.28 E-value=3.1e-08 Score=91.06 Aligned_cols=180 Identities=17% Similarity=0.167 Sum_probs=113.5
Q ss_pred CCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCC-Cccc-cccccCCCCCCCEE
Q 038552 104 SLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQ-LKGK-VSIDFSSLKNLSWL 181 (659)
Q Consensus 104 ~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~-l~~~-~~~~l~~l~~L~~L 181 (659)
.|+++||++..++..--..+...+.+|+.|.+.++++...+-..+++-..|+.|+++.++ ++.. ...-+.+++.|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 578888887777644444555567888888888888877777778888888888888763 3211 12235678888888
Q ss_pred ECCCCCCCCCCCCCccccccccCCCCCcEEEccCCc--cccccChhHHhccccCCEEEcccCc-ccccCCcccccCCCcC
Q 038552 182 NLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQ--FGGELPHSIANLSSTMTDFRIGANQ-ISGTIPPGIRNLVNLI 258 (659)
Q Consensus 182 ~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~--~~~~~~~~~~~~~~~L~~L~l~~~~-~~~~~~~~l~~l~~L~ 258 (659)
+++++.+...... .... .--++|+.|+++++. +...-...+..-.+++..|++++|. ++......+.+++.|+
T Consensus 266 NlsWc~l~~~~Vt--v~V~--hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~ 341 (419)
T KOG2120|consen 266 NLSWCFLFTEKVT--VAVA--HISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQ 341 (419)
T ss_pred CchHhhccchhhh--HHHh--hhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchhe
Confidence 8888866542110 0111 112567778887763 2222223344445578888888774 3333334567888899
Q ss_pred eeecccccCCCCCCc---cccCCCCCcEEEccCC
Q 038552 259 ALTMEINKLHGTIPD---TIGELKNLQQLSLYNN 289 (659)
Q Consensus 259 ~L~l~~n~l~~~~~~---~~~~~~~L~~L~l~~n 289 (659)
+|.++.|.. .+|+ .+...|+|.+|++.++
T Consensus 342 ~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 342 HLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred eeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 999988854 3444 3455677777776654
No 48
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=98.23 E-value=3.9e-07 Score=82.85 Aligned_cols=120 Identities=23% Similarity=0.320 Sum_probs=61.7
Q ss_pred cccccCCCCCcEEEccCCccccccChhHHhccccCCEEEcccCcccccCCcccccCCCcCeeecccccCCCCCCccc---
Q 038552 199 VTFLTNCSSLKVISLYANQFGGELPHSIANLSSTMTDFRIGANQISGTIPPGIRNLVNLIALTMEINKLHGTIPDTI--- 275 (659)
Q Consensus 199 ~~~l~~~~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~--- 275 (659)
...+-.|++|+..+|+.|.|....|..+..+ ++.-+.|++|.|++|.+.-.-..-+
T Consensus 85 l~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~---------------------is~~t~l~HL~l~NnGlGp~aG~rigka 143 (388)
T COG5238 85 LKALLKCPRLQKVDLSDNAFGSEFPEELGDL---------------------ISSSTDLVHLKLNNNGLGPIAGGRIGKA 143 (388)
T ss_pred HHHHhcCCcceeeeccccccCcccchHHHHH---------------------HhcCCCceeEEeecCCCCccchhHHHHH
Confidence 3456677788888888777776666655442 2344455555555554431111111
Q ss_pred ----------cCCCCCcEEEccCCCCCCCCCc-----cccCCCCCcEEEccCCccccccC-----ccCcCCCCCCEEeCC
Q 038552 276 ----------GELKNLQQLSLYNNSLQGSIPS-----SLGNLTKLVELPLSYNNLQGNIP-----SSLGNCQILRMFNAS 335 (659)
Q Consensus 276 ----------~~~~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~-----~~~~~~~~L~~L~l~ 335 (659)
..-|.|+.+....|++.. .+. .+..-..|+++.+..|.+....- ..+..+.+|+.||+.
T Consensus 144 l~~la~nKKaa~kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlq 222 (388)
T COG5238 144 LFHLAYNKKAADKPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQ 222 (388)
T ss_pred HHHHHHHhhhccCCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeecc
Confidence 123556666666666541 111 11122456666666665442110 122345666777777
Q ss_pred Ccccc
Q 038552 336 RNKLT 340 (659)
Q Consensus 336 ~n~l~ 340 (659)
+|-++
T Consensus 223 DNtft 227 (388)
T COG5238 223 DNTFT 227 (388)
T ss_pred ccchh
Confidence 66665
No 49
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=98.22 E-value=6.9e-07 Score=82.37 Aligned_cols=186 Identities=19% Similarity=0.142 Sum_probs=90.9
Q ss_pred CCCCCcEEeccccCCCc--cccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCc-cCcccccCCCCC
Q 038552 29 SLLNLQTLAIDFNYLTG--QLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSG-MFPRSICNISSL 105 (659)
Q Consensus 29 ~~~~L~~L~ls~~~~~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L 105 (659)
.+..++.+||.+|.++. .+...+.++|.|++|+|+.|.+...+-..-..+.+|++|-|.+..+.- .....+..++.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 45566777777776653 233344567777777777776643322111345667777776665541 233345556666
Q ss_pred CEEeccCccccccChH--H-HhcCCCCCcEEEccCCcCCc--ccChhccCCCCCCEEEccCCCCccc-cccccCCCCCCC
Q 038552 106 EWIYLPFNRFSGSLPL--D-IAVNLPNLKALAIGGNNFFG--SIPNSLSNASNLEILDLTSNQLKGK-VSIDFSSLKNLS 179 (659)
Q Consensus 106 ~~L~l~~n~~~~~~~~--~-~~~~l~~L~~L~l~~n~~~~--~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~l~~l~~L~ 179 (659)
+.|.++.|.+. .+.. + +..--+.++++.+-.|.... .+...-.-++++..+-+..|.+... ....+..++.+.
T Consensus 149 telHmS~N~~r-q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~ 227 (418)
T KOG2982|consen 149 TELHMSDNSLR-QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLS 227 (418)
T ss_pred hhhhhccchhh-hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcch
Confidence 66666666432 1100 0 00001233344433332210 0000112234455555555544322 122344455555
Q ss_pred EEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCcccc
Q 038552 180 WLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGG 220 (659)
Q Consensus 180 ~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~ 220 (659)
-|+|..+++. .|+..+.+..+++|..|.+.++++.+
T Consensus 228 ~LnL~~~~id-----swasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 228 CLNLGANNID-----SWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred hhhhcccccc-----cHHHHHHHcCCchhheeeccCCcccc
Confidence 6666666553 23555666666667766666666543
No 50
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=98.21 E-value=1.7e-07 Score=85.17 Aligned_cols=66 Identities=23% Similarity=0.216 Sum_probs=33.2
Q ss_pred cccCCCcCeeecccccCCCCC----CccccCCCCCcEEEccCCCCCCCCCccc------cCCCCCcEEEccCCccc
Q 038552 251 IRNLVNLIALTMEINKLHGTI----PDTIGELKNLQQLSLYNNSLQGSIPSSL------GNLTKLVELPLSYNNLQ 316 (659)
Q Consensus 251 l~~l~~L~~L~l~~n~l~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~~~------~~l~~L~~L~l~~n~l~ 316 (659)
+..+.+|+.||+.+|.++-.. ...+...+.|+.|.+.+|-++......+ ...|+|..|...+|...
T Consensus 210 l~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 210 LFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred HHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 445566666666666654322 1233344556666666665553322211 12455555555555544
No 51
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=98.20 E-value=1.6e-07 Score=76.13 Aligned_cols=84 Identities=21% Similarity=0.281 Sum_probs=41.3
Q ss_pred CCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECCCCcccccchhhhcCCCCCCeeeC
Q 038552 376 KNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLSGLIPEFLKNLSFMEFLDL 455 (659)
Q Consensus 376 ~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~l~l 455 (659)
..|+..+|++|.+....+..-...+.+++|++++|.++ .+|..+..++.|+.|+++.|.+.. .|..+..+.++-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~-~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNA-EPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCcccc-chHHHHHHHhHHHhcC
Confidence 34444455555554322222223345555555555555 344445555555555555555542 2444444555555555
Q ss_pred cCCcCc
Q 038552 456 SYNHFE 461 (659)
Q Consensus 456 ~~n~l~ 461 (659)
.+|.+.
T Consensus 131 ~~na~~ 136 (177)
T KOG4579|consen 131 PENARA 136 (177)
T ss_pred CCCccc
Confidence 555443
No 52
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=98.11 E-value=8.5e-07 Score=81.79 Aligned_cols=187 Identities=21% Similarity=0.214 Sum_probs=86.8
Q ss_pred CCCcCeeecccccCCCC--CCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccc-cCccCcCCCCCC
Q 038552 254 LVNLIALTMEINKLHGT--IPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGN-IPSSLGNCQILR 330 (659)
Q Consensus 254 l~~L~~L~l~~n~l~~~--~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~ 330 (659)
++.++.+||.+|.++.. +...+.++|.|+.|+++.|++...+-..-....+|+.|.|.+..+... ....+..+|.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 34455555555555431 222344566666677766666533222113445666666666655432 223445566666
Q ss_pred EEeCCCcccccccchhhhhcccccceeccccccccCCCc--cccccCCCCceeecCCCcccccCCccccCCCCCCeEECC
Q 038552 331 MFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLP--LQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNIS 408 (659)
Q Consensus 331 ~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~ 408 (659)
.|.++.|.+. .+++..|.....-+ ..+...+.+..+.++-|++... ++++..+.+.
T Consensus 150 elHmS~N~~r---------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~ 207 (418)
T KOG2982|consen 150 ELHMSDNSLR---------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVC 207 (418)
T ss_pred hhhhccchhh---------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeee
Confidence 6666666443 22333332221111 0111222222222233333222 2345555555
Q ss_pred CCCCCCC-CcccccCCCCCCEEECCCCcccccc-hhhhcCCCCCCeeeCcCCcCcc
Q 038552 409 RNFFHGI-IPLSLSSLKSIKEFNVSSNNLSGLI-PEFLKNLSFMEFLDLSYNHFEG 462 (659)
Q Consensus 409 ~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~l~l~~n~l~~ 462 (659)
.|.+... ....+..++.+..|+|+.|++..-- -+.+..++.|..|.+++|++..
T Consensus 208 e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 208 EGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 5554322 1223344455556666666653211 1445556666666666666643
No 53
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=97.99 E-value=5e-07 Score=73.41 Aligned_cols=105 Identities=24% Similarity=0.286 Sum_probs=68.7
Q ss_pred cCeeecccccCCCCCCcc---ccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEe
Q 038552 257 LIALTMEINKLHGTIPDT---IGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFN 333 (659)
Q Consensus 257 L~~L~l~~n~l~~~~~~~---~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 333 (659)
+..++|+.|++. .+++. +.....|..++|++|.+....+..-..++.++.|++++|.++ .+|..+..++.|+.++
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 344566666553 22332 334556667788888887433333344567788888888887 6777788888888888
Q ss_pred CCCcccccccchhhhhcccccceecccccccc
Q 038552 334 ASRNKLTGALPHQLLSITTLTLSLDLSNNLLN 365 (659)
Q Consensus 334 l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~ 365 (659)
++.|.+. ..|..+..+.++. .|+..+|.+.
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~-~Lds~~na~~ 136 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLD-MLDSPENARA 136 (177)
T ss_pred cccCccc-cchHHHHHHHhHH-HhcCCCCccc
Confidence 8888877 5666666666666 6777777665
No 54
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.89 E-value=3.9e-05 Score=76.47 Aligned_cols=57 Identities=16% Similarity=0.180 Sum_probs=29.6
Q ss_pred cccCCCcCeeecccccCCCCCCccccCCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCC
Q 038552 251 IRNLVNLIALTMEINKLHGTIPDTIGELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYN 313 (659)
Q Consensus 251 l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 313 (659)
+..+..+..|++++|.+. .+|. -..+|+.|.+++|.-...+|..+ .++|+.|++++|
T Consensus 48 ~~~~~~l~~L~Is~c~L~-sLP~---LP~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~C 104 (426)
T PRK15386 48 IEEARASGRLYIKDCDIE-SLPV---LPNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHC 104 (426)
T ss_pred HHHhcCCCEEEeCCCCCc-ccCC---CCCCCcEEEccCCCCcccCCchh--hhhhhheEccCc
Confidence 334566666777666555 2331 12356666666644333444433 235666666655
No 55
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]
Probab=97.83 E-value=6e-06 Score=89.50 Aligned_cols=119 Identities=19% Similarity=0.300 Sum_probs=51.8
Q ss_pred CCCCCEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCCCEEEccCCCCcc-ccccccCCCCCCCE
Q 038552 102 ISSLEWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNLEILDLTSNQLKG-KVSIDFSSLKNLSW 180 (659)
Q Consensus 102 l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~ 180 (659)
+|.|+.|.+.+-.+...--..+...+++|..||+++++++.. .+++++++|++|.+.+-.+.. ..-.++.+|++|++
T Consensus 147 LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L~v 224 (699)
T KOG3665|consen 147 LPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLFNLKKLRV 224 (699)
T ss_pred CcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHhcccCCCe
Confidence 455555555544332221122333455555555555555432 445555555555555433321 11123445555555
Q ss_pred EECCCCCCCCCCCCCccccccccCCCCCcEEEccCCcccccc
Q 038552 181 LNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGGEL 222 (659)
Q Consensus 181 L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~~~ 222 (659)
||++.........-...+.+.-..+|+|+.||.+++.+.+.+
T Consensus 225 LDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~ 266 (699)
T KOG3665|consen 225 LDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEI 266 (699)
T ss_pred eeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHH
Confidence 555554332211000011122223455555555555544433
No 56
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.77 E-value=3.3e-05 Score=50.76 Aligned_cols=35 Identities=37% Similarity=0.541 Sum_probs=13.3
Q ss_pred CCeEECCCCCCCCCCcccccCCCCCCEEECCCCccc
Q 038552 402 LEYLNISRNFFHGIIPLSLSSLKSIKEFNVSSNNLS 437 (659)
Q Consensus 402 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 437 (659)
|++|++++|+++ .+|..++++++|+.|++++|+++
T Consensus 3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 344444444444 22223444444444444444443
No 57
>KOG4341 consensus F-box protein containing LRR [General function prediction only]
Probab=97.76 E-value=8.3e-07 Score=85.82 Aligned_cols=136 Identities=21% Similarity=0.170 Sum_probs=60.5
Q ss_pred CCCCCcEEEccCCc-cccccChhHHhccccCCEEEcccCc-ccccCCccc-ccCCCcCeeecccccCCC--CCCccccCC
Q 038552 204 NCSSLKVISLYANQ-FGGELPHSIANLSSTMTDFRIGANQ-ISGTIPPGI-RNLVNLIALTMEINKLHG--TIPDTIGEL 278 (659)
Q Consensus 204 ~~~~L~~L~l~~n~-~~~~~~~~~~~~~~~L~~L~l~~~~-~~~~~~~~l-~~l~~L~~L~l~~n~l~~--~~~~~~~~~ 278 (659)
.|..|+.|+.+++. +++.....++....+|+.+.+..|+ |+..-...+ .+++.|+.+++..+.... .+...-.++
T Consensus 292 ~c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C 371 (483)
T KOG4341|consen 292 GCHALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNC 371 (483)
T ss_pred hhhHhhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCC
Confidence 34455555554442 2222222333333455555555553 221111111 244556666665553321 111222345
Q ss_pred CCCcEEEccCCCCCCCC-----CccccCCCCCcEEEccCCcccc-ccCccCcCCCCCCEEeCCCccc
Q 038552 279 KNLQQLSLYNNSLQGSI-----PSSLGNLTKLVELPLSYNNLQG-NIPSSLGNCQILRMFNASRNKL 339 (659)
Q Consensus 279 ~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~l~~n~l 339 (659)
+.|+.+.+++|...... ...-..+..|+.+.+++++... ..-+.+..+++|+.+++-+++.
T Consensus 372 ~~lr~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q~ 438 (483)
T KOG4341|consen 372 PRLRVLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQD 438 (483)
T ss_pred chhccCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechhh
Confidence 66666666655433111 1122334566666666665432 2223445566666666665543
No 58
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=97.74 E-value=9e-05 Score=63.11 Aligned_cols=122 Identities=18% Similarity=0.187 Sum_probs=40.6
Q ss_pred hhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCC
Q 038552 26 EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSL 105 (659)
Q Consensus 26 ~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 105 (659)
+|.++.+|+.+.+.. .+......+|.++++|+.+.+.++ +.......|.++++|+.+.+.. .+.......|..+++|
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l 83 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNL 83 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTE
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccc
Confidence 344444555555442 233333344455545555555443 3223333445554555555533 2222233344445555
Q ss_pred CEEeccCccccccChHHHhcCCCCCcEEEccCCcCCcccChhccCCCCC
Q 038552 106 EWIYLPFNRFSGSLPLDIAVNLPNLKALAIGGNNFFGSIPNSLSNASNL 154 (659)
Q Consensus 106 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L 154 (659)
+.+.+..+ +. .++...+... +|+.+.+.. .+..+....|.++++|
T Consensus 84 ~~i~~~~~-~~-~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 84 KNIDIPSN-IT-EIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp CEEEETTT--B-EEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred cccccCcc-cc-EEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 55555433 32 3444444333 555555543 2222333444444444
No 59
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.72 E-value=3.7e-05 Score=50.51 Aligned_cols=36 Identities=31% Similarity=0.442 Sum_probs=14.7
Q ss_pred CCcEEEccCCccCcccccccCCCCCCCEEEeecCcCC
Q 038552 56 ALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFS 92 (659)
Q Consensus 56 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 92 (659)
+|++|++++|.+. .+|..+++|++|++|++++|.++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 3444444444442 23333444444444444444443
No 60
>KOG4341 consensus F-box protein containing LRR [General function prediction only]
Probab=97.69 E-value=1.7e-06 Score=83.78 Aligned_cols=110 Identities=20% Similarity=0.149 Sum_probs=50.0
Q ss_pred ccCCCcCeeeccccc-CCCCCCccc-cCCCCCcEEEccCCCCCC--CCCccccCCCCCcEEEccCCcccccc-----Ccc
Q 038552 252 RNLVNLIALTMEINK-LHGTIPDTI-GELKNLQQLSLYNNSLQG--SIPSSLGNLTKLVELPLSYNNLQGNI-----PSS 322 (659)
Q Consensus 252 ~~l~~L~~L~l~~n~-l~~~~~~~~-~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~-----~~~ 322 (659)
.+..+|+.+.++.++ |+..--..+ .+++.|+.+++..+.... .+...-.+++.|+.+.+++|...... ...
T Consensus 317 ~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~lslshce~itD~gi~~l~~~ 396 (483)
T KOG4341|consen 317 QHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRVLSLSHCELITDEGIRHLSSS 396 (483)
T ss_pred cCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhccCChhhhhhhhhhhhhhhhhc
Confidence 345666666666653 222111111 245566666666654331 12222234666666666665433111 111
Q ss_pred CcCCCCCCEEeCCCcccc-cccchhhhhcccccceeccccc
Q 038552 323 LGNCQILRMFNASRNKLT-GALPHQLLSITTLTLSLDLSNN 362 (659)
Q Consensus 323 ~~~~~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~~L~l~~n 362 (659)
-..+..|..+.++++..+ ...-+.+..++.++ .+++-++
T Consensus 397 ~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Le-ri~l~~~ 436 (483)
T KOG4341|consen 397 SCSLEGLEVLELDNCPLITDATLEHLSICRNLE-RIELIDC 436 (483)
T ss_pred cccccccceeeecCCCCchHHHHHHHhhCcccc-eeeeech
Confidence 233455666666666543 12223334444444 3444433
No 61
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.67 E-value=0.00018 Score=71.84 Aligned_cols=134 Identities=19% Similarity=0.282 Sum_probs=61.8
Q ss_pred CCCCCcEEEccCCCCCCCCCccccCCCCCcEEEccCCccccccCccCcCCCCCCEEeCCCcccccccchhhhhcccccce
Q 038552 277 ELKNLQQLSLYNNSLQGSIPSSLGNLTKLVELPLSYNNLQGNIPSSLGNCQILRMFNASRNKLTGALPHQLLSITTLTLS 356 (659)
Q Consensus 277 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~ 356 (659)
.+.++..|++++|.+. .+|. -.++|++|.+++|.-...+|..+. ++|+.|++++|.....+|.. +. .
T Consensus 50 ~~~~l~~L~Is~c~L~-sLP~---LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~sLP~s------Le-~ 116 (426)
T PRK15386 50 EARASGRLYIKDCDIE-SLPV---LPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEISGLPES------VR-S 116 (426)
T ss_pred HhcCCCEEEeCCCCCc-ccCC---CCCCCcEEEccCCCCcccCCchhh--hhhhheEccCcccccccccc------cc-e
Confidence 3456666666666555 3341 123466666665443334443332 35666666666222233332 22 3
Q ss_pred ecccccccc--CCCccccccCCCCceeecCCCc-ccc-cCCccccCCCCCCeEECCCCCCCCCCcccccCCCCCCEEECC
Q 038552 357 LDLSNNLLN--GSLPLQVGNLKNLVKLDISGNQ-FSG-VIPVTLSACVSLEYLNISRNFFHGIIPLSLSSLKSIKEFNVS 432 (659)
Q Consensus 357 L~l~~n~l~--~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 432 (659)
|+++.+... +.+| ++|+.|.+.+++ ... .+|.. -.++|++|++++|... ..|..+. .+|+.|+++
T Consensus 117 L~L~~n~~~~L~~LP------ssLk~L~I~~~n~~~~~~lp~~--LPsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls 185 (426)
T PRK15386 117 LEIKGSATDSIKNVP------NGLTSLSINSYNPENQARIDNL--ISPSLKTLSLTGCSNI-ILPEKLP--ESLQSITLH 185 (426)
T ss_pred EEeCCCCCcccccCc------chHhheeccccccccccccccc--cCCcccEEEecCCCcc-cCccccc--ccCcEEEec
Confidence 444443321 1222 245555554322 110 01111 1246777777776654 3333333 467777776
Q ss_pred CC
Q 038552 433 SN 434 (659)
Q Consensus 433 ~n 434 (659)
.|
T Consensus 186 ~n 187 (426)
T PRK15386 186 IE 187 (426)
T ss_pred cc
Confidence 65
No 62
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=97.62 E-value=0.00017 Score=61.32 Aligned_cols=105 Identities=17% Similarity=0.182 Sum_probs=39.6
Q ss_pred CCCCCCCCEEEccCCcccccCchhhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCC
Q 038552 3 LSRYSNLIELRVSKNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLV 82 (659)
Q Consensus 3 ~~~~~~L~~L~ls~n~~~~~~~~~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 82 (659)
|.++++|+.+.+.. .+......+|.++.+|+.+.+..+ +......+|.++++|+.+.+.+ .+.......|..+++|+
T Consensus 8 F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l~ 84 (129)
T PF13306_consen 8 FYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNLK 84 (129)
T ss_dssp TTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTEC
T ss_pred HhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccccccccccccccccc
Confidence 44555555555543 233333444555555555555443 3333334455555555555543 22222233444555555
Q ss_pred EEEeecCcCCccCcccccCCCCCCEEeccC
Q 038552 83 DLNVGENRFSGMFPRSICNISSLEWIYLPF 112 (659)
Q Consensus 83 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 112 (659)
.+.+..+ +.......|.++ +|+.+.+..
T Consensus 85 ~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~ 112 (129)
T PF13306_consen 85 NIDIPSN-ITEIGSSSFSNC-NLKEINIPS 112 (129)
T ss_dssp EEEETTT--BEEHTTTTTT--T--EEE-TT
T ss_pred ccccCcc-ccEEchhhhcCC-CceEEEECC
Confidence 5555433 332333344444 555555543
No 63
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]
Probab=97.57 E-value=0.00016 Score=63.42 Aligned_cols=58 Identities=21% Similarity=0.209 Sum_probs=27.2
Q ss_pred CcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEEeccCcccc
Q 038552 57 LKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWIYLPFNRFS 116 (659)
Q Consensus 57 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~ 116 (659)
...++|++|.+. ..+.|..+++|.+|.+++|+|+..-|.--.-+++|+.|.|.+|++.
T Consensus 44 ~d~iDLtdNdl~--~l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~ 101 (233)
T KOG1644|consen 44 FDAIDLTDNDLR--KLDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQ 101 (233)
T ss_pred cceecccccchh--hcccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchh
Confidence 344555555542 1233455555555555555555333322222344555555555443
No 64
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]
Probab=97.56 E-value=3.4e-05 Score=83.79 Aligned_cols=135 Identities=20% Similarity=0.274 Sum_probs=67.2
Q ss_pred CCCcEEeccccCCCc-cccccc-cCCCCCcEEEccCCccCc-ccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCE
Q 038552 31 LNLQTLAIDFNYLTG-QLPDFV-GNLSALKVFYIIGNSLGG-KIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEW 107 (659)
Q Consensus 31 ~~L~~L~ls~~~~~~-~~~~~~-~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 107 (659)
.+|+.|++++..... .-|..+ ..+|+|+.|.+.+-.+.. ..-.-..++++|..||+++++++.. ..++++++|+.
T Consensus 122 ~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~ 199 (699)
T KOG3665|consen 122 QNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQV 199 (699)
T ss_pred HhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHH
Confidence 356666665543211 111112 235666666666544311 1112234556666666666666532 45566666666
Q ss_pred EeccCccccc-cChHHHhcCCCCCcEEEccCCcCCccc------ChhccCCCCCCEEEccCCCCcccc
Q 038552 108 IYLPFNRFSG-SLPLDIAVNLPNLKALAIGGNNFFGSI------PNSLSNASNLEILDLTSNQLKGKV 168 (659)
Q Consensus 108 L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~~~~~~------~~~l~~l~~L~~L~l~~n~l~~~~ 168 (659)
|.+.+=.+.. .--.+++ .+++|+.||++........ -+.-..+|+|+.||.++..+.+..
T Consensus 200 L~mrnLe~e~~~~l~~LF-~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~ 266 (699)
T KOG3665|consen 200 LSMRNLEFESYQDLIDLF-NLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEI 266 (699)
T ss_pred HhccCCCCCchhhHHHHh-cccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHH
Confidence 6665444431 1113444 5666666666655433211 012234677888887776665443
No 65
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]
Probab=97.51 E-value=0.00016 Score=63.50 Aligned_cols=127 Identities=21% Similarity=0.221 Sum_probs=81.6
Q ss_pred CEEEccCCcccccCchhhcC-CCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeec
Q 038552 10 IELRVSKNKLEGQIPEEIGS-LLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGE 88 (659)
Q Consensus 10 ~~L~ls~n~~~~~~~~~~~~-~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 88 (659)
++++|.+..+.- .+.++. ..+.-.+||++|.+... ..|..++.|.+|.+++|.|+...|.--..+++|+.|.|.+
T Consensus 22 ~e~~LR~lkip~--ienlg~~~d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 22 RELDLRGLKIPV--IENLGATLDQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred cccccccccccc--hhhccccccccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 455555555441 111221 23567788888887632 3477788888888888888766665555677888888888
Q ss_pred CcCCcc-CcccccCCCCCCEEeccCccccccCh--HHHhcCCCCCcEEEccCCcC
Q 038552 89 NRFSGM-FPRSICNISSLEWIYLPFNRFSGSLP--LDIAVNLPNLKALAIGGNNF 140 (659)
Q Consensus 89 n~l~~~-~~~~~~~l~~L~~L~l~~n~~~~~~~--~~~~~~l~~L~~L~l~~n~~ 140 (659)
|++... --.-+..|++|++|.+-+|+.+..-- ..+...+++|+.||+..-..
T Consensus 98 Nsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kVt~ 152 (233)
T KOG1644|consen 98 NSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKVTR 152 (233)
T ss_pred cchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhhhH
Confidence 887622 11245667888888888887762111 12233678888888866543
No 66
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]
Probab=96.76 E-value=0.001 Score=61.23 Aligned_cols=65 Identities=22% Similarity=0.192 Sum_probs=32.5
Q ss_pred hhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCC--ccCcccccccCCCCCCCEEEeecCcCC
Q 038552 26 EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGN--SLGGKIPTTLGLLRNLVDLNVGENRFS 92 (659)
Q Consensus 26 ~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n--~l~~~~~~~~~~l~~L~~L~l~~n~l~ 92 (659)
....+..|+.|++.+..++.. ..|..+++|+.|.++.| .+.+.++--...+++|++|+++.|.+.
T Consensus 38 l~d~~~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~ 104 (260)
T KOG2739|consen 38 LTDEFVELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIK 104 (260)
T ss_pred ccccccchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccc
Confidence 333444555555555554422 22445556666666655 333333333344566666666666554
No 67
>KOG2123 consensus Uncharacterized conserved protein [Function unknown]
Probab=96.68 E-value=7.6e-05 Score=68.59 Aligned_cols=87 Identities=20% Similarity=0.161 Sum_probs=48.6
Q ss_pred CCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCcc-CcccccCCCCCCEE
Q 038552 30 LLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGM-FPRSICNISSLEWI 108 (659)
Q Consensus 30 ~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L 108 (659)
+.+.+.|+..+|.++++ ....+++.|++|.|+-|.|+... .|..|++|+.|.|..|.|... .-..+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~--pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLA--PLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccccch--hHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 34556666666666532 23456666666666666664332 356666666666666665421 11234556666666
Q ss_pred eccCccccccCh
Q 038552 109 YLPFNRFSGSLP 120 (659)
Q Consensus 109 ~l~~n~~~~~~~ 120 (659)
+|..|+-.|.-+
T Consensus 94 WL~ENPCc~~ag 105 (388)
T KOG2123|consen 94 WLDENPCCGEAG 105 (388)
T ss_pred hhccCCcccccc
Confidence 666665554433
No 68
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]
Probab=96.29 E-value=0.0033 Score=57.89 Aligned_cols=66 Identities=26% Similarity=0.373 Sum_probs=29.4
Q ss_pred cccCCCCceeecCCC--cccccCCccccCCCCCCeEECCCCCCCCC-CcccccCCCCCCEEECCCCccc
Q 038552 372 VGNLKNLVKLDISGN--QFSGVIPVTLSACVSLEYLNISRNFFHGI-IPLSLSSLKSIKEFNVSSNNLS 437 (659)
Q Consensus 372 l~~l~~L~~L~L~~n--~l~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~ 437 (659)
+..+++|++|.+|.| ++++..+.....+++|++|++++|++... --..+..+.+|..|++.+|.-+
T Consensus 61 ~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~~Ldl~n~~~~ 129 (260)
T KOG2739|consen 61 FPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENLKSLDLFNCSVT 129 (260)
T ss_pred CCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcchhhhhcccCCcc
Confidence 334455555555555 33333333333445555555555554420 0012233444445555555443
No 69
>KOG2123 consensus Uncharacterized conserved protein [Function unknown]
Probab=96.23 E-value=0.00025 Score=65.27 Aligned_cols=95 Identities=22% Similarity=0.258 Sum_probs=68.3
Q ss_pred eeccccccccCCCccccccCCCCceeecCCCcccccCCccccCCCCCCeEECCCCCCCCCCc-ccccCCCCCCEEECCCC
Q 038552 356 SLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGVIPVTLSACVSLEYLNISRNFFHGIIP-LSLSSLKSIKEFNVSSN 434 (659)
Q Consensus 356 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n 434 (659)
.|++.++.++++ .-...++.|+.|.||=|.|+.. +.+..|+.|++|+|..|.|..... .-+.++++|+.|.|..|
T Consensus 23 KLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL--~pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~LWL~EN 98 (388)
T KOG2123|consen 23 KLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSL--APLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTLWLDEN 98 (388)
T ss_pred hhcccCCCccHH--HHHHhcccceeEEeeccccccc--hhHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhHhhccC
Confidence 677778877643 2346788888899998888754 347788888899998888874321 24577888888888888
Q ss_pred cccccch-----hhhcCCCCCCeee
Q 038552 435 NLSGLIP-----EFLKNLSFMEFLD 454 (659)
Q Consensus 435 ~l~~~~~-----~~l~~l~~L~~l~ 454 (659)
+=.|.-+ ..+.-+|+|+.||
T Consensus 99 PCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 99 PCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred CcccccchhHHHHHHHHcccchhcc
Confidence 7766543 3456677777775
No 70
>KOG4308 consensus LRR-containing protein [Function unknown]
Probab=96.11 E-value=2.2e-05 Score=81.46 Aligned_cols=168 Identities=22% Similarity=0.204 Sum_probs=78.1
Q ss_pred hccCCCCCCEEEccCCCCcccccc----ccCCC-CCCCEEECCCCCCCCCCCCCccccccccCCCCCcEEEccCCcccc-
Q 038552 147 SLSNASNLEILDLTSNQLKGKVSI----DFSSL-KNLSWLNLEQNNLGMGTANDLDFVTFLTNCSSLKVISLYANQFGG- 220 (659)
Q Consensus 147 ~l~~l~~L~~L~l~~n~l~~~~~~----~l~~l-~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~~~~- 220 (659)
.+...+.|+.|++++|.+.+.... .+... ..++.|++..|.++..... .+...+..+..++.++++.|.+..
T Consensus 110 ~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~--~l~~~L~~~~~l~~l~l~~n~l~~~ 187 (478)
T KOG4308|consen 110 ALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAA--PLAAVLEKNEHLTELDLSLNGLIEL 187 (478)
T ss_pred HhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchH--HHHHHHhcccchhHHHHHhcccchh
Confidence 345566666677776666532211 12222 3455666666666554333 445556667777777777776531
Q ss_pred ---ccChhHHh---ccccCCEEEcccCcccccC----CcccccCCC-cCeeecccccCCCCC----CccccCC-CCCcEE
Q 038552 221 ---ELPHSIAN---LSSTMTDFRIGANQISGTI----PPGIRNLVN-LIALTMEINKLHGTI----PDTIGEL-KNLQQL 284 (659)
Q Consensus 221 ---~~~~~~~~---~~~~L~~L~l~~~~~~~~~----~~~l~~l~~-L~~L~l~~n~l~~~~----~~~~~~~-~~L~~L 284 (659)
.++..+.. ...+++.|++++|.++... ...+...+. +..+++..|.+.+.. ...+..+ ..++.+
T Consensus 188 g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~g~~~L~~~l~~~~~~l~~l 267 (478)
T KOG4308|consen 188 GLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDVGVEKLLPCLSVLSETLRVL 267 (478)
T ss_pred hhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchHHHHHHHHHhcccchhhhhh
Confidence 11222221 1224555555555544211 111222233 444555555544321 1122223 444555
Q ss_pred EccCCCCCCCC----CccccCCCCCcEEEccCCccc
Q 038552 285 SLYNNSLQGSI----PSSLGNLTKLVELPLSYNNLQ 316 (659)
Q Consensus 285 ~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~ 316 (659)
++..|.+.... ...+..++.++++.++.|.+.
T Consensus 268 ~l~~nsi~~~~~~~L~~~l~~~~~l~~l~l~~n~l~ 303 (478)
T KOG4308|consen 268 DLSRNSITEKGVRDLAEVLVSCRQLEELSLSNNPLT 303 (478)
T ss_pred hhhcCCccccchHHHHHHHhhhHHHHHhhcccCccc
Confidence 55555555332 222333445555555555544
No 71
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only]
Probab=95.97 E-value=0.0019 Score=69.15 Aligned_cols=111 Identities=18% Similarity=0.157 Sum_probs=49.1
Q ss_pred CCCCcEEeccccCCCcc--ccccccCCCCCcEEEccCC-ccCcccc----cccCCCCCCCEEEeecCc-CCccCcccccC
Q 038552 30 LLNLQTLAIDFNYLTGQ--LPDFVGNLSALKVFYIIGN-SLGGKIP----TTLGLLRNLVDLNVGENR-FSGMFPRSICN 101 (659)
Q Consensus 30 ~~~L~~L~ls~~~~~~~--~~~~~~~l~~L~~L~l~~n-~l~~~~~----~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~ 101 (659)
++.|+.|.+..+.-... .-.....++.|+.|+++++ ......+ .....+.+|+.|+++.+. ++...-..+..
T Consensus 187 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~~ 266 (482)
T KOG1947|consen 187 CPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALAS 266 (482)
T ss_pred CchhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHHh
Confidence 45555555555433222 2233445556666665542 1101111 122344555566665555 33332222222
Q ss_pred -CCCCCEEeccCcc-ccccChHHHhcCCCCCcEEEccCCcC
Q 038552 102 -ISSLEWIYLPFNR-FSGSLPLDIAVNLPNLKALAIGGNNF 140 (659)
Q Consensus 102 -l~~L~~L~l~~n~-~~~~~~~~~~~~l~~L~~L~l~~n~~ 140 (659)
|++|++|.+.++. +++.--..+...++.|+.|+++++..
T Consensus 267 ~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~~ 307 (482)
T KOG1947|consen 267 RCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCHG 307 (482)
T ss_pred hCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCcc
Confidence 5555555555444 33222233333455556665555543
No 72
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=95.20 E-value=0.0054 Score=62.05 Aligned_cols=49 Identities=29% Similarity=0.274 Sum_probs=42.6
Q ss_pred cCCcccHHHHHHHhhcCCccccccCCChHHHHHHHhccccccccccccch
Q 038552 549 QFPMVSYAELSKATSEFASSNMIEGLTLHEYAKMALQEKVMEIIDPSLLM 598 (659)
Q Consensus 549 ~~~~~~~~eL~~AT~~Fs~~~~i~~~~l~~~~~~~~~~~~~~i~d~~l~~ 598 (659)
..+.|+|+||.+||+||+++++|+.++++.++++.++++ ..++.+++..
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~ 109 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSS 109 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecC
Confidence 567899999999999999999999999998888999887 4677777743
No 73
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only]
Probab=95.13 E-value=0.0042 Score=66.54 Aligned_cols=16 Identities=44% Similarity=0.613 Sum_probs=9.1
Q ss_pred ccCCCCCcEEEccCCc
Q 038552 299 LGNLTKLVELPLSYNN 314 (659)
Q Consensus 299 ~~~l~~L~~L~l~~n~ 314 (659)
...++.++.+.+..+.
T Consensus 358 ~~~~~~l~~~~l~~~~ 373 (482)
T KOG1947|consen 358 LRSCPKLTDLSLSYCG 373 (482)
T ss_pred HhcCCCcchhhhhhhh
Confidence 3445666666665555
No 74
>KOG4308 consensus LRR-containing protein [Function unknown]
Probab=94.75 E-value=0.00034 Score=72.77 Aligned_cols=188 Identities=24% Similarity=0.276 Sum_probs=100.3
Q ss_pred cCeeecccccCCCCCC----ccccCCCCCcEEEccCCCCCCCCCc----cccCC-CCCcEEEccCCccccc----cCccC
Q 038552 257 LIALTMEINKLHGTIP----DTIGELKNLQQLSLYNNSLQGSIPS----SLGNL-TKLVELPLSYNNLQGN----IPSSL 323 (659)
Q Consensus 257 L~~L~l~~n~l~~~~~----~~~~~~~~L~~L~l~~n~l~~~~~~----~~~~l-~~L~~L~l~~n~l~~~----~~~~~ 323 (659)
+.++.+.+|.+..... ..+...++|+.|++++|.+.+.-.. .+... ..+++|++..|.++.. +...+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 6677777777654433 2344566777777777776632111 11111 3444455555554432 12223
Q ss_pred cCCCCCCEEeCCCcccccccchhhhhcccccceeccccccccCCCccccccCCCCceeecCCCccccc----CCccccCC
Q 038552 324 GNCQILRMFNASRNKLTGALPHQLLSITTLTLSLDLSNNLLNGSLPLQVGNLKNLVKLDISGNQFSGV----IPVTLSAC 399 (659)
Q Consensus 324 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~l~~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~~ 399 (659)
.....++.++++.|.+. +.....+ ....+..+....++++|++++|.++.. ....+...
T Consensus 169 ~~~~~l~~l~l~~n~l~---~~g~~~l--------------~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~ 231 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLI---ELGLLVL--------------SQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASG 231 (478)
T ss_pred hcccchhHHHHHhcccc---hhhhHHH--------------hhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhcc
Confidence 33444444444444432 0000000 000111233466777888888876522 11234444
Q ss_pred CC-CCeEECCCCCCCCC----CcccccCC-CCCCEEECCCCccccc----chhhhcCCCCCCeeeCcCCcCc
Q 038552 400 VS-LEYLNISRNFFHGI----IPLSLSSL-KSIKEFNVSSNNLSGL----IPEFLKNLSFMEFLDLSYNHFE 461 (659)
Q Consensus 400 ~~-L~~L~l~~n~l~~~----~~~~~~~l-~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~l~l~~n~l~ 461 (659)
++ +.+|++..|.+.+. ....+..+ ..++.++++.|.++.. +...+..++.++.+.+++|++.
T Consensus 232 ~~~~~el~l~~n~l~d~g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L~~~l~~~~~l~~l~l~~n~l~ 303 (478)
T KOG4308|consen 232 ESLLRELDLASNKLGDVGVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDLAEVLVSCRQLEELSLSNNPLT 303 (478)
T ss_pred chhhHHHHHHhcCcchHHHHHHHHHhcccchhhhhhhhhcCCccccchHHHHHHHhhhHHHHHhhcccCccc
Confidence 55 66688888877644 22344455 6778888888888654 3355566778888888888774
No 75
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=94.73 E-value=0.016 Score=31.39 Aligned_cols=10 Identities=30% Similarity=0.521 Sum_probs=3.7
Q ss_pred cEEEccCCcc
Q 038552 58 KVFYIIGNSL 67 (659)
Q Consensus 58 ~~L~l~~n~l 67 (659)
++|++++|.+
T Consensus 3 ~~Ldls~n~l 12 (22)
T PF00560_consen 3 EYLDLSGNNL 12 (22)
T ss_dssp SEEEETSSEE
T ss_pred cEEECCCCcC
Confidence 3333333333
No 76
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=94.64 E-value=0.017 Score=31.30 Aligned_cols=12 Identities=33% Similarity=0.639 Sum_probs=6.0
Q ss_pred CCEEECCCCccc
Q 038552 426 IKEFNVSSNNLS 437 (659)
Q Consensus 426 L~~L~l~~n~l~ 437 (659)
|+.||+++|+++
T Consensus 2 L~~Ldls~n~l~ 13 (22)
T PF00560_consen 2 LEYLDLSGNNLT 13 (22)
T ss_dssp ESEEEETSSEES
T ss_pred ccEEECCCCcCE
Confidence 445555555554
No 77
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=91.87 E-value=0.11 Score=50.82 Aligned_cols=31 Identities=19% Similarity=0.296 Sum_probs=27.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+.++...|.+.+|.+||+|.||+.+|+.++
T Consensus 254 ~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 254 EVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 4668888999999999999999999999874
No 78
>KOG0473 consensus Leucine-rich repeat protein [Function unknown]
Probab=91.71 E-value=0.0051 Score=55.39 Aligned_cols=88 Identities=20% Similarity=0.145 Sum_probs=64.3
Q ss_pred hhcCCCCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCC
Q 038552 26 EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSL 105 (659)
Q Consensus 26 ~~~~~~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 105 (659)
.+..+...+.||++.|++. .....|+.++.|..|+++.|.+ ...|.+++.+..++.+++..|..+ ..|.+++..+++
T Consensus 37 ei~~~kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~-~~~~~d~~q~~e~~~~~~~~n~~~-~~p~s~~k~~~~ 113 (326)
T KOG0473|consen 37 EIASFKRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQI-KFLPKDAKQQRETVNAASHKNNHS-QQPKSQKKEPHP 113 (326)
T ss_pred hhhccceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhH-hhChhhHHHHHHHHHHHhhccchh-hCCccccccCCc
Confidence 3455667777888877765 4455566777777888887777 566777788778888888777766 677788888888
Q ss_pred CEEeccCcccc
Q 038552 106 EWIYLPFNRFS 116 (659)
Q Consensus 106 ~~L~l~~n~~~ 116 (659)
+++++..+.+.
T Consensus 114 k~~e~k~~~~~ 124 (326)
T KOG0473|consen 114 KKNEQKKTEFF 124 (326)
T ss_pred chhhhccCcch
Confidence 88887777654
No 79
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=90.24 E-value=0.22 Score=48.81 Aligned_cols=31 Identities=16% Similarity=0.219 Sum_probs=27.4
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+.++...|.+.+|.+||||.+|+++|+.++
T Consensus 254 ~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 254 EIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 3567788899999999999999999998764
No 80
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=89.65 E-value=0.33 Score=47.10 Aligned_cols=30 Identities=23% Similarity=0.221 Sum_probs=26.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
.+.++...|.+.+|.+||+|.+|+++|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 357888999999999999999999999765
No 81
>KOG0473 consensus Leucine-rich repeat protein [Function unknown]
Probab=89.50 E-value=0.0076 Score=54.34 Aligned_cols=84 Identities=18% Similarity=0.232 Sum_probs=41.7
Q ss_pred CCCCCcEEEccCCccCcccccccCCCCCCCEEEeecCcCCccCcccccCCCCCCEEeccCccccccChHHHhcCCCCCcE
Q 038552 53 NLSALKVFYIIGNSLGGKIPTTLGLLRNLVDLNVGENRFSGMFPRSICNISSLEWIYLPFNRFSGSLPLDIAVNLPNLKA 132 (659)
Q Consensus 53 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~ 132 (659)
.......||++.|.+. ..-..|.-++.|..|+++.|.+. ..|.+++....++.+++..|..+ ..|.... ..+.+++
T Consensus 40 ~~kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~~-~~~~d~~q~~e~~~~~~~~n~~~-~~p~s~~-k~~~~k~ 115 (326)
T KOG0473|consen 40 SFKRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQIK-FLPKDAKQQRETVNAASHKNNHS-QQPKSQK-KEPHPKK 115 (326)
T ss_pred ccceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhHh-hChhhHHHHHHHHHHHhhccchh-hCCcccc-ccCCcch
Confidence 3344445555555441 22233444455555555555554 45555555555555555555554 4554444 4555555
Q ss_pred EEccCCcC
Q 038552 133 LAIGGNNF 140 (659)
Q Consensus 133 L~l~~n~~ 140 (659)
+++..+.+
T Consensus 116 ~e~k~~~~ 123 (326)
T KOG0473|consen 116 NEQKKTEF 123 (326)
T ss_pred hhhccCcc
Confidence 55555544
No 82
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=89.47 E-value=0.34 Score=47.76 Aligned_cols=33 Identities=15% Similarity=0.302 Sum_probs=29.1
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHHHh
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTRES 653 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~ 653 (659)
.+.++...|++.+|.+||+|.+|+++|+.+...
T Consensus 253 ~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 253 EVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 356888899999999999999999999998653
No 83
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=88.70 E-value=0.43 Score=46.98 Aligned_cols=31 Identities=19% Similarity=0.237 Sum_probs=27.3
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+.++...|.+.+|.+||+|.+++.+|+.+-
T Consensus 257 ~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 257 EMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 3567888999999999999999999998763
No 84
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=88.41 E-value=0.38 Score=47.13 Aligned_cols=31 Identities=13% Similarity=0.053 Sum_probs=27.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+..+...|.+.+|.+||+|.+|+.+|+.+.
T Consensus 252 ~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 252 EVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 4667889999999999999999999998874
No 85
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=88.18 E-value=0.31 Score=24.39 Aligned_cols=11 Identities=36% Similarity=0.661 Sum_probs=3.4
Q ss_pred CCEEEeecCcC
Q 038552 81 LVDLNVGENRF 91 (659)
Q Consensus 81 L~~L~l~~n~l 91 (659)
|++|++++|++
T Consensus 3 L~~L~l~~n~L 13 (17)
T PF13504_consen 3 LRTLDLSNNRL 13 (17)
T ss_dssp -SEEEETSS--
T ss_pred cCEEECCCCCC
Confidence 44444444433
No 86
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=88.01 E-value=0.49 Score=45.84 Aligned_cols=29 Identities=21% Similarity=0.221 Sum_probs=26.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.+|+++|+.+
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 56888899999999999999999999865
No 87
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=87.74 E-value=0.53 Score=26.55 Aligned_cols=21 Identities=33% Similarity=0.330 Sum_probs=11.6
Q ss_pred CCCCEEeccCccccccChHHHh
Q 038552 103 SSLEWIYLPFNRFSGSLPLDIA 124 (659)
Q Consensus 103 ~~L~~L~l~~n~~~~~~~~~~~ 124 (659)
++|++|+|++|.++ .+|.+++
T Consensus 2 ~~L~~L~L~~N~l~-~lp~~~f 22 (26)
T smart00370 2 PNLRELDLSNNQLS-SLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCC-cCCHHHc
Confidence 45556666666555 5555443
No 88
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=87.74 E-value=0.53 Score=26.55 Aligned_cols=21 Identities=33% Similarity=0.330 Sum_probs=11.6
Q ss_pred CCCCEEeccCccccccChHHHh
Q 038552 103 SSLEWIYLPFNRFSGSLPLDIA 124 (659)
Q Consensus 103 ~~L~~L~l~~n~~~~~~~~~~~ 124 (659)
++|++|+|++|.++ .+|.+++
T Consensus 2 ~~L~~L~L~~N~l~-~lp~~~f 22 (26)
T smart00369 2 PNLRELDLSNNQLS-SLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCC-cCCHHHc
Confidence 45556666666555 5555443
No 89
>KOG3864 consensus Uncharacterized conserved protein [Function unknown]
Probab=87.61 E-value=0.076 Score=47.19 Aligned_cols=82 Identities=12% Similarity=0.111 Sum_probs=54.4
Q ss_pred CCCcEEeccccCCCccccccccCCCCCcEEEccCCccCcc-cccccC-CCCCCCEEEeecCc-CCccCcccccCCCCCCE
Q 038552 31 LNLQTLAIDFNYLTGQLPDFVGNLSALKVFYIIGNSLGGK-IPTTLG-LLRNLVDLNVGENR-FSGMFPRSICNISSLEW 107 (659)
Q Consensus 31 ~~L~~L~ls~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~-~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~ 107 (659)
..++.++-+++.|....-+.+.+++.++.|.+.+|.-.+. --+.++ -.++|+.|++++|. |+..--..+..+++|+.
T Consensus 101 ~~IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~ 180 (221)
T KOG3864|consen 101 VKIEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRR 180 (221)
T ss_pred ceEEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHH
Confidence 4577788888877766666777788888888877652111 111122 34788888888775 66555556777788888
Q ss_pred EeccC
Q 038552 108 IYLPF 112 (659)
Q Consensus 108 L~l~~ 112 (659)
|.+.+
T Consensus 181 L~l~~ 185 (221)
T KOG3864|consen 181 LHLYD 185 (221)
T ss_pred HHhcC
Confidence 87754
No 90
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=87.26 E-value=0.59 Score=45.19 Aligned_cols=29 Identities=14% Similarity=0.141 Sum_probs=25.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.+++++|+.+
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 45677889999999999999999999764
No 91
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=87.19 E-value=0.59 Score=46.04 Aligned_cols=31 Identities=19% Similarity=0.224 Sum_probs=27.6
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+.++...|.+.+|.+||+|.+|+..|+.+.
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 4668889999999999999999999998763
No 92
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=86.96 E-value=0.2 Score=27.68 Aligned_cols=20 Identities=25% Similarity=0.307 Sum_probs=9.8
Q ss_pred CCCCCEEEccCCcccccCch
Q 038552 6 YSNLIELRVSKNKLEGQIPE 25 (659)
Q Consensus 6 ~~~L~~L~ls~n~~~~~~~~ 25 (659)
+++|++|+|++|.+++....
T Consensus 1 ~~~L~~L~l~~n~i~~~g~~ 20 (24)
T PF13516_consen 1 NPNLETLDLSNNQITDEGAS 20 (24)
T ss_dssp -TT-SEEE-TSSBEHHHHHH
T ss_pred CCCCCEEEccCCcCCHHHHH
Confidence 35666666666666544333
No 93
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=86.66 E-value=0.71 Score=26.03 Aligned_cols=16 Identities=38% Similarity=0.700 Sum_probs=7.9
Q ss_pred CCCCEEECCCCccccc
Q 038552 424 KSIKEFNVSSNNLSGL 439 (659)
Q Consensus 424 ~~L~~L~l~~n~l~~~ 439 (659)
++|+.|++++|.+...
T Consensus 2 ~~L~~L~L~~N~l~~l 17 (26)
T smart00370 2 PNLRELDLSNNQLSSL 17 (26)
T ss_pred CCCCEEECCCCcCCcC
Confidence 3455555555555433
No 94
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=86.66 E-value=0.71 Score=26.03 Aligned_cols=16 Identities=38% Similarity=0.700 Sum_probs=7.9
Q ss_pred CCCCEEECCCCccccc
Q 038552 424 KSIKEFNVSSNNLSGL 439 (659)
Q Consensus 424 ~~L~~L~l~~n~l~~~ 439 (659)
++|+.|++++|.+...
T Consensus 2 ~~L~~L~L~~N~l~~l 17 (26)
T smart00369 2 PNLRELDLSNNQLSSL 17 (26)
T ss_pred CCCCEEECCCCcCCcC
Confidence 3455555555555433
No 95
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=86.60 E-value=0.55 Score=46.34 Aligned_cols=28 Identities=14% Similarity=0.128 Sum_probs=25.6
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+.++...|.+.+|.+||+|.+|+++|.
T Consensus 267 ~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 267 PVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 4778999999999999999999999885
No 96
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=86.51 E-value=0.56 Score=45.23 Aligned_cols=28 Identities=18% Similarity=0.308 Sum_probs=25.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+.++...|.+.+|.+||+|.++.+.|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 5577789999999999999999999975
No 97
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=86.50 E-value=0.62 Score=47.06 Aligned_cols=31 Identities=26% Similarity=0.296 Sum_probs=27.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+..+...|.+.+|.+||+|.+|+++|+.+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5578888999999999999999999987653
No 98
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=85.96 E-value=0.74 Score=45.24 Aligned_cols=32 Identities=16% Similarity=0.312 Sum_probs=28.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHHh
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRES 653 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~ 653 (659)
+..+...|.+.+|.+||+|.+|...|+.+...
T Consensus 251 l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 251 VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 56788899999999999999999999998764
No 99
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=85.87 E-value=0.59 Score=45.12 Aligned_cols=26 Identities=23% Similarity=0.337 Sum_probs=20.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
+..+...|.+.+|.+||+|.++++.|
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 55778889999999999999999886
No 100
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=85.86 E-value=0.71 Score=46.65 Aligned_cols=32 Identities=19% Similarity=0.241 Sum_probs=28.0
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
.+.++...|.+.+|.+||++.+|+++|+.+-+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 35688899999999999999999999987643
No 101
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=85.73 E-value=0.64 Score=44.64 Aligned_cols=27 Identities=19% Similarity=0.271 Sum_probs=24.5
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
.+.++..+|.+.+|.+||+|.+|+++|
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 366889999999999999999999887
No 102
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=85.62 E-value=0.64 Score=44.82 Aligned_cols=29 Identities=21% Similarity=0.218 Sum_probs=25.7
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
.+.+++..|++.+|.+||+|.+++++|+.
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 35678889999999999999999999974
No 103
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=85.45 E-value=0.7 Score=44.90 Aligned_cols=31 Identities=13% Similarity=0.100 Sum_probs=27.8
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+.++...|.+.+|.+||++.+|...|+.++
T Consensus 243 ~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 243 DVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 4678888999999999999999999998763
No 104
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=85.42 E-value=0.9 Score=44.85 Aligned_cols=33 Identities=21% Similarity=0.316 Sum_probs=28.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHHhh
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRESF 654 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~~ 654 (659)
+.++...|.+.+|.+||+|.+|+++|+.+...+
T Consensus 247 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 247 VYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 457788999999999999999999999887643
No 105
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=85.24 E-value=0.71 Score=44.37 Aligned_cols=27 Identities=15% Similarity=0.280 Sum_probs=24.4
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
.+..+...|.+.+|.+||+|.+++++|
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 367888899999999999999999887
No 106
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=85.05 E-value=0.68 Score=45.65 Aligned_cols=28 Identities=21% Similarity=0.165 Sum_probs=25.3
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+.++...|.+.+|.+||+|.+|++.|+
T Consensus 268 ~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 268 DIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 3678899999999999999999999885
No 107
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=84.82 E-value=0.65 Score=45.41 Aligned_cols=29 Identities=24% Similarity=0.324 Sum_probs=25.7
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
.+.++...|.+.+|.+||+|++|.+.|+.
T Consensus 254 ~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 254 RVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 46677789999999999999999999874
No 108
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=84.70 E-value=0.87 Score=43.90 Aligned_cols=30 Identities=13% Similarity=0.229 Sum_probs=27.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
+.++...|.+.+|.+||+|.+|+.+|+.+.
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 557888899999999999999999998775
No 109
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=84.60 E-value=0.88 Score=44.18 Aligned_cols=29 Identities=24% Similarity=0.382 Sum_probs=26.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.+++.+|+.+
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 240 VYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 56788889999999999999999999876
No 110
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=84.57 E-value=0.92 Score=43.87 Aligned_cols=30 Identities=13% Similarity=0.157 Sum_probs=25.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
+.++...|.+.+|.+||++.+|.+.++.+|
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 345555799999999999999999999875
No 111
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=84.56 E-value=0.74 Score=45.22 Aligned_cols=28 Identities=21% Similarity=0.216 Sum_probs=25.2
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+..+..+|.+.+|.+||+|.|+++.|+
T Consensus 260 ~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 260 ELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3567889999999999999999999986
No 112
>PHA02988 hypothetical protein; Provisional
Probab=84.42 E-value=0.97 Score=44.30 Aligned_cols=31 Identities=16% Similarity=0.256 Sum_probs=26.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+.++.-.|.+.+|.+||+|.+|+..|+..+.
T Consensus 251 l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 251 IKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 3455567999999999999999999988764
No 113
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=84.37 E-value=0.82 Score=44.29 Aligned_cols=26 Identities=15% Similarity=0.152 Sum_probs=22.4
Q ss_pred HHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.++..+|.+.+|.+||+|.||+.+++
T Consensus 243 ~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 243 TDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 34555899999999999999999875
No 114
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=83.87 E-value=0.99 Score=44.54 Aligned_cols=28 Identities=21% Similarity=0.297 Sum_probs=25.2
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+.++..+|.+.+|.+||+|.+|++.|+
T Consensus 268 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 268 SLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4567888999999999999999999885
No 115
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=83.82 E-value=0.84 Score=46.92 Aligned_cols=28 Identities=18% Similarity=0.284 Sum_probs=24.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+.++...|.+.+|.+||+|.+|+++|+.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 4567788999999999999999999975
No 116
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=83.70 E-value=1.3 Score=43.29 Aligned_cols=31 Identities=13% Similarity=0.192 Sum_probs=26.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+..+...|.+.+|..||+|.|++++|..+..
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 3456678999999999999999999988764
No 117
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=83.55 E-value=1.1 Score=43.80 Aligned_cols=31 Identities=19% Similarity=0.232 Sum_probs=27.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+.++...|.+.+|+.||++.+|+.+|+.+.+
T Consensus 248 ~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 248 LFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 4577888999999999999999999988764
No 118
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=83.52 E-value=1.1 Score=43.45 Aligned_cols=29 Identities=21% Similarity=0.183 Sum_probs=25.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+..+...|.+.+|.+||+|.+|+++|..+
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 45677789999999999999999999764
No 119
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=83.34 E-value=1.1 Score=43.38 Aligned_cols=29 Identities=14% Similarity=0.227 Sum_probs=25.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.++++.|+.+
T Consensus 243 ~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 243 LYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 45778899999999999999999999764
No 120
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=83.31 E-value=0.91 Score=43.74 Aligned_cols=28 Identities=18% Similarity=0.096 Sum_probs=25.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+.++...|.+.+|.+||+|.++..+|+.
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4577889999999999999999999974
No 121
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=83.23 E-value=0.84 Score=43.87 Aligned_cols=31 Identities=13% Similarity=0.185 Sum_probs=26.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+.++...|.+.+|.+||++.+|+++|+++.
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 3557888999999999999999999998763
No 122
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=83.22 E-value=1.2 Score=42.92 Aligned_cols=29 Identities=14% Similarity=0.149 Sum_probs=24.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+..+...|.+.+|.+||+|.+|.+++.++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 34555689999999999999999998765
No 123
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=83.05 E-value=1.1 Score=43.40 Aligned_cols=30 Identities=13% Similarity=0.143 Sum_probs=25.5
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
.+.++...|.+.+|.+||+|.+|++.|+.+
T Consensus 243 ~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 243 ELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 355666779999999999999999999764
No 124
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=82.99 E-value=1.5 Score=43.52 Aligned_cols=32 Identities=16% Similarity=0.141 Sum_probs=28.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHHh
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRES 653 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~ 653 (659)
+.++...|.+.+|.+||+|.+|+..|+.+...
T Consensus 271 ~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 271 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 44667789999999999999999999988764
No 125
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=82.76 E-value=1.1 Score=43.28 Aligned_cols=29 Identities=17% Similarity=0.159 Sum_probs=25.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.+|+.+|+.+
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 45677889999999999999999998764
No 126
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=82.51 E-value=1.1 Score=44.41 Aligned_cols=28 Identities=25% Similarity=0.203 Sum_probs=24.7
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+.++...|.+.+|.+||+|.+|++.|+
T Consensus 276 ~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 276 GLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 3567788999999999999999999885
No 127
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=82.46 E-value=0.96 Score=43.19 Aligned_cols=28 Identities=14% Similarity=0.220 Sum_probs=24.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+..+...|.+.+|.+||+|.+|+++|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4667888999999999999999999875
No 128
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=82.29 E-value=1.3 Score=43.87 Aligned_cols=31 Identities=16% Similarity=0.145 Sum_probs=27.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+.++...|.+.+|.+||+|.+|++.|.++..
T Consensus 268 ~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 268 LYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 4456778999999999999999999988764
No 129
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=81.92 E-value=1.4 Score=42.42 Aligned_cols=30 Identities=13% Similarity=0.120 Sum_probs=26.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
+.++...|.+.+|.+||++.+|+.+|..++
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 446667799999999999999999998775
No 130
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=81.85 E-value=1.3 Score=44.96 Aligned_cols=31 Identities=19% Similarity=0.297 Sum_probs=26.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+.++...|.+.+|.+||+|.+|++.|+.+-+
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4577788999999999999999999987643
No 131
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=81.43 E-value=1.1 Score=43.00 Aligned_cols=27 Identities=19% Similarity=0.370 Sum_probs=24.4
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
.+.++...|.+.+|.+||+|.+|+++|
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 366888999999999999999999986
No 132
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=81.35 E-value=1.3 Score=45.41 Aligned_cols=29 Identities=21% Similarity=0.218 Sum_probs=25.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.+|+++|+.+
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 34556689999999999999999999875
No 133
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=81.29 E-value=1.4 Score=43.06 Aligned_cols=30 Identities=10% Similarity=0.172 Sum_probs=26.7
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
.+.++...|.+.+|.+||++.+|+..++.+
T Consensus 254 ~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 254 EVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 466788899999999999999999999865
No 134
>KOG3864 consensus Uncharacterized conserved protein [Function unknown]
Probab=81.05 E-value=0.23 Score=44.31 Aligned_cols=35 Identities=31% Similarity=0.316 Sum_probs=19.0
Q ss_pred CCCCCEEEccCC-CCccccccccCCCCCCCEEECCC
Q 038552 151 ASNLEILDLTSN-QLKGKVSIDFSSLKNLSWLNLEQ 185 (659)
Q Consensus 151 l~~L~~L~l~~n-~l~~~~~~~l~~l~~L~~L~l~~ 185 (659)
.++|+.|++++| .|+...-..+..+++|+.|.+.+
T Consensus 150 ~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~l~~ 185 (221)
T KOG3864|consen 150 APSLQDLDLSGCPRITDGGLACLLKLKNLRRLHLYD 185 (221)
T ss_pred ccchheeeccCCCeechhHHHHHHHhhhhHHHHhcC
Confidence 355666666655 34443334455566666666543
No 135
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=80.97 E-value=1.3 Score=42.34 Aligned_cols=28 Identities=21% Similarity=0.199 Sum_probs=24.6
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+..+...|.+.+|.+||+|.+|.++|.
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3556778899999999999999999985
No 136
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=80.88 E-value=1.1 Score=43.72 Aligned_cols=27 Identities=15% Similarity=0.262 Sum_probs=24.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+...|.+.+|.+||+|.|++.+|+
T Consensus 250 ~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 250 LFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 567888999999999999999999886
No 137
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=80.38 E-value=1.7 Score=42.12 Aligned_cols=29 Identities=17% Similarity=0.124 Sum_probs=25.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.++.+.|+++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 55677789999999999999999998754
No 138
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=80.09 E-value=1.8 Score=42.85 Aligned_cols=31 Identities=16% Similarity=0.249 Sum_probs=27.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+..+...|...+|.+||+|.+++++|..+.+
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5567788999999999999999999988754
No 139
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=79.74 E-value=1.3 Score=42.46 Aligned_cols=29 Identities=14% Similarity=0.210 Sum_probs=24.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||++.+|..+|+.+
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 44667779999999999999999999753
No 140
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=79.17 E-value=2.5 Score=42.12 Aligned_cols=32 Identities=16% Similarity=0.183 Sum_probs=27.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHHh
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRES 653 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~ 653 (659)
+..+...|.+.+|.+||+|.+|...|.++...
T Consensus 265 l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 265 LYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 44677899999999999999999999988753
No 141
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=79.16 E-value=1.5 Score=42.84 Aligned_cols=27 Identities=26% Similarity=0.335 Sum_probs=24.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+...|.+.+|.+||+|.+|+..|+
T Consensus 255 ~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 255 VYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 557888999999999999999999885
No 142
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=79.01 E-value=1.5 Score=42.15 Aligned_cols=29 Identities=14% Similarity=0.112 Sum_probs=24.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+..+...|.+.+|.+||+|.++++.|+.+
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 44667789999999999999999998753
No 143
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=78.48 E-value=1.3 Score=42.65 Aligned_cols=27 Identities=22% Similarity=0.181 Sum_probs=22.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+...|.+.+|.+||+|.+++++|+
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 446666799999999999999999873
No 144
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=78.35 E-value=2.1 Score=42.38 Aligned_cols=29 Identities=21% Similarity=0.305 Sum_probs=25.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|.+|++.|+.+
T Consensus 273 ~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 273 IYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 56777889999999999999999999763
No 145
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=78.21 E-value=1.8 Score=44.94 Aligned_cols=30 Identities=13% Similarity=0.088 Sum_probs=26.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
+..+...|.+.+|.+||+|.+|+++|+.+-
T Consensus 369 l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 369 VYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 567788899999999999999999998753
No 146
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=78.02 E-value=1.7 Score=41.79 Aligned_cols=28 Identities=18% Similarity=0.095 Sum_probs=24.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+.++-..|.+.+|.+||+|.+|+++|+.
T Consensus 227 l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 227 MYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 3456678999999999999999999864
No 147
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=77.83 E-value=2.3 Score=42.16 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=26.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+.++...|.+.+|.+||+|.+++.+|+.+-+
T Consensus 252 ~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 252 VYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 4567788999999999999999999987753
No 148
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=77.05 E-value=2.5 Score=42.59 Aligned_cols=31 Identities=16% Similarity=0.187 Sum_probs=27.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+.++...|.+.+|.+||+|.+++..|+.+..
T Consensus 265 l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 265 LYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 5577788999999999999999999988863
No 149
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=76.88 E-value=2.7 Score=40.72 Aligned_cols=31 Identities=16% Similarity=0.225 Sum_probs=26.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+.++...|...+|.+||++.+++..|+.++.
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 4456678999999999999999999998875
No 150
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=76.75 E-value=1.9 Score=41.38 Aligned_cols=28 Identities=14% Similarity=0.199 Sum_probs=23.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+.++...|.+.+|.+||++.+++..|+
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 3567778899999999999999998763
No 151
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=76.30 E-value=2.8 Score=40.39 Aligned_cols=29 Identities=21% Similarity=0.157 Sum_probs=25.7
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
.+.++...|.+.+|.+||+|.++..+|+.
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 35688889999999999999999999874
No 152
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=76.22 E-value=2.2 Score=41.86 Aligned_cols=31 Identities=19% Similarity=0.141 Sum_probs=26.5
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.+.++...|.+.+|.+||+|.++++.|....
T Consensus 249 ~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 249 RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 4667788999999999999999999887643
No 153
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=76.12 E-value=2.2 Score=44.20 Aligned_cols=29 Identities=21% Similarity=0.083 Sum_probs=24.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++...|.+.+|.+||+|++++..|+.+
T Consensus 371 l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 371 IYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 34555679999999999999999999875
No 154
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=75.83 E-value=2.5 Score=40.62 Aligned_cols=29 Identities=17% Similarity=0.178 Sum_probs=25.3
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
.+.++...|.+.+|.+||+|.++...|+.
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 35678889999999999999999998863
No 155
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=74.91 E-value=2.7 Score=40.85 Aligned_cols=28 Identities=18% Similarity=0.349 Sum_probs=24.1
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+.++...|.+.+|.+||++.+|++.|+
T Consensus 249 ~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 249 PVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3557778899999999999999998774
No 156
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=74.39 E-value=2.7 Score=40.58 Aligned_cols=27 Identities=26% Similarity=0.253 Sum_probs=23.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+.++.-.|.+.+|.+||+|.+|.++|+
T Consensus 242 ~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 242 IYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 456777899999999999999999986
No 157
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=74.28 E-value=2.4 Score=41.24 Aligned_cols=26 Identities=23% Similarity=0.330 Sum_probs=22.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
+..+...|.+.+|.+||+|.+|++.|
T Consensus 248 ~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 248 LATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHhh
Confidence 45666789999999999999999876
No 158
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=74.27 E-value=4.6 Score=39.00 Aligned_cols=20 Identities=25% Similarity=0.381 Sum_probs=16.5
Q ss_pred hcCCCCCcCCCChHHHHHHHH
Q 038552 628 LCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 628 ~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.|. .+|.+||+|.+|+++|.
T Consensus 248 ~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 248 FCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHh-hCcccCCCHHHHHHHhc
Confidence 466 46999999999998873
No 159
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=73.87 E-value=3.1 Score=41.44 Aligned_cols=31 Identities=16% Similarity=0.262 Sum_probs=27.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+..+...|.+.+|.+||+|.+++..+..+..
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 5577788999999999999999999987754
No 160
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=73.79 E-value=3.1 Score=39.82 Aligned_cols=28 Identities=18% Similarity=0.218 Sum_probs=24.3
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+..+...|.+.+|.+||++.+|+..|.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 3557778999999999999999998874
No 161
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=73.23 E-value=2.6 Score=41.09 Aligned_cols=27 Identities=26% Similarity=0.368 Sum_probs=24.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+...|.+.+|.+||++.+|..+|+
T Consensus 253 ~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 253 VYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 457778899999999999999999886
No 162
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=73.22 E-value=2.9 Score=40.16 Aligned_cols=28 Identities=21% Similarity=0.205 Sum_probs=24.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+..+...|.+.+|.+||++.+|..+|+.
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4466678999999999999999999974
No 163
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=72.85 E-value=3.1 Score=40.63 Aligned_cols=28 Identities=25% Similarity=0.338 Sum_probs=23.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+..+...|.+.+|.+||+|.+|.++|.+
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 255 MYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 4456668999999999999999998853
No 164
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=72.73 E-value=3.4 Score=39.68 Aligned_cols=28 Identities=25% Similarity=0.203 Sum_probs=23.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+..+...|.+.+|.+||+|.+|.+.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3445567999999999999999999864
No 165
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=71.91 E-value=3.2 Score=40.25 Aligned_cols=28 Identities=21% Similarity=0.281 Sum_probs=24.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+..+...|.+.+|.+||++.++..+|+
T Consensus 249 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 249 KLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 3567888999999999999999999885
No 166
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=71.86 E-value=3 Score=39.86 Aligned_cols=27 Identities=19% Similarity=0.197 Sum_probs=23.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+.++...|.+.+|..||+|.+++..|+
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 456777999999999999999999875
No 167
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=71.34 E-value=3.8 Score=39.85 Aligned_cols=27 Identities=22% Similarity=0.438 Sum_probs=23.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+...|.+.+|.+||++.||..+|+
T Consensus 253 ~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 253 VYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 457778899999999999999999885
No 168
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=71.21 E-value=3.6 Score=39.49 Aligned_cols=28 Identities=25% Similarity=0.247 Sum_probs=24.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+.++...|.+.+|.+||++.++...|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 5567778999999999999999999864
No 169
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=70.78 E-value=3.4 Score=39.41 Aligned_cols=27 Identities=26% Similarity=0.317 Sum_probs=23.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+.++...|.+.+|.+||++.+|...|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 556777899999999999999999875
No 170
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=70.72 E-value=3.2 Score=39.70 Aligned_cols=27 Identities=19% Similarity=0.310 Sum_probs=23.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+...|.+.+|.+||++.+++..|+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 236 LYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 456777899999999999999998873
No 171
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=69.70 E-value=4 Score=39.71 Aligned_cols=32 Identities=19% Similarity=0.233 Sum_probs=27.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHHh
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRES 653 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~ 653 (659)
+..+...|.+.+|..||++.++...|+.++..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 45667789999999999999999999877643
No 172
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=68.56 E-value=5.4 Score=35.48 Aligned_cols=32 Identities=13% Similarity=0.080 Sum_probs=26.7
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
.+.++...|.+.+|.+||++.+++..+..+..
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 35677778999999999999999998876643
No 173
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=67.84 E-value=3.7 Score=39.39 Aligned_cols=26 Identities=8% Similarity=-0.031 Sum_probs=22.0
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+.++...|++.+|.+||+|.+|++.
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhC
Confidence 35577788999999999999999863
No 174
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=67.29 E-value=4.8 Score=38.57 Aligned_cols=28 Identities=18% Similarity=0.161 Sum_probs=24.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCH 649 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~ 649 (659)
+.++...|.+.+|..||++.++...|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 5677888999999999999999998864
No 175
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=66.66 E-value=3.7 Score=39.25 Aligned_cols=27 Identities=22% Similarity=0.288 Sum_probs=23.4
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
.+.++...|.+.+|.+||+|.+|++.|
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 355777889999999999999999887
No 176
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=66.15 E-value=4.7 Score=37.87 Aligned_cols=25 Identities=8% Similarity=0.032 Sum_probs=22.1
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++...|.+.+|.+||+|.+|++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 4667888999999999999999986
No 177
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=65.10 E-value=4.6 Score=38.93 Aligned_cols=26 Identities=19% Similarity=0.245 Sum_probs=22.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
+..+...|.+.+|.+||+|.+++..+
T Consensus 236 ~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 236 LADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 34566689999999999999998875
No 178
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily.
Probab=64.34 E-value=6.1 Score=22.38 Aligned_cols=13 Identities=38% Similarity=0.529 Sum_probs=6.0
Q ss_pred CCCeEECCCCCCC
Q 038552 401 SLEYLNISRNFFH 413 (659)
Q Consensus 401 ~L~~L~l~~n~l~ 413 (659)
+|+.|++++|+|.
T Consensus 3 ~L~~L~L~~NkI~ 15 (26)
T smart00365 3 NLEELDLSQNKIK 15 (26)
T ss_pred ccCEEECCCCccc
Confidence 3444444444443
No 179
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=64.33 E-value=5.8 Score=38.53 Aligned_cols=25 Identities=12% Similarity=0.161 Sum_probs=21.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+...|.+.+|.+||+|.+|+..
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 229 FKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHh
Confidence 4566678999999999999999984
No 180
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=63.92 E-value=5 Score=38.30 Aligned_cols=26 Identities=27% Similarity=0.435 Sum_probs=22.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKL 647 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L 647 (659)
+.++...|...+|.+||++.++..+|
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 45677899999999999999998764
No 181
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=62.93 E-value=5.8 Score=37.84 Aligned_cols=24 Identities=13% Similarity=0.102 Sum_probs=21.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|++||+|.++++
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhh
Confidence 556777899999999999999875
No 182
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=62.23 E-value=7.2 Score=37.38 Aligned_cols=29 Identities=7% Similarity=0.013 Sum_probs=24.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+..+-..|.+.+|.+||+|.+|.+.|+.+
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34567789999999999999999988653
No 183
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=61.66 E-value=5.7 Score=37.96 Aligned_cols=24 Identities=13% Similarity=0.102 Sum_probs=20.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||+|.+|+.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhh
Confidence 345556789999999999999986
No 184
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=61.54 E-value=12 Score=38.06 Aligned_cols=34 Identities=18% Similarity=0.200 Sum_probs=27.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHHhhh
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRESFL 655 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~~~ 655 (659)
+..+-..|=+.+|..||++.+++.+|+.+...+.
T Consensus 275 l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 275 LSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 3344445999999999999999999999876554
No 185
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=61.30 E-value=7.1 Score=37.77 Aligned_cols=28 Identities=18% Similarity=0.317 Sum_probs=24.7
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.+.++...|.+.+|.+||++.+++.+|.
T Consensus 247 ~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 247 RLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 3567888999999999999999999875
No 186
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=61.13 E-value=8.9 Score=40.01 Aligned_cols=27 Identities=26% Similarity=0.294 Sum_probs=24.3
Q ss_pred HhcCCCCCcCCCChHHHHHHHHHHHHh
Q 038552 627 VLCSMESPFERMDMRDIVAKLCHTRES 653 (659)
Q Consensus 627 l~C~~~~p~~RP~M~~Vv~~L~~~~~~ 653 (659)
-.|.+.+|.+||+|.+|++.++.+...
T Consensus 397 ~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 397 KQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHhccCChhhccCHHHHHHHHHHHHhc
Confidence 389999999999999999999988654
No 187
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=59.47 E-value=4.8 Score=23.20 Aligned_cols=14 Identities=50% Similarity=0.600 Sum_probs=9.0
Q ss_pred CCCCEEEccCCccc
Q 038552 7 SNLIELRVSKNKLE 20 (659)
Q Consensus 7 ~~L~~L~ls~n~~~ 20 (659)
++|++|||++|.+.
T Consensus 2 ~~L~~LdL~~N~i~ 15 (28)
T smart00368 2 PSLRELDLSNNKLG 15 (28)
T ss_pred CccCEEECCCCCCC
Confidence 45666666666665
No 188
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=59.40 E-value=11 Score=35.25 Aligned_cols=29 Identities=14% Similarity=0.102 Sum_probs=24.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
+.++--+|.|.+|..||+..++...++.+
T Consensus 272 l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 272 LHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 45667789999999999999999888754
No 189
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=58.92 E-value=6 Score=38.51 Aligned_cols=25 Identities=8% Similarity=0.029 Sum_probs=21.4
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+..+...|.+.+|.+||+|.+|+.
T Consensus 255 ~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 255 DGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhc
Confidence 3557788899999999999999874
No 190
>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region. The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].
Probab=58.86 E-value=5.3 Score=33.90 Aligned_cols=27 Identities=22% Similarity=0.269 Sum_probs=12.3
Q ss_pred cceEEEehHHHHHHHHHHHHHHHHHhh
Q 038552 507 TLLRVLIPVVVSCLILSSCLTIIYARR 533 (659)
Q Consensus 507 ~~~~~~i~~~~~~~~~~~~~~~~~~~~ 533 (659)
.++++++++.+++++.++++++++++|
T Consensus 50 IVIGvVVGVGg~ill~il~lvf~~c~r 76 (154)
T PF04478_consen 50 IVIGVVVGVGGPILLGILALVFIFCIR 76 (154)
T ss_pred EEEEEEecccHHHHHHHHHhheeEEEe
Confidence 345566665554444333333333333
No 191
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=58.61 E-value=8.2 Score=37.73 Aligned_cols=24 Identities=17% Similarity=0.152 Sum_probs=21.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+-..|.+.+|.+||+|.||+.
T Consensus 242 ~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 242 FKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHh
Confidence 557778999999999999999987
No 192
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=58.56 E-value=6.8 Score=38.19 Aligned_cols=25 Identities=12% Similarity=0.235 Sum_probs=21.5
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+..+...|.+.+|.+||+|.+|++
T Consensus 258 ~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 258 LVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHHHHHhcCCcccchhHHHHhc
Confidence 4567788899999999999999874
No 193
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=57.60 E-value=7.7 Score=37.02 Aligned_cols=24 Identities=13% Similarity=0.085 Sum_probs=21.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||+|.++++
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhc
Confidence 557788899999999999999875
No 194
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=57.07 E-value=8.9 Score=37.26 Aligned_cols=25 Identities=12% Similarity=-0.110 Sum_probs=22.1
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++...|.+.+|.+||++.|++.
T Consensus 255 ~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 255 EAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhh
Confidence 4668888999999999999999875
No 195
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type.
Probab=56.74 E-value=7.2 Score=22.04 Aligned_cols=13 Identities=62% Similarity=0.874 Sum_probs=7.0
Q ss_pred CCCEEECCCCccc
Q 038552 425 SIKEFNVSSNNLS 437 (659)
Q Consensus 425 ~L~~L~l~~n~l~ 437 (659)
+|+.|++++|+++
T Consensus 3 ~L~~L~vs~N~Lt 15 (26)
T smart00364 3 SLKELNVSNNQLT 15 (26)
T ss_pred ccceeecCCCccc
Confidence 4555555555554
No 196
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=56.64 E-value=6.5 Score=38.34 Aligned_cols=27 Identities=19% Similarity=0.176 Sum_probs=22.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+...|.+.+|.+||+|.||.++.-
T Consensus 242 ~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 242 LRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 445556799999999999999998753
No 197
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=56.35 E-value=13 Score=36.16 Aligned_cols=31 Identities=13% Similarity=0.243 Sum_probs=26.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
+..+...|...+|.+||++.++...|..+..
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 4566778999999999999999999988743
No 198
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=54.83 E-value=7 Score=32.12 Aligned_cols=25 Identities=12% Similarity=0.151 Sum_probs=8.6
Q ss_pred EehHHHHHHHHHHHHHHHHHhhhcc
Q 038552 512 LIPVVVSCLILSSCLTIIYARRRRF 536 (659)
Q Consensus 512 ~i~~~~~~~~~~~~~~~~~~~~~~~ 536 (659)
++++++.++..++++.|+.+|+++|
T Consensus 70 i~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 70 IFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred hHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 3333333333333333443444333
No 199
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=54.41 E-value=7.5 Score=37.90 Aligned_cols=25 Identities=16% Similarity=0.268 Sum_probs=21.6
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+..+...|.+.+|.+||+|++|++
T Consensus 260 ~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 260 PALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHHHHhccCchhcccHHHHhc
Confidence 4567778899999999999999875
No 200
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=54.27 E-value=10 Score=36.06 Aligned_cols=24 Identities=13% Similarity=0.121 Sum_probs=19.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|++.+|.+||+|.+++.
T Consensus 233 l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 233 AKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHhCcCChhhCCCHHHHhh
Confidence 345556899999999999999875
No 201
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=54.22 E-value=10 Score=36.45 Aligned_cols=24 Identities=17% Similarity=0.207 Sum_probs=20.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||+|.+|+.
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHh
Confidence 345567899999999999999875
No 202
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=53.53 E-value=9.1 Score=36.46 Aligned_cols=24 Identities=17% Similarity=0.127 Sum_probs=20.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+-..|.+.+|.+||+|.++++
T Consensus 229 l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 229 LRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHHHccCChhhCCCHHHHhh
Confidence 446667899999999999999875
No 203
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility]
Probab=53.23 E-value=76 Score=32.87 Aligned_cols=37 Identities=30% Similarity=0.305 Sum_probs=20.3
Q ss_pred CCcEEEccCCcccccc---CccCcCCCCCCEEeCCCcccc
Q 038552 304 KLVELPLSYNNLQGNI---PSSLGNCQILRMFNASRNKLT 340 (659)
Q Consensus 304 ~L~~L~l~~n~l~~~~---~~~~~~~~~L~~L~l~~n~l~ 340 (659)
-+..+.++.|.+.... ...+..-+.+..|++++|...
T Consensus 414 ~l~el~ls~~~lka~l~s~in~l~stqtl~kldisgn~mg 453 (553)
T KOG4242|consen 414 VLAELSLSPGPLKAGLESAINKLLSTQTLAKLDISGNGMG 453 (553)
T ss_pred cccCcccCCCcccccHHHHHHhhccCcccccccccCCCcc
Confidence 3555666666554221 122344466777777777654
No 204
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=53.06 E-value=11 Score=36.61 Aligned_cols=25 Identities=12% Similarity=0.071 Sum_probs=20.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+-..|.+.+|.+||+|.||+.-
T Consensus 259 ~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 259 FNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhc
Confidence 3455667999999999999999863
No 205
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=52.97 E-value=8.3 Score=36.73 Aligned_cols=23 Identities=17% Similarity=0.184 Sum_probs=19.1
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.++-..|.+.+|.+||+|.+|+.
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhc
Confidence 34455799999999999999875
No 206
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=52.48 E-value=9.3 Score=48.11 Aligned_cols=32 Identities=25% Similarity=0.265 Sum_probs=17.5
Q ss_pred ECCCCCCCCCCcccccCCCCCCEEECCCCccc
Q 038552 406 NISRNFFHGIIPLSLSSLKSIKEFNVSSNNLS 437 (659)
Q Consensus 406 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 437 (659)
||++|+|....+..|..+++|+.|+|++|++.
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~ 32 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFE 32 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccc
Confidence 35555555444555555555555555555553
No 207
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=51.99 E-value=11 Score=36.61 Aligned_cols=25 Identities=8% Similarity=-0.004 Sum_probs=22.3
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++...|.+.+|.+||++.+|+.
T Consensus 259 ~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 259 SALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhh
Confidence 5678888999999999999999875
No 208
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=51.87 E-value=12 Score=36.39 Aligned_cols=26 Identities=12% Similarity=0.135 Sum_probs=21.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+..+...|.+.+|.+||+|.+|+..
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 228 PFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHhC
Confidence 35567778999999999999999764
No 209
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification]
Probab=51.86 E-value=7.3 Score=40.66 Aligned_cols=38 Identities=21% Similarity=0.223 Sum_probs=18.2
Q ss_pred CCCCCeEECCCC--CCCCCCccccc--CCCCCCEEECCCCcccc
Q 038552 399 CVSLEYLNISRN--FFHGIIPLSLS--SLKSIKEFNVSSNNLSG 438 (659)
Q Consensus 399 ~~~L~~L~l~~n--~l~~~~~~~~~--~l~~L~~L~l~~n~l~~ 438 (659)
.|.|..|+|++| .+... .++. +...|++|-+.+|++..
T Consensus 243 apklk~L~LS~N~~~~~~~--~el~K~k~l~Leel~l~GNPlc~ 284 (585)
T KOG3763|consen 243 APKLKTLDLSHNHSKISSE--SELDKLKGLPLEELVLEGNPLCT 284 (585)
T ss_pred cchhheeecccchhhhcch--hhhhhhcCCCHHHeeecCCcccc
Confidence 455666666666 22211 1121 12345666666666643
No 210
>KOG4242 consensus Predicted myosin-I-binding protein [Cell motility]
Probab=51.75 E-value=54 Score=33.87 Aligned_cols=84 Identities=17% Similarity=0.063 Sum_probs=42.7
Q ss_pred CCceeecCCCcccccCCc--cccCCCCCCeEECCCCCCCCC-Ccccc--------cCCCCCCEEECCCCcccccch---h
Q 038552 377 NLVKLDISGNQFSGVIPV--TLSACVSLEYLNISRNFFHGI-IPLSL--------SSLKSIKEFNVSSNNLSGLIP---E 442 (659)
Q Consensus 377 ~L~~L~L~~n~l~~~~~~--~~~~~~~L~~L~l~~n~l~~~-~~~~~--------~~l~~L~~L~l~~n~l~~~~~---~ 442 (659)
.+++|.+..|.+.+..-. .+..-++.+.+++..-.-... .+... ..-.-+..+.++.|.+..-.. .
T Consensus 355 R~q~l~~rdnnldgeg~~vgk~~~s~s~r~l~agrs~~kqvm~s~~~a~~v~k~~~~~g~l~el~ls~~~lka~l~s~in 434 (553)
T KOG4242|consen 355 RVQVLLQRDNNLDGEGGAVGKRKQSKSGRILKAGRSGDKQVMDSSTEAPPVSKKSRTHGVLAELSLSPGPLKAGLESAIN 434 (553)
T ss_pred eeeEeeccccccccccccccceeeccccccccccccCCceeccccccchhhhhhhcccccccCcccCCCcccccHHHHHH
Confidence 477777777766544322 233445666666654322100 00000 111235667777777654322 2
Q ss_pred hhcCCCCCCeeeCcCCcC
Q 038552 443 FLKNLSFMEFLDLSYNHF 460 (659)
Q Consensus 443 ~l~~l~~L~~l~l~~n~l 460 (659)
.+..-+.+..+++++|..
T Consensus 435 ~l~stqtl~kldisgn~m 452 (553)
T KOG4242|consen 435 KLLSTQTLAKLDISGNGM 452 (553)
T ss_pred hhccCcccccccccCCCc
Confidence 334456677888888754
No 211
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=51.14 E-value=12 Score=36.27 Aligned_cols=25 Identities=12% Similarity=0.090 Sum_probs=21.5
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+..+...|.+.+|.+||+|.+++.
T Consensus 255 ~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 255 QALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHHhccCcccCcCHHHHhh
Confidence 3557778899999999999999875
No 212
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=49.81 E-value=11 Score=35.79 Aligned_cols=23 Identities=17% Similarity=0.027 Sum_probs=18.7
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.++-..|.+.+|.+||+|.+|++
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhh
Confidence 34446688999999999999975
No 213
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=48.92 E-value=13 Score=35.82 Aligned_cols=20 Identities=20% Similarity=0.336 Sum_probs=16.7
Q ss_pred hcCCCCCcCCCChHHHHHHHH
Q 038552 628 LCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 628 ~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
.|. .+|.+||+|.+|++.|+
T Consensus 249 ~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 249 FCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHh-cCcccCCCHHHHHHHhc
Confidence 365 47999999999999875
No 214
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=48.51 E-value=12 Score=35.63 Aligned_cols=25 Identities=8% Similarity=0.037 Sum_probs=21.1
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++-..|.+.+|.+||+|.++++
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 4556777899999999999999875
No 215
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=48.35 E-value=14 Score=35.77 Aligned_cols=25 Identities=12% Similarity=0.186 Sum_probs=21.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+...|.+.+|..||+|.+++..
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhC
Confidence 4456778999999999999999984
No 216
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=48.09 E-value=12 Score=37.14 Aligned_cols=25 Identities=20% Similarity=0.351 Sum_probs=21.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++..+|.+.+|.+||+|.+|...
T Consensus 263 ~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 263 FQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 4567778999999999999999875
No 217
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=48.00 E-value=13 Score=35.94 Aligned_cols=23 Identities=22% Similarity=0.343 Sum_probs=19.3
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+...|.+.+|.+||+|++|+.
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhh
Confidence 34556799999999999999976
No 218
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=47.85 E-value=13 Score=36.37 Aligned_cols=26 Identities=12% Similarity=0.070 Sum_probs=22.0
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+.++...|.+.+|.+||+|.||+..
T Consensus 257 ~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 257 DALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 35577778999999999999999873
No 219
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=46.37 E-value=15 Score=35.36 Aligned_cols=24 Identities=8% Similarity=0.087 Sum_probs=19.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+-..|.+.+|.+||++.+|+.
T Consensus 245 ~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 245 FQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhh
Confidence 345556899999999999999874
No 220
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=45.92 E-value=13 Score=35.68 Aligned_cols=24 Identities=13% Similarity=0.084 Sum_probs=19.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+||++.+|++
T Consensus 248 ~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 248 FNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhc
Confidence 335556799999999999999975
No 221
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=45.88 E-value=14 Score=34.93 Aligned_cols=24 Identities=13% Similarity=0.151 Sum_probs=19.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||+|.+|..
T Consensus 227 ~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 227 FKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHccCChhhCCCHHHHhc
Confidence 445556899999999999999874
No 222
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=45.68 E-value=14 Score=36.52 Aligned_cols=25 Identities=8% Similarity=-0.056 Sum_probs=21.6
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++...|.+.+|.+||++.+++.
T Consensus 288 ~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 288 QGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 4667788899999999999999874
No 223
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=45.19 E-value=13 Score=36.05 Aligned_cols=25 Identities=16% Similarity=0.281 Sum_probs=20.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++...|.+.+|..||+|.+|+..
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcC
Confidence 3455667999999999999998753
No 224
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=45.11 E-value=15 Score=35.39 Aligned_cols=23 Identities=17% Similarity=0.236 Sum_probs=19.1
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+-..|.+.+|..||+|.+|++
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 246 LDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHHHhcCChhhCCCHHHHhh
Confidence 34456799999999999999875
No 225
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily.
Probab=45.08 E-value=16 Score=20.47 Aligned_cols=11 Identities=27% Similarity=0.280 Sum_probs=5.3
Q ss_pred CCCCeEECCCC
Q 038552 400 VSLEYLNISRN 410 (659)
Q Consensus 400 ~~L~~L~l~~n 410 (659)
++|++|+|++|
T Consensus 2 ~~L~~L~l~~C 12 (26)
T smart00367 2 PNLRELDLSGC 12 (26)
T ss_pred CCCCEeCCCCC
Confidence 34444444444
No 226
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=44.96 E-value=15 Score=34.92 Aligned_cols=23 Identities=13% Similarity=0.046 Sum_probs=19.1
Q ss_pred HHhHhcCCCCCcCCCChHHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+-..|.+.+|.+||++.+++..
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 44457999999999999999764
No 227
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=44.48 E-value=14 Score=35.51 Aligned_cols=18 Identities=11% Similarity=0.222 Sum_probs=15.4
Q ss_pred hcCCCCCcCCCChHHHHH
Q 038552 628 LCSMESPFERMDMRDIVA 645 (659)
Q Consensus 628 ~C~~~~p~~RP~M~~Vv~ 645 (659)
.|...+|.+||+|.||..
T Consensus 243 ~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 243 GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHhcCChhhCcCHHHHhc
Confidence 477789999999999864
No 228
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=44.33 E-value=14 Score=36.02 Aligned_cols=24 Identities=8% Similarity=0.066 Sum_probs=20.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||+|.++..
T Consensus 263 l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 263 FNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhc
Confidence 556778899999999999999874
No 229
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=44.32 E-value=17 Score=35.25 Aligned_cols=25 Identities=12% Similarity=-0.008 Sum_probs=21.1
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++-..|.+.+|.+||+|.+++.
T Consensus 254 ~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 254 EGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHhccCcccccCHHHHhh
Confidence 4556777899999999999999874
No 230
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=44.14 E-value=17 Score=35.25 Aligned_cols=24 Identities=8% Similarity=-0.027 Sum_probs=20.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||+|.+++.
T Consensus 260 ~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 260 GLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHHhccCCccCCCHHHHhc
Confidence 446667899999999999999874
No 231
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=43.40 E-value=17 Score=35.23 Aligned_cols=23 Identities=13% Similarity=0.017 Sum_probs=19.1
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+-..|.+.+|.+||+|.+|+.
T Consensus 258 ~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 258 RDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhcCCCcccCCCHHHHhc
Confidence 35566799999999999999874
No 232
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=43.21 E-value=15 Score=33.32 Aligned_cols=29 Identities=14% Similarity=0.084 Sum_probs=24.8
Q ss_pred HHHHHHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 618 CLNAIIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 618 ~~~~~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
++..+.++...|.+.+|.+||++.+++..
T Consensus 186 ~l~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 186 ELPELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 34678888999999999999999998863
No 233
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=43.03 E-value=17 Score=35.29 Aligned_cols=24 Identities=17% Similarity=0.276 Sum_probs=20.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||++.+++.
T Consensus 259 ~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 259 ALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHHHHhcCCccccCCHHHHhc
Confidence 456777899999999999999874
No 234
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=43.02 E-value=15 Score=35.65 Aligned_cols=23 Identities=9% Similarity=0.111 Sum_probs=19.0
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.++--.|.+.+|.+||+|.+|+.
T Consensus 259 ~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 259 LDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 35556799999999999999864
No 235
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=42.93 E-value=18 Score=34.58 Aligned_cols=24 Identities=17% Similarity=0.337 Sum_probs=19.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+-..|.+.+|.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhh
Confidence 345556799999999999999875
No 236
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=42.67 E-value=18 Score=36.34 Aligned_cols=26 Identities=8% Similarity=0.055 Sum_probs=22.3
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+..+...|.+.+|.+||+|.+|+..
T Consensus 270 ~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 270 DALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhccCCcccccCHHHHhhC
Confidence 35677888999999999999999864
No 237
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=42.31 E-value=17 Score=34.61 Aligned_cols=25 Identities=12% Similarity=0.142 Sum_probs=20.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+...|.+.+|.+||++.+++..
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhC
Confidence 3345557999999999999999864
No 238
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=41.99 E-value=17 Score=35.49 Aligned_cols=24 Identities=13% Similarity=0.008 Sum_probs=20.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||+|.+++.
T Consensus 260 ~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 260 GVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 456777899999999999999986
No 239
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=41.66 E-value=15 Score=36.81 Aligned_cols=24 Identities=13% Similarity=0.133 Sum_probs=20.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++--.|.+.+|.+|||+.+|++
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhc
Confidence 456777899999999999999975
No 240
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=41.48 E-value=20 Score=34.25 Aligned_cols=22 Identities=14% Similarity=0.155 Sum_probs=18.4
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+-..|++.+|.+||+|.+++.
T Consensus 239 ~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 239 DFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHccCCcccCCCHHHHhc
Confidence 4445899999999999999864
No 241
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=41.24 E-value=17 Score=36.51 Aligned_cols=31 Identities=16% Similarity=0.139 Sum_probs=24.6
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHH--HHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAK--LCHTR 651 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~--L~~~~ 651 (659)
.+..+...|.+.+|.+||+|.+++.- +..++
T Consensus 266 ~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 266 LAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 35677788999999999999999875 54443
No 242
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=41.21 E-value=21 Score=33.87 Aligned_cols=24 Identities=17% Similarity=-0.024 Sum_probs=20.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||++.+|++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhc
Confidence 456777899999999999999874
No 243
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=41.19 E-value=22 Score=34.04 Aligned_cols=23 Identities=22% Similarity=0.411 Sum_probs=19.0
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+-..|.+.+|.+||++.+++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhh
Confidence 34445799999999999999875
No 244
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=41.03 E-value=19 Score=35.13 Aligned_cols=25 Identities=12% Similarity=0.324 Sum_probs=21.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++.-.|.+.+|.+||++.+|+..
T Consensus 243 l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 243 FVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 4456668999999999999999873
No 245
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=40.77 E-value=19 Score=34.23 Aligned_cols=22 Identities=14% Similarity=0.188 Sum_probs=18.4
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
++-..|.+.+|.+||+|.+++.
T Consensus 233 ~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 233 DFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHhhcCcccCcCHHHHhc
Confidence 4455799999999999999874
No 246
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=40.36 E-value=19 Score=35.56 Aligned_cols=25 Identities=16% Similarity=0.239 Sum_probs=21.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+...|.+.+|.+||++.+++..
T Consensus 271 ~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 271 FHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 4556678999999999999999874
No 247
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=39.04 E-value=16 Score=35.16 Aligned_cols=25 Identities=8% Similarity=0.098 Sum_probs=20.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++.-.|.+.+|.+||++.+++.-
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcC
Confidence 3355567999999999999998753
No 248
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=38.93 E-value=24 Score=34.15 Aligned_cols=25 Identities=12% Similarity=0.057 Sum_probs=21.4
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++...|.+.+|.+||++.+|+.
T Consensus 254 ~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 254 EGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHhhccCcccCCCHHHHhh
Confidence 3567778899999999999999875
No 249
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=38.69 E-value=22 Score=34.89 Aligned_cols=25 Identities=16% Similarity=0.238 Sum_probs=21.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++..+|.+.+|.+||+|.+++..
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 4455678999999999999999765
No 250
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=38.67 E-value=23 Score=34.39 Aligned_cols=25 Identities=8% Similarity=0.022 Sum_probs=20.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+..+.-.|.+.+|.+||+|.+++.
T Consensus 257 ~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 257 EALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHHHHHHhccChhhCCCHHHHhh
Confidence 3556667899999999999999875
No 251
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=38.58 E-value=25 Score=33.89 Aligned_cols=25 Identities=20% Similarity=0.361 Sum_probs=20.5
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++...|.+.+|.+||++.+++..
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhC
Confidence 3455567999999999999999764
No 252
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=38.51 E-value=23 Score=35.22 Aligned_cols=25 Identities=12% Similarity=0.171 Sum_probs=21.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+.-.|.+.+|.+||+|.+|...
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhC
Confidence 4456668999999999999999874
No 253
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=38.29 E-value=21 Score=35.17 Aligned_cols=25 Identities=12% Similarity=0.178 Sum_probs=20.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+--.|.+.+|.+||+|.+|+..
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcC
Confidence 3444558999999999999999873
No 254
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=37.98 E-value=18 Score=34.18 Aligned_cols=24 Identities=13% Similarity=0.200 Sum_probs=19.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||+|.+++.
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHhCChhhCcCHHHHhc
Confidence 345667899999999999999874
No 255
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=37.91 E-value=22 Score=33.88 Aligned_cols=24 Identities=13% Similarity=0.145 Sum_probs=20.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++.-+|.+.+|.+||++.+|+.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 456778899999999999999875
No 256
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=37.48 E-value=24 Score=35.38 Aligned_cols=25 Identities=20% Similarity=0.381 Sum_probs=20.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++--.|.+.+|.+||++.+++.-
T Consensus 277 l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 277 FQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC
Confidence 4456667999999999999999764
No 257
>KOG3763 consensus mRNA export factor TAP/MEX67 [RNA processing and modification]
Probab=37.25 E-value=20 Score=37.69 Aligned_cols=65 Identities=18% Similarity=0.060 Sum_probs=38.9
Q ss_pred CCCCCCeEECCCCCCCCCC--cccccCCCCCCEEECCCC--cccccchhhhc--CCCCCCeeeCcCCcCcccC
Q 038552 398 ACVSLEYLNISRNFFHGII--PLSLSSLKSIKEFNVSSN--NLSGLIPEFLK--NLSFMEFLDLSYNHFEGEV 464 (659)
Q Consensus 398 ~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n--~l~~~~~~~l~--~l~~L~~l~l~~n~l~~~~ 464 (659)
+.+.+..++|++|++...- ..--...|+|+.|+|++| .+... ..+. ....|++|-+.+|++....
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~--~el~K~k~l~Leel~l~GNPlc~tf 286 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSE--SELDKLKGLPLEELVLEGNPLCTTF 286 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcch--hhhhhhcCCCHHHeeecCCccccch
Confidence 4456667777777765321 111134588999999999 33321 2222 2335788889999886543
No 258
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=37.11 E-value=21 Score=35.77 Aligned_cols=26 Identities=12% Similarity=0.112 Sum_probs=22.1
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+..+...|.+.+|.+||+|.+++..
T Consensus 267 ~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 267 KALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 35677788999999999999998764
No 259
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=36.76 E-value=28 Score=33.42 Aligned_cols=21 Identities=19% Similarity=0.274 Sum_probs=16.9
Q ss_pred HhcCCCCCcCCCChHHHHHHHH
Q 038552 627 VLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 627 l~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
..|. .+|.+||++.+|..+|.
T Consensus 248 ~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 248 QFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHh-cCcccccCHHHHHHHhc
Confidence 3454 48999999999999873
No 260
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=36.50 E-value=24 Score=34.76 Aligned_cols=25 Identities=12% Similarity=0.110 Sum_probs=21.2
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+.++...|.+.+|.+||++.+++.
T Consensus 283 ~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 283 EGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hHHHHHHHHcccCcccCcCHHHHhc
Confidence 4567778899999999999998864
No 261
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=36.30 E-value=24 Score=34.39 Aligned_cols=23 Identities=13% Similarity=0.171 Sum_probs=19.9
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+-..|.+.+|.+||++.+++.
T Consensus 264 ~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 264 KDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHhccCchhcCCHHHHhc
Confidence 46778899999999999999874
No 262
>PTZ00382 Variant-specific surface protein (VSP); Provisional
Probab=35.83 E-value=51 Score=25.94 Aligned_cols=6 Identities=0% Similarity=0.124 Sum_probs=2.3
Q ss_pred eEEEeh
Q 038552 509 LRVLIP 514 (659)
Q Consensus 509 ~~~~i~ 514 (659)
..++++
T Consensus 69 agi~vg 74 (96)
T PTZ00382 69 AGISVA 74 (96)
T ss_pred EEEEee
Confidence 333333
No 263
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=35.63 E-value=24 Score=33.27 Aligned_cols=29 Identities=24% Similarity=0.193 Sum_probs=24.5
Q ss_pred HHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
.++--.|..++|.+||.-..||-+|++++
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34444599999999999999999999875
No 264
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=35.56 E-value=20 Score=34.89 Aligned_cols=28 Identities=11% Similarity=-0.089 Sum_probs=22.9
Q ss_pred HHHhHhcCCCCCcCCCChHHHHHHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVAKLCHT 650 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~~L~~~ 650 (659)
..+...|.+.+|.+||++++|...|+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 3455679999999999999999888654
No 265
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=35.43 E-value=26 Score=33.47 Aligned_cols=23 Identities=17% Similarity=0.203 Sum_probs=19.0
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+-..|.+.+|.+||+|.+|..
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhc
Confidence 44556799999999999998864
No 266
>PF15102 TMEM154: TMEM154 protein family
Probab=35.26 E-value=35 Score=28.89 Aligned_cols=9 Identities=56% Similarity=1.073 Sum_probs=3.9
Q ss_pred ceEEEehHH
Q 038552 508 LLRVLIPVV 516 (659)
Q Consensus 508 ~~~~~i~~~ 516 (659)
++.++|+.+
T Consensus 58 iLmIlIP~V 66 (146)
T PF15102_consen 58 ILMILIPLV 66 (146)
T ss_pred EEEEeHHHH
Confidence 344444433
No 267
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=35.20 E-value=26 Score=34.35 Aligned_cols=22 Identities=9% Similarity=-0.005 Sum_probs=19.2
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
++...|.+.+|.+||+|.+|+.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 4556799999999999999987
No 268
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=35.06 E-value=25 Score=34.30 Aligned_cols=24 Identities=8% Similarity=0.012 Sum_probs=20.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|++.+|.+||++.+++.
T Consensus 264 ~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 264 GEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHHhccCcccccCHHHHhc
Confidence 456667899999999999999864
No 269
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=35.03 E-value=30 Score=32.93 Aligned_cols=25 Identities=12% Similarity=0.191 Sum_probs=20.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+-..|++.+|.+||++.+++..
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 3455556999999999999999874
No 270
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=34.75 E-value=30 Score=34.58 Aligned_cols=32 Identities=19% Similarity=0.316 Sum_probs=25.0
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHHH--HHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVAK--LCHTRE 652 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~~--L~~~~~ 652 (659)
.+..+...|.+.+|.+|||+.+|++- +..+++
T Consensus 283 ~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 283 AFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 45677888999999999999999753 455444
No 271
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=34.74 E-value=30 Score=34.64 Aligned_cols=24 Identities=8% Similarity=0.062 Sum_probs=20.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||++.+++.
T Consensus 268 ~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 268 ALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHHHccCCcccCCCHHHHhc
Confidence 556778899999999999999864
No 272
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=34.70 E-value=31 Score=34.55 Aligned_cols=24 Identities=21% Similarity=0.439 Sum_probs=20.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+||++.|+..
T Consensus 275 ~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 275 FQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred HHHHHHHhccCCcccCcCHHHHhh
Confidence 456777899999999999999964
No 273
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=34.48 E-value=26 Score=34.48 Aligned_cols=24 Identities=13% Similarity=0.068 Sum_probs=20.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||++.+++.
T Consensus 283 ~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 283 ALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHHhcCChhhccCHHHHhc
Confidence 456788899999999999999874
No 274
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=33.96 E-value=28 Score=34.87 Aligned_cols=24 Identities=17% Similarity=0.062 Sum_probs=20.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||++.||+.
T Consensus 266 ~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 266 ALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHHHcCcCcccCCCHHHHhc
Confidence 346667799999999999999985
No 275
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=33.76 E-value=28 Score=35.06 Aligned_cols=25 Identities=16% Similarity=0.064 Sum_probs=20.9
Q ss_pred HHHHHhHhcCCCCCcCCCChHHHHH
Q 038552 621 AIIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 621 ~~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+..+...|.+.+|.+||++.+|..
T Consensus 273 ~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 273 LAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHHHhCCCChhhCCCHHHHhc
Confidence 3556777899999999999999864
No 276
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=33.75 E-value=28 Score=34.11 Aligned_cols=24 Identities=8% Similarity=-0.022 Sum_probs=20.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++--.|.+.+|.+||++.+|+.
T Consensus 275 ~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 275 ALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHccCChhhCCCHHHHhc
Confidence 456667799999999999999874
No 277
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=33.66 E-value=30 Score=32.72 Aligned_cols=24 Identities=17% Similarity=0.121 Sum_probs=20.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||++.+|+.
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhc
Confidence 446667899999999999999874
No 278
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=33.64 E-value=30 Score=33.65 Aligned_cols=25 Identities=12% Similarity=0.208 Sum_probs=21.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+.++-..|.+.+|..||+|.+|+..
T Consensus 246 l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 246 FKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhC
Confidence 4466778999999999999999763
No 279
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=33.13 E-value=27 Score=33.82 Aligned_cols=24 Identities=8% Similarity=-0.014 Sum_probs=19.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+|||+.+++.
T Consensus 257 ~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 257 GRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHhcCChhhcCCHHHHhc
Confidence 345667799999999999999864
No 280
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=33.12 E-value=31 Score=33.04 Aligned_cols=24 Identities=8% Similarity=0.104 Sum_probs=19.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||++.+|..
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhc
Confidence 345666799999999999998864
No 281
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=32.91 E-value=33 Score=32.70 Aligned_cols=23 Identities=13% Similarity=-0.038 Sum_probs=18.9
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+--.|++.+|.+||++.++.+
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhh
Confidence 34556799999999999999864
No 282
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=32.81 E-value=30 Score=35.08 Aligned_cols=24 Identities=8% Similarity=0.045 Sum_probs=20.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+-..|.+.+|.+|||+.|+++
T Consensus 287 ~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 287 ARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHHHHhcCCchhcCCHHHHhc
Confidence 456677899999999999999886
No 283
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=32.60 E-value=35 Score=33.42 Aligned_cols=24 Identities=8% Similarity=-0.024 Sum_probs=20.0
Q ss_pred HHHhHhcCCCCCcCCCChHHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.++-..|.+.+|.+||++.+|+..
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhC
Confidence 345567999999999999999873
No 284
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=32.45 E-value=31 Score=33.67 Aligned_cols=22 Identities=14% Similarity=0.039 Sum_probs=18.4
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
++-..|.+.+|++||++.||+.
T Consensus 268 ~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 268 DLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHHhccCccccCCHHHHhc
Confidence 4445799999999999999874
No 285
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=32.39 E-value=28 Score=33.67 Aligned_cols=22 Identities=14% Similarity=0.239 Sum_probs=18.4
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
++...|.+.+|.+||++.+|++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhc
Confidence 4455799999999999999865
No 286
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=32.30 E-value=30 Score=33.69 Aligned_cols=23 Identities=17% Similarity=0.148 Sum_probs=19.1
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.++...|.+.+|.+||||.+++.
T Consensus 265 ~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 265 EDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHhCcCcccCcCHHHHhc
Confidence 35567899999999999999863
No 287
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=32.09 E-value=31 Score=33.68 Aligned_cols=24 Identities=8% Similarity=-0.007 Sum_probs=19.8
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+||++.|++.
T Consensus 267 ~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 267 GLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHccCChhhcCCHHHHhc
Confidence 445667799999999999999864
No 288
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=31.77 E-value=32 Score=33.31 Aligned_cols=23 Identities=9% Similarity=-0.018 Sum_probs=19.1
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.++-..|.+.+|.+||+|.+|+.
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 34556899999999999998864
No 289
>PLN00181 protein SPA1-RELATED; Provisional
Probab=31.76 E-value=31 Score=39.55 Aligned_cols=23 Identities=13% Similarity=0.096 Sum_probs=19.6
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+..+|.+.+|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 35556799999999999999975
No 290
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=31.35 E-value=31 Score=33.53 Aligned_cols=24 Identities=8% Similarity=0.067 Sum_probs=20.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+.-.|.+.+|.+||++.+++.
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHcc
Confidence 456667799999999999999885
No 291
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=30.99 E-value=39 Score=33.39 Aligned_cols=25 Identities=12% Similarity=0.097 Sum_probs=20.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+--.|.+.+|.+||++.+|+..
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhC
Confidence 3455568999999999999998764
No 292
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=30.79 E-value=31 Score=34.69 Aligned_cols=30 Identities=7% Similarity=-0.087 Sum_probs=23.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH--HHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK--LCHTR 651 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~--L~~~~ 651 (659)
+.++-..|.+.+|.+||++.+|+.- ++..+
T Consensus 273 ~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 273 AVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 4466677999999999999999853 44444
No 293
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=30.78 E-value=36 Score=34.09 Aligned_cols=25 Identities=12% Similarity=0.066 Sum_probs=21.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+-..|.+.+|.+||++.+++..
T Consensus 270 ~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 270 ALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhC
Confidence 4566778999999999999998763
No 294
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=30.56 E-value=35 Score=33.13 Aligned_cols=24 Identities=8% Similarity=-0.054 Sum_probs=19.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+||++.++..
T Consensus 261 ~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 261 GAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHHHhccCcccCCCHHHHhc
Confidence 346666899999999999998863
No 295
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=29.76 E-value=28 Score=33.08 Aligned_cols=27 Identities=15% Similarity=0.041 Sum_probs=21.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAKLC 648 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~L~ 648 (659)
+..+-..|.+.+|..||++.+|.+.|+
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 345556688999999999988877664
No 296
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=29.75 E-value=17 Score=39.91 Aligned_cols=35 Identities=20% Similarity=0.258 Sum_probs=31.5
Q ss_pred HHHHHHHHHhHhcCCCCCcCCCChHHHHHHHHHHH
Q 038552 617 ECLNAIIRTGVLCSMESPFERMDMRDIVAKLCHTR 651 (659)
Q Consensus 617 ~~~~~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~ 651 (659)
+|-..+-++.+.|=|.+..+||.-.++|.+|+.+.
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 66667889999999999999999999999998764
No 297
>PF05393 Hum_adeno_E3A: Human adenovirus early E3A glycoprotein; InterPro: IPR008652 This family consists of several early glycoproteins (E3A), from human adenovirus type 2.; GO: 0016021 integral to membrane
Probab=29.63 E-value=62 Score=24.47 Aligned_cols=15 Identities=13% Similarity=0.308 Sum_probs=6.5
Q ss_pred HHHHHHHHhhhcccC
Q 038552 524 SCLTIIYARRRRFAH 538 (659)
Q Consensus 524 ~~~~~~~~~~~~~~~ 538 (659)
++.++.++.+|+|.+
T Consensus 48 VilwfvCC~kRkrsR 62 (94)
T PF05393_consen 48 VILWFVCCKKRKRSR 62 (94)
T ss_pred HHHHHHHHHHhhhcc
Confidence 333444444444443
No 298
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=29.10 E-value=39 Score=33.76 Aligned_cols=25 Identities=16% Similarity=0.105 Sum_probs=20.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+...|.+.+|.+||++.+++..
T Consensus 264 ~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 264 AIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4455566999999999999998653
No 299
>PF05454 DAG1: Dystroglycan (Dystrophin-associated glycoprotein 1); InterPro: IPR008465 Dystroglycan is one of the dystrophin-associated glycoproteins, which is encoded by a 5.5 kb transcript in Homo sapiens. The protein product is cleaved into two non-covalently associated subunits, [alpha] (N-terminal) and [beta] (C-terminal). In skeletal muscle the dystroglycan complex works as a transmembrane linkage between the extracellular matrix and the cytoskeleton [alpha]-dystroglycan is extracellular and binds to merosin ([alpha]-2 laminin) in the basement membrane, while [beta]-dystroglycan is a transmembrane protein and binds to dystrophin, which is a large rod-like cytoskeletal protein, absent in Duchenne muscular dystrophy patients. Dystrophin binds to intracellular actin cables. In this way, the dystroglycan complex, which links the extracellular matrix to the intracellular actin cables, is thought to provide structural integrity in muscle tissues. The dystroglycan complex is also known to serve as an agrin receptor in muscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular junction. There is also evidence which suggests the function of dystroglycan as a part of the signal transduction pathway because it is shown that Grb2, a mediator of the Ras-related signal pathway, can interact with the cytoplasmic domain of dystroglycan. In general, aberrant expression of dystrophin-associated protein complex underlies the pathogenesis of Duchenne muscular dystrophy, Becker muscular dystrophy and severe childhood autosomal recessive muscular dystrophy. Interestingly, no genetic disease has been described for either [alpha]- or [beta]-dystroglycan. Dystroglycan is widely distributed in non-muscle tissues as well as in muscle tissues. During epithelial morphogenesis of kidney, the dystroglycan complex is shown to act as a receptor for the basement membrane. Dystroglycan expression in Mus musculus brain and neural retina has also been reported. However, the physiological role of dystroglycan in non-muscle tissues has remained unclear [].; PDB: 1EG4_P.
Probab=29.07 E-value=18 Score=34.92 Aligned_cols=14 Identities=29% Similarity=0.496 Sum_probs=0.0
Q ss_pred ccCCcccHHHHHHH
Q 038552 548 KQFPMVSYAELSKA 561 (659)
Q Consensus 548 ~~~~~~~~~eL~~A 561 (659)
.+.+.+=-+|++.|
T Consensus 189 KGiPvIF~dElee~ 202 (290)
T PF05454_consen 189 KGIPVIFQDELEES 202 (290)
T ss_dssp --------------
T ss_pred cCCceecccccccc
Confidence 45555555666653
No 300
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=28.85 E-value=42 Score=32.73 Aligned_cols=24 Identities=8% Similarity=-0.057 Sum_probs=19.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+-..|.+.+|.+||++.+|+.
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhc
Confidence 334556689999999999999975
No 301
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=28.77 E-value=44 Score=32.42 Aligned_cols=23 Identities=13% Similarity=0.130 Sum_probs=19.4
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+...|.+.+|.+||++.++..
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhc
Confidence 34556799999999999999886
No 302
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=28.60 E-value=37 Score=33.30 Aligned_cols=22 Identities=9% Similarity=0.016 Sum_probs=18.8
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+...|.+.+|.+||+|.+|+.
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhh
Confidence 4456799999999999999986
No 303
>PHA03265 envelope glycoprotein D; Provisional
Probab=28.21 E-value=57 Score=31.95 Aligned_cols=29 Identities=17% Similarity=0.415 Sum_probs=12.7
Q ss_pred cceEEEehHHHHHHHHHHHHHHHHHhhhc
Q 038552 507 TLLRVLIPVVVSCLILSSCLTIIYARRRR 535 (659)
Q Consensus 507 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 535 (659)
..++++++..++.++++..+.+++||||+
T Consensus 348 ~~~g~~ig~~i~glv~vg~il~~~~rr~k 376 (402)
T PHA03265 348 TFVGISVGLGIAGLVLVGVILYVCLRRKK 376 (402)
T ss_pred cccceEEccchhhhhhhhHHHHHHhhhhh
Confidence 34555555554444333333333444443
No 304
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=27.99 E-value=42 Score=33.98 Aligned_cols=23 Identities=13% Similarity=0.170 Sum_probs=19.0
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.++--.|.+.+|.+||++.||++
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 34445799999999999999976
No 305
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=27.95 E-value=46 Score=31.76 Aligned_cols=22 Identities=5% Similarity=-0.201 Sum_probs=18.2
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+--.|.+.+|.+||++.+|+.
T Consensus 242 ~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 242 DFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhh
Confidence 3445799999999999999875
No 306
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=27.83 E-value=38 Score=33.54 Aligned_cols=23 Identities=17% Similarity=0.166 Sum_probs=19.4
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+--.|.+.+|.+||+|.+++.
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 34555899999999999999885
No 307
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=27.46 E-value=41 Score=32.55 Aligned_cols=24 Identities=17% Similarity=-0.042 Sum_probs=19.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+||++.+|+.
T Consensus 257 ~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 257 GIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 345556699999999999999874
No 308
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=27.06 E-value=46 Score=33.31 Aligned_cols=24 Identities=17% Similarity=0.181 Sum_probs=20.7
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||++.||+.
T Consensus 289 ~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 289 AIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHcCCCchhccCHHHHhc
Confidence 456778899999999999999985
No 309
>PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ]. Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q.
Probab=26.99 E-value=21 Score=25.28 Aligned_cols=10 Identities=30% Similarity=0.199 Sum_probs=0.0
Q ss_pred eEEEehHHHH
Q 038552 509 LRVLIPVVVS 518 (659)
Q Consensus 509 ~~~~i~~~~~ 518 (659)
.+++++.++.
T Consensus 12 aavIaG~Vvg 21 (64)
T PF01034_consen 12 AAVIAGGVVG 21 (64)
T ss_dssp ----------
T ss_pred HHHHHHHHHH
Confidence 3444444433
No 310
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=26.48 E-value=50 Score=31.56 Aligned_cols=24 Identities=17% Similarity=0.301 Sum_probs=20.3
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++...|.+.+|.+||++.+++.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhc
Confidence 446778899999999999999864
No 311
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=26.25 E-value=45 Score=33.73 Aligned_cols=24 Identities=13% Similarity=0.051 Sum_probs=20.9
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+||++.|++.
T Consensus 287 ~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 287 ARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhc
Confidence 456778899999999999999985
No 312
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=26.20 E-value=49 Score=31.50 Aligned_cols=22 Identities=9% Similarity=-0.002 Sum_probs=18.7
Q ss_pred HHhHhcCCCCCcCCCChHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~ 645 (659)
.+--.|.+.+|.+||++.+++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhh
Confidence 4445799999999999999875
No 313
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=26.06 E-value=63 Score=35.87 Aligned_cols=29 Identities=10% Similarity=0.086 Sum_probs=24.8
Q ss_pred HHhHhcCCCCCcCCCChHHHHHHHHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVAKLCHTRE 652 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~~L~~~~~ 652 (659)
.+--.|.+++|.+||++-+|...+-.++.
T Consensus 285 ~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 285 DLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 44456999999999999999999988865
No 314
>PHA03209 serine/threonine kinase US3; Provisional
Probab=26.01 E-value=39 Score=34.29 Aligned_cols=21 Identities=10% Similarity=-0.140 Sum_probs=17.7
Q ss_pred HhHhcCCCCCcCCCChHHHHH
Q 038552 625 TGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 625 val~C~~~~p~~RP~M~~Vv~ 645 (659)
+--.|++.+|.+|||+.||+.
T Consensus 330 li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 330 LVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHHcCCcccCcCHHHHhc
Confidence 444689999999999999874
No 315
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=25.21 E-value=51 Score=32.81 Aligned_cols=30 Identities=17% Similarity=0.133 Sum_probs=23.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH--HHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK--LCHTR 651 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~--L~~~~ 651 (659)
+..+-..|.+.+|.+||++.+++.. +.+++
T Consensus 265 ~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 265 AIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 4566677999999999999999874 44444
No 316
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=24.97 E-value=47 Score=32.58 Aligned_cols=23 Identities=4% Similarity=-0.151 Sum_probs=19.7
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+-..|.+.+|.+|||+.||+.
T Consensus 263 ~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 263 AELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHHhcCCcccCcCHHHHhc
Confidence 45667799999999999999986
No 317
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=24.68 E-value=50 Score=33.70 Aligned_cols=24 Identities=17% Similarity=0.127 Sum_probs=20.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||++.+++.
T Consensus 264 ~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 264 AVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHhCCCChhhCcCHHHHhc
Confidence 446677899999999999999875
No 318
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=23.78 E-value=56 Score=31.92 Aligned_cols=20 Identities=15% Similarity=0.323 Sum_probs=17.0
Q ss_pred HhcCCCCCcCCCChHHHHHH
Q 038552 627 VLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 627 l~C~~~~p~~RP~M~~Vv~~ 646 (659)
-.|.+.+|.+||++.++++.
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 253 DLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHccCChhHCcCHHHHhhC
Confidence 34888999999999999863
No 319
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=23.15 E-value=60 Score=31.47 Aligned_cols=24 Identities=8% Similarity=-0.017 Sum_probs=20.0
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++-..|.+.+|.+||++.+++.
T Consensus 260 ~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 260 LLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHHHccCCcccCCCHHHHhc
Confidence 456667799999999999998764
No 320
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=22.73 E-value=58 Score=31.43 Aligned_cols=23 Identities=13% Similarity=0.086 Sum_probs=19.3
Q ss_pred HHHhHhcCCCCCcCCCChHHHHH
Q 038552 623 IRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 623 ~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
..+...|.+.+|.+||++.+|..
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 34555699999999999999976
No 321
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=22.69 E-value=67 Score=31.47 Aligned_cols=23 Identities=13% Similarity=0.104 Sum_probs=19.1
Q ss_pred HHhHhcCCCCCcCCCChHHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+--.|.+.+|.+||++.+|+..
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhC
Confidence 44457889999999999999873
No 322
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=22.31 E-value=58 Score=32.76 Aligned_cols=24 Identities=8% Similarity=0.098 Sum_probs=20.1
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+...|.+.+|.+||++.+|+.
T Consensus 276 ~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 276 ALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHHHhCCCchhccCHHHHhC
Confidence 446667799999999999999874
No 323
>PRK13281 succinylarginine dihydrolase; Provisional
Probab=22.27 E-value=43 Score=33.47 Aligned_cols=41 Identities=20% Similarity=0.370 Sum_probs=31.4
Q ss_pred ChHHHHHHHhccc--cccccccccchhhhccccchhhhhHHHHHHHHHHHHHHhH
Q 038552 575 TLHEYAKMALQEK--VMEIIDPSLLMDVIENNSKIREDRRAKLEECLNAIIRTGV 627 (659)
Q Consensus 575 ~l~~~~~~~~~~~--~~~i~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~val 627 (659)
.|-.||.+.|+++ ..++.||.|..+.. ...+++..++++|-
T Consensus 394 ~L~~wV~~hYRd~L~~~DLaDP~Ll~E~r------------~ALdeLtqiL~LGs 436 (442)
T PRK13281 394 RLNAWVDRHYRDRLTPADLADPQLLRESR------------TALDELTQILDLGS 436 (442)
T ss_pred HHHHHHHHhccccCChhhccCHHHHHHHH------------HHHHHHHHHhcccc
Confidence 5789999999998 56899999975433 23477888887764
No 324
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=21.92 E-value=60 Score=32.04 Aligned_cols=24 Identities=8% Similarity=0.022 Sum_probs=20.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+..+-..|.+.+|.+|||..|+++
T Consensus 290 ~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 290 VFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHHHhccCcccccCHHHHhc
Confidence 455667899999999999999874
No 325
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=21.83 E-value=61 Score=31.66 Aligned_cols=23 Identities=9% Similarity=0.024 Sum_probs=19.5
Q ss_pred HHhHhcCCCCCcCCCChHHHHHH
Q 038552 624 RTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 624 ~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
.+-..|.+.+|.+||++.+++..
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 44567999999999999999875
No 326
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=21.56 E-value=66 Score=34.49 Aligned_cols=25 Identities=8% Similarity=0.014 Sum_probs=20.4
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVAK 646 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~~ 646 (659)
+..+.-.|.+.+|.+||++.+++..
T Consensus 273 l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 273 MQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHcccChhhCcCHHHHHhC
Confidence 3456667999999999999998763
No 327
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=20.94 E-value=55 Score=34.60 Aligned_cols=24 Identities=17% Similarity=0.387 Sum_probs=21.6
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+++++-.|.+.+|..||++.++++
T Consensus 603 li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 603 LIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHHHHHhcCcccCCCcHHHhc
Confidence 678888999999999999999875
No 328
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=20.74 E-value=91 Score=36.14 Aligned_cols=37 Identities=22% Similarity=0.300 Sum_probs=31.0
Q ss_pred HHHHHHhHhcCCCCCcCCCChHHHHHHHHHHHHhhhc
Q 038552 620 NAIIRTGVLCSMESPFERMDMRDIVAKLCHTRESFLG 656 (659)
Q Consensus 620 ~~~~~val~C~~~~p~~RP~M~~Vv~~L~~~~~~~~~ 656 (659)
.++-+|=..|-+.+|++||+-++++..+..+.....+
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 3556788889999999999999999999888765543
No 329
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=20.57 E-value=66 Score=31.04 Aligned_cols=24 Identities=13% Similarity=0.163 Sum_probs=19.2
Q ss_pred HHHHhHhcCCCCCcCCCChHHHHH
Q 038552 622 IIRTGVLCSMESPFERMDMRDIVA 645 (659)
Q Consensus 622 ~~~val~C~~~~p~~RP~M~~Vv~ 645 (659)
+.++--.|.+.+|.+||+..|++.
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 255 FIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHHHhCCChhhCcCHHHHhc
Confidence 344555899999999999998864
No 330
>TIGR03241 arg_catab_astB succinylarginine dihydrolase. Members of this family are succinylarginine dihydrolase (EC 3.5.3.23), the second of five enzymes in the arginine succinyltransferase (AST) pathway.
Probab=20.57 E-value=49 Score=33.14 Aligned_cols=41 Identities=22% Similarity=0.454 Sum_probs=31.2
Q ss_pred ChHHHHHHHhccc--cccccccccchhhhccccchhhhhHHHHHHHHHHHHHHhH
Q 038552 575 TLHEYAKMALQEK--VMEIIDPSLLMDVIENNSKIREDRRAKLEECLNAIIRTGV 627 (659)
Q Consensus 575 ~l~~~~~~~~~~~--~~~i~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~val 627 (659)
.|-.||.+.|+++ ..++.||.|..+.. ...+++..++++|-
T Consensus 396 ~L~~wV~~hYRdrL~~~DLaDP~Ll~E~r------------~ALDeLtqiL~LGs 438 (443)
T TIGR03241 396 TLNAWVDRHYRDRLSAADLADPQLLIECR------------TALDELTQILNLGS 438 (443)
T ss_pred HHHHHHHHhccccCChhhccCHHHHHHHH------------HHHHHHHHHhcCcC
Confidence 5789999999998 56899999975433 23477888887663
No 331
>PF12191 stn_TNFRSF12A: Tumour necrosis factor receptor stn_TNFRSF12A_TNFR domain; InterPro: IPR022316 The tumour necrosis factor (TNF) receptor (TNFR) superfamily comprises more than 20 type-I transmembrane proteins. Family members are defined based on similarity in their extracellular domain - a region that contains many cysteine residues arranged in a specific repetitive pattern []. The cysteines allow formation of an extended rod-like structure, responsible for ligand binding []. Upon receptor activation, different intracellular signalling complexes are assembled for different members of the TNFR superfamily, depending on their intracellular domains and sequences []. Activation of TNFRs can therefore induce a range of disparate effects, including cell proliferation, differentiation, survival, or apoptotic cell death, depending upon the receptor involved []. TNFRs are widely distributed and play important roles in many crucial biological processes, such as lymphoid and neuronal development, innate and adaptive immunity, and maintenance of cellular homeostasis []. Drugs that manipulate their signalling have potential roles in the prevention and treatment of many diseases, such as viral infections, coronary heart disease, transplant rejection, and immune disease []. TNF receptor 12 (also known as TWEAK receptor, and fibroblast growth factor-inducible-14 (Fn14)) has been implicated in endothelial cell growth and migration []. The receptor may also play a role in cell-matrix interactions [].; PDB: 2KN0_A 2RPJ_A 2KMZ_A 2EQP_A.
Probab=20.24 E-value=59 Score=26.66 Aligned_cols=7 Identities=29% Similarity=0.790 Sum_probs=0.0
Q ss_pred HHHHhhh
Q 038552 528 IIYARRR 534 (659)
Q Consensus 528 ~~~~~~~ 534 (659)
++|||.|
T Consensus 99 lv~rrcr 105 (129)
T PF12191_consen 99 LVWRRCR 105 (129)
T ss_dssp -------
T ss_pred HHHhhhh
Confidence 3334333
No 332
>PF04996 AstB: Succinylarginine dihydrolase; InterPro: IPR007079 Succinylarginine dihydrolase (AstB) transforms N(2)-succinylglutamate into succinate and glutamate. This enzyme is the second in the five-step ammonia-producing arginine succinyltransferase pathway, the major pathway in Escherichia coli and in other related bacteria for arginine catabolism as a sole nitrogen source. AstB assumes a five-stranded alpha/beta propeller structure, placing it in the amidinotransferase (AT) superfamily of proteins, which are characterised by their Cys-His-Glu active site triad [].; GO: 0009015 N-succinylarginine dihydrolase activity, 0006525 arginine metabolic process; PDB: 1YNH_B 1YNF_B 1YNI_C.
Probab=20.12 E-value=51 Score=33.08 Aligned_cols=40 Identities=20% Similarity=0.391 Sum_probs=25.3
Q ss_pred ChHHHHHHHhccc--cccccccccchhhhccccchhhhhHHHHHHHHHHHHHHh
Q 038552 575 TLHEYAKMALQEK--VMEIIDPSLLMDVIENNSKIREDRRAKLEECLNAIIRTG 626 (659)
Q Consensus 575 ~l~~~~~~~~~~~--~~~i~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~va 626 (659)
.|..||.+.|+++ ..++.||.|..+.. ...+++..++++|
T Consensus 391 ~L~~wV~~hYRd~L~~~DLaDP~Ll~E~r------------~AldeLt~iL~Lg 432 (439)
T PF04996_consen 391 RLNQWVDRHYRDRLTPADLADPQLLNESR------------TALDELTQILGLG 432 (439)
T ss_dssp HHHHHHHHH--S-B-GGGGG-HHHHHHHH------------HHHHHHHHHTT--
T ss_pred HHHHHHHHhCcccCChhhccCHHHHHHHH------------HHHHHHHHHhcCC
Confidence 5789999999998 56899999975432 2347777777776
Done!